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Abstract
Abstract
The isolated perfused eye of many species has become a frequently used model in the 
study of ocular phannacology. Due to its availability, cheapness and comfortable 
size for experimental use the bovine eye provides an attractive model for conducting 
perfusion experiments. Although initially rejected by Kishida et al. (1985), the 
bovine perfused eye has been proved to be a valid model for studying aqueous 
humour dynamics and the phamiacology o f various antiglaucoma drugs, including 
the P-adrenoceptor antagonist, timolol, and the carbonic anhydrase inhibitor, MK- 
927 (Wilson et al., 1993). A general aim o f this study was to develop the in vitro 
bovine perfused eye, to show whether it is a useful model for experimental work in 
studying dmg mechanisms in the eye, whether from a phaniiacodynamic or 
phamiacokinetic point o f view.
Pharmacodynamic Study
The procedure for dissection and setting up o f the constant flow method for the 
bovine perfused eye was initially described by Wilson and co-workers (1993). 
Bovine eyes, obtained from the local abattoir, were cannulated via the long posterior 
ciliary artery and perfused with Krebs’ solution. In order to monitor drug effects on 
intraocular pressure the anterior chamber was cannulated and connected to a water 
manometer. Since some drugs affect vascular resistance, the arterial perfusion 
pressure was continuously measured. Drug solutions or vehicles were administered 
by one o f three routes; (i) by addition of drug to the perfusate reservoir at an exact
Abstract
concentration, (ii) as a bolus dose injected intra-arterially or (iii) as a bolus dose 
injected intracamerally.
Constriction o f the pupil, in response to pilocarpine (10'^’ M), shown by a significant 
decrease in pupil diameter, indicated that following intra-arterial administration, 
drugs have access to the anterior segment o f the eye, including the iris sphincter and 
therefore very probably the ciliaiy muscle, since their arterial supply is common.
To investigate the bovine perfused eye as a model for studying intraocular pressure 
and aqueous humour dynamics, we studied four different drugs known to alter either 
aqueous humour fomiation or aqueous humour outflow. The drugs used were 
pilocarpine, a cholinergic agonist; apraclonidine, an a^-adrenergic agonist; and the 
prostaglandins, PGF,^ and PGE^
Pilocarpine (3 x lO'^ - 5 x 10'^ M) was found to cause a significant increase in 
intraocular pressure, suggesting that the drug might be increasing intraocular pressure 
by disrupting the integrity of the blood-aqueous barrier. In order to test this bovine f;
Iserum albumin (1% w/v) was included in the perfusate and aqueous humour sampled
at the end of the experiment was assayed for protein content. However, after f
■‘i
including bovine serum albumin in the perfusate intraocular pressure was found to be 
reduced significantly by three concentrations of pilocarpine, 10'  ^ M, 3 x 10'^ ’ M and y
l-O'-LM. Pilocarpine did not significantly increase protein content in the aqueous
Ihumour, indicating that the observed increases in intraocular pressure are not due to a rf
breakdown in the blood-aqueous barrier. No satisfactory explanation for this ii
;
■
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anomaly could be found.
Intra-arterial injection o f high doses o f apraclonidine (100 and 300 nmol) produced a 
biphasic response characterised by a significant large increase in intraocular pressure 
during the initial 30 min period after drug injection followed by a smaller increase 
over the next 60 min. Intracameral injection o f apraclonidine did not significantly 
increase intraocular pressure. As vascular perfusion pressure was significantly 
increased following intra-arterial, but not intracameral injection o f the drug, this 
suggests that the increase in perfusion pressure, presumably due to a-adrenoceptor 
mediated vasoconstriction, contributes to the concurrent increase in intraocular 
pressure.
Intra-arterial injection o f PGF,^ (20 - 2000 nmol) failed to decrease intraocular 
pressure in eyes perfused with Ki'ebs’ solution or Krebs’ solution supplemented with 
bovine serum albumin. PGF^^ also did not affect aqueous humour protein 
concentration, indicating that the blood-aqueous barrier remains intact following 
drug administration.
PGE,, administered as bolus doses injected by the intra-arterial or intracameral route, 
shows a trend towards an elevated protein concentration in the aqueous humour. 
However, due to large variation this only produced statistical significance following 
intra-arterial injection of 60 nmol or intracameral injection of 600 nmol. No direct 
correlation was found between aqueous protein concentration and intraocular 
pressure. Expression of the data as a scatter plot of all the individual experiments
i i i
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indicates that more than one population o f data exists. The data show that as 
intraocular pressure values increase above 165 mm H^O, the associated protein 
concentrations either remain normal or increase markedly to a level indicating 
breakdown of the blood-aqueous barrier.
Although previous investigations, in a variety o f species, have shown reductions in 
intraocular pressure in response to administration o f pilocarpine, apraclonidine or 
prostaglandins, there were no intraocular pressure -lowering effects observed in the 
bovine perfused eye. The lack o f a correlation between the bovine perfused eye and 
other species in the intraocular pressure response to pilocarpine, PGF,„ and PGE, is 
not surprising due to anatomy o f the bovine eye. The lack o f functional activity in 
the ciliary muscle (Prince et aL, 1960) coupled with the observed I OP responses 
suggests that this preparation is not suitable for investigating lOP-lowering drugs 
which act primarily on AH outflow. However, the model is useful for investigating 
lOP-lowering drugs that act primarily by altering AH formation (Wilson et aL, 
1993).
Pharmacokinetic Study
The effects on ocular drug absorption o f different formulations o f the anti-viral drug, 
aciclovir, were studied utilising single time point determinations. Variation in 
absorption caused by experimentally induced corneal damage was also assessed. 
Different formulations o f aciclovir were tested in three different vehicles; (i) a 
standard ocular ointment, white soft paraffin; (ii) a novel vehicle, polyvinylalcohol
iv
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(PVA) film; (iii) an experimental aqueous gel. As well as leaving the cornea 
undamaged, with the barrier function o f the epithelium intact, the cornea was 
damaged both physically, by removing the epithelium, and chemically, by alkali 
burning, in an attempt to mimic the damage to the cornea associated with herpes 
simplex virus infection.
180 min after topical application of the drug formulations, aqueous humour and 
corneal tissue were removed from the eye and added to acid extraction media for 
HPLC analysis and calculation o f the level of drug absorption.
Physically removing the layers o f the epithelium or exposing the cornea to alkali 
soaked discs o f filter paper provides two relatively reproducible methods o f inducing
experimental damage to the cornea o f the bovine perfused eye.
The results show that experimentally damaging the cornea, effectively removing the 
barrier properties of the comeal epithelium, increases the amount of aciclovir 
absorption in the cornea and aqueous humour compared with the undamaged cornea. 
The observed increases in absorption o f aciclovir following experimental damage are 
much greater when the drug formulations have hydrophilic properties, such as the 
PVA film and aqueous gel. From the present work, the formulations can be ranked 
in order of corneal and aqueous humour absorption of aciclovir;
Ointment < PVA Film < Aqueous Gel
■II
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In this model the level o f drug penetration in the cornea and aqueous humour can be 
measured without the complications associated with in vivo studies. Due to the lack 
o f in vivo factors such as blinking, drug dilution, drainage and conjunctival 
absorption the levels o f absorption found in the present model are likely to be 
exaggerated. Nevertheless, the bovine perfused eye provides a useful model for 
pharmacokinetic studies, which is perhaps superior to the isolated corneal preparation 
nomially used to assess corneal dmg absoiption since conditions are more 
physiological and no edge-damage has been inflicted on the cornea.
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GENERAL INTRODUCTTON 
Gross anatomy of the bovine eve
Through the process o f evolution, the bovine eye has developed into a fluid-filled 
sphere, whose relative rigidity provides the optical alignment o f the cornea, lens and 
retina, which is necessary for vision (Figure 1).
The globe o f the eye consists o f three layers. The outermost, protective layer is made 
up o f the opaque sclera and the transparent cornea, which are joined together at the 
corneoscleral limbus. The middle layer, the uvea, is mainly vascular, consisting of 
the choroid, ciliary body and iris. The innermost layer, the retina, contains the 
essential nervous elements necessary for vision, the pigment epithelium, rods, cones 
and bipolar cells.
Within the eye three chambers are enclosed: the vitreous cavity, the anterior chamber 
and the posterior chamber. The vitreous cavity is the largest and is located behind 
the lens and ciliaiy body and adjacent to the retina. This chamber is filled with a 
clear jelly, the vitreous humour. AH, a transparent colourless fluid, which supplies 
nutrients to the avascular structures of the eye, fills the anterior and posterior 
chambers. The anterior chamber contains most o f the aqueous and is located 
between the iris and the posterior surface of the cornea. The posterior chamber is 
smaller and is located between the iris and the lens. The two chambers communicate 
through the pupil.
y
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Choroid
Vitreous chamberSclera
Ciliary body
Cornea
LensAnterior chamber
Pupil
Iris
Posterior chamber
Ora ciliaris retinae Retina
anterior posterior
Figure 1. Vertical section o f  the bovine eye, showing the prominent gross struetnres. 
The eye is not drawn to scale. Dimensions: 28 - 30 mm antero-posteriorly; 30 mm 
vert really. Adapted from ‘Atlas o f  Bovine Anatom y’ (Pasquini, 1982).
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The transparent comea o f the bovine eye covers the anterior surface of the globe and 
represents the major refractive component of the eye. The cornea is roughly oval­
shaped with horizontal and vertical measurements ranging from 27 -  34.5 mm and 20 
-  30.5 mm respectively (Doughty et al.^ 1995; Prince et al., 1960). Studies on 
bovine corneas have produced a range of central corneal thickness values generally 
falling in the range o f 725 -  1450 pm (Doughty, 1997; Doughty et at., 1995; Lee & 
Davison, 1984; Merindano et a t ,  1998; Prince et aL, 1960). Regardless of 
thickness, bovine corneal dimensions evaluated within 3 hr post mortem have a 
uniform thickness, within ± 3%, from centre to edge (Doughty et al., 1995). A 
positive correlation has also been shown between the horizontal comeal diameter and 
central corneal thickness (Doughty et al., 1995).
The bovine cornea consists of four layers (anterior to posterior): the epithelium, 
stroma, Descemet’s membrane and endothelium (Samuelson, 1991).
The outermost comeal layer, the epithelium, is approx. 1 4 - 1 8  cell layers thick 
(Diescem, 1975; Prince et al., 1960) and usually measures about 90 pm in thickness 
(Prince et al., 1960). In the mammalian eye, intercellular tight junctions (zonula 
occhidens) surround the most superficial cells of the corneal epithelium (G rass & 
Robinson, 1988b). In contrast to primates and humans, Bowman’s layer, which is 
located beneath the basement membrane, is not present in the bovine cornea (Table 
1). ■
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The comeal stroma is a highly hydrophilic tissue containing mostly water, which 
constitutes the bulk o f the corneal tissue in mammalian species (Maurice & Riley, 
1970; Maurice, 1984; Samuelson, 1991). The stroma has long been recognised for 
its capacity to absorb water and is composed o f an extracellular matrix of 
proteoglycans and lamellar ananged collagen fibrils running parallel to the comeal 
surface (Maurice & Riley, 1970; Maurice, 1984; Pepose & Ubels, 1992). The 
regular arrangement of collagen fibrils is essential for normal visual acuity (Jarvinen 
et al., 1995).
Descemet’s membrane located between the stroma and endothelium, ranges from 10 
-  25 pm in thickness (Prince et al., 1960). This layer, consisting of type IV 
collagen, laminin and fibronectin, is highly resistant to proteolytic enzymes.
A single layer o f endothelial cells, which adhere to Descemet’s membrane, covers the 
posterior surface o f the cornea. This layer is approx. 6 pm thick in the bovine comea 
(Diescem, 1975; Prince et al., 1960). In mammals the endothelium is believed to 
constitute <1 % of the total corneal tissue (Grass & Robinson, 1988b; Maurice & 
Riley, 1970). Histological examination has shown that the bovine corneal 
endothelium consists o f a continuous mosaic o f uniformly polyglonal cells (Doughty 
et al., 1995).
Tire dens is a transparent crystalline structure, located immediately posterior to the 
iris and is supported by a series o f fibres called the suspensory ligaments, which are 
attached to the ciliary body. Doughty et al. (1995) calculated the lens wet mass to be
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approx. 2.5g in a population of 20 bovine eyes.
The iris, the most anterior portion of the uvea, located between the comea and the 
crystalline lens, is darkly pigmented and appears black or brown in colour. In the 
bovine eye, the pupil is oval and horizontally orientated (Diescem, 1975; Prince et 
al., 1960). As in the horse, the pupil o f the bovine eye is held relatively immobile by 
radially arranged muscle fibres at the 3 and 9 o’clock positions. When the pupil is 
fully dilated it becomes almost circular. The iris is covered by two layers of 
epithelia, which are continuous forward extensions of the pigmented and non- 
pigmented epithelial layers o f the ciliary body.
The ciliary body extends from the termination point o f the retina, the ora ciliaris 
retinae, to the iris root (Prince et al., 1960). There is no evidence of any great deal 
o f functional activity in the bovine ciliary body and the ciliary muscle is relatively 
long with very few circular or radial muscle fibres (Prince et al., 1960). This 
suggests that like other ungulates the ability for accommodation in the bovine eye is 
limited (Diescem, 1975). This is probably due to a combination o f the rudimentary 
circular and radial ciliary muscle fibres (Prince et al., 1960), great size of lens and 
relative weakness o f the lens capsule (Walls, 1963).
In contrast to primates, there is no scleral spur found in the bovine eye (Table 1). 
Instead the iris is supported against the contractile forces o f the ciliary and sphincter 
(pupillary constriction) muscles, by the pectinate ligament (Walls, 1963). This tissue 
is very well developed in ungulates and consists of heavy connective tissue fibres.
Introduction: General
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which run from the îimbal region o f the fibrous tunic to the root o f the iris.
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Finger-like ridges, the ciliary processes, project from the ciliary body and 
occasionally the posterior surface o f the iris. The large processes are each 3 -5  mm 
in length and number approx. 90 - 110 in bovine and 70 in humans (Prince et al.,
1960). Ciliary epithelium, lining the ciliary processes, are the cells responsible for 
aqueous humour (AH) production.
Ocular circulation
The bovine eye has a vascularisation where the majority o f the blood flow is supplied 
by the ciliary artery (Figure 2) (Prince et aL, 1960). This is in contrast with primate 
and human eyes, where the principal supply is derived from the internal ophthalmic 
artery (Table 1).
The vascular supply to the orbit is mainly provided by the external ophthalmic artery, 
the largest branch o f the internal maxillary artery, a continuation of the external 
carotid artery. Branches o f the external ophthalmic artery include the external 
arterial rete and lacrimal artery.
The ciliary artery, which originates from the external rete, bifurcates into the larger 
medial and smaller lateral ciliary arteries, which travel parallel to each other and the 
optic nerve. Both arteries branch into several short posterior ciliary arteries at the 
globe, which penetrate the sclera near the optic nerve at the posterior pole of the
Introduction: General
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globe. Two branches o f the medial ciliary artei*y each form a long posterior ciliary 
artery, which pass superficially within the sclera across the medial and lateral sides 
o f the globe, penetrating fully before the equator is reached. The small internal 
ophthalmic artery, which travels along the surface of the optic nerve, anastamoses 
with the medial long posterior ciliary artery a few millimetres short of the posterior 
pole o f the globe.
The short posterior arteries form a capillary layer adjacent to the retina known as the 
choriocapillaris, which is responsible for the nutrition o f the outermost layer o f the 
retina. After entering the sclera beyond the equator, the long posterior ciliary arteries 
run anteriorly through the choroid to the ciliary body where they anastomose with the 
anterior ciliary arteries to form the well developed major arterial circle at the 
periphei-y o f the iris (Diescem, 1975). The major arterial circle supplies the ciliary 
body and iris, as well as providing a minor contribution to the choroidal circulation 
in some species.
Blood from the choroid, iris and ciliary processes drain into the episcleral veins, 
which run through the sclera, continuing into the four vortex veins, which emerge 
through the sclera at each quadrant of the equator. Four vortex veins, one in each 
quadrant o f the eye, drain blood from the anterior uvea o f the eye. After leaving the 
globe the vortex veins join to the supraorbital vein, the inferior orbital vein and the 
external rete, which after anastomotic communication, join the orbital vein (Prince et 
a/., 1960).
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Table 1. Anatomical differences between the human and bovine eye
Feature Human eye Bovine eye
Globe dimensions 21-26 mm (antero-posterior) 28-30 mm (antero-posterior)
23-25 (diameter) 30 mm (diameter)
Main arterial blood 
supply
Internal ophthalmic artery Ciliary artery
Distance from iris root to 
ora serrata/ ora ciliaris 
retinae
6 mm 6.5 mm
Ciliary muscle Well developed Poorly developed
Lens dimensions ~4 mm (antero-posterior) -13.3 mm (antero-posterior)
-1 0  mm (diameter) -19.5 mm (diameter)
Lens Volume (cnV) 0.2 2.2
Accommodation Extensive Limited
Termination point of 
retina/ start of ciliaiy 
body
Ora semata Ora ciliaris retinae
Scleral Spur Present Absent (well developed 
pectinate ligament)
Anterior Chamber 
Volume (cnV)
0.35 1.7
Ciliary Processes -70 90-110
Pupil Circular Oval (transverse)
Comeal dimensions -11.7 mm (horizontal) 27-34.5 mm (horizontal)
-10.6  mm (vertical) 20-30.5 mm (vertical)
Comeal thickness (total) -500  pm (central) 725-1450 pm (thickness
-1000 pm (peripheral) relatively unifonn)
Corneal epithelium 5 - 6 cell layers 14-18 cell layers
50-60 pm thick -9 0  pm thick
Bowman’s layer Present 
8-14 pm thick
Absent
Descemet’s membrane 8-12 pm thick 10-25 pm thick
Corneal endothelium 1 cell layer 1 cell layer
Polygonal mosaic Polygonal mosaic
5-6 pm thick 6 pm thick
"I
y
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Adapted from Cole (1970), Doughty (1997), Doughty et al. (1995), Forrester et al. 
(1996), Prince et al. (1960), Ross & Romrell (1989), Shahidullah (1994), Tripathi 
& Tripathi (1984), Williams & Warwick (1980).
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Ciliary epithelium
The ciliary processes project inwards from ciliary body into the posterior chamber. 
Structurally, each process consists o f a mass o f capillaries surrounded by loose 
connective tissue (stroma), covered by an epithelial layer.
In the mammalian eye the ciliaiy epithelium, which separates the stroma of the 
ciliary processes from the AH and vitreous humour, consists o f a hi layer o f cells. 
The inner layer, in direct contact with the AH and vitreous humour, is non-pigmented 
epithelium (NPE). The outer layer is heavily pigmented (PE), and lies between the 
NPE and the ciliary stroma. In rabbits these epithelia show characteristics consistent 
with secretory epithelia, such as basal infoldings and interdigitations o f the lateral 
surfaces of adjacent cells (Pappas & Smelser, 1958). These characteristics are 
found to be more developed in the NPE cells. Since the secreted AH must be derived 
from blood plasma and the extracellular fluid in the stroma o f the ciliary processes, 
and secretion must occur across both epithelial layers, the relationship between the 
epithelial layers is very important. The PE and NPE cells lie apex-to-apex (Figure 
3). Therefore, the basal surface o f the PE cells faces the ciliary stroma, and the basal 
surface of the NPE cells faces the AH.
Several studies have demonstrated that the ciliary epithelium of the mammalian eye 
is densely populated by a variety of specialised intercellular junctions (Figure 3). In 
the rabbit and primate eye it has been shown that zonula occludenta, zonula 
adhaerens, gap junctions and desmosonies connect the NPE to one another, whereas
10
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Figure 3. Schem atic diagram o f  nonpigmented and pigm ented epithelial cells, 
show ing the apex-to-apex relationship. BI, basal infolding; BM , basement 
membrane; CC, ciliary channels; DES, desm osonies; FE, fenestrated 
capillary endothelial; GJ, gap junction; MEL, m elanosom e; MIT, 
microchondrion; RBC, red blood cell; RER, rough endoplasm ic reticulum; TJ, 
tight junction. (Caprioli,  1992).
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gap junctions, puncta adhaerentia and desmosoines connect PE ceils to one another 
and to NPE cells (Raviola & Raviola, 1978). The ciliary epithelium is also the site 
o f the attachment of suspensory ligaments. The physiological and anatomical 
functions necessary for maintaining the continuous flow o f AH and the mechanical 
stability o f the epithelium depend upon the specialised intercellular junctions.
The zonula occludenta, or tight junctions, found at the apex between NPE cells, 
represent the permeability barrier that prevents the diffusion of blood-borne 
macromolecules into the AH of rabbit and primate eyes (Raviola, 1974; Raviola, 
1977; Smith & Rudt, 1973). Freeze-fracturing techniques show that zonula 
occludenta are only found connecting the lateral surfaces o f the NPE cells. Although 
zonula occludenta between NPE cells are impermeable to macromolecules, it is 
believed they only restrict the paracellular movement o f ions and small molecules 
without preventing it altogether (Raviola & Raviola, 1978).
Gap junctions are found at the interface between PE and NPE cells, interconnecting 
the lateral surfaces of the PE cells and, to a lesser extent, the lateral surfaces of the 
NPE cells (Lütjen-Drecoll, 1982). Gap junctions mediate the electricEil and 
metabolic coupling between cells, therefore the extensive connections between cells 
in the ciliary epithelium suggests that epithelial cells function as a syncytium (Green 
et al,^ 1985; Gilula et a/., 1972; Pappas et uL, 1971; Wiederhoit & Zaduiiaisky, 
1986). It is therefore likely that gap junctions allow the passage o f intracellular ions 
and small molecules between the epithelial layers (Gilula et al., 1972; Pappas et al., 
1971; Raviola & Raviola, 1978).
12
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Desmosonies are commonly found between the lateral surfaces of the NPE cells, and 
in small numbers between PE cells and the interface of the two epithelial layers. It is 
generally accepted that the function o f desmosonies is intercellular cohesion 
(Raviola & Raviola, 1978). In the ciliary epithelium they probably provide the 
mechanical stability to withstand the forces exerted on the ciliary zonule by 
contraction and relaxation o f the ciliary muscle during accommodation o f the lens 
(Raviola, 1971).
Blood-aqueous barrier
The presence o f a barrier, preventing the free movement of molecules from blood 
plasma into the AH is well known. This results in aqueous that is much different in 
composition than blood plasma or a simple ultrafiltrate o f plasma.
Tight junctions between the apices of NPE cells o f the ciliary epithelium and 
posterior surface o f the iris represents the principal site of the blood-aqueous barrier 
(BAB). In the rabbit and primate eye the existence o f this barrier has been observed 
experimentally by the impermeability o f the NPE cell layer to the tracer molecule, 
horseradish peroxidase (Raviola, 1974; Raviola, 1977; Smith & Rudt, 1973).
Tire _ anterior surface of the iris is devoid o f epithelia, permitting free exchange of 
macromolecules between AH circulating in the anterior chamber and the iris stroma. 
However, the blood vessels, in contrast with vessels in the ciliary processes, are lined
13
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with an impermeable endothelial barrier (Raviola, 1977).
Under normal conditions the functional integrity of the blood-aqueous bam er 
excludes large molecules from the AH. However, the presence of a low level of 
protein in the AH of normal eyes (<1% of plasma protein concentration) 
demonstrates that the barrier function is not absolute (Novak & Leopold, 1988) or 
else that some proteins are secreted by the NPE. If lOP is experimentally depressed 
below venous pressure the direction o f flow o f AH out o f the eye is reversed and 
large amounts of plasma proteins enter the anterior chamber from the canal of 
Schlemm which fills with venous blood (Raviola, 1974).
Aqueous humour
AH is a transparent colourless fluid formed from plasma by the epithelial cells of the 
ciliary processes. AH fulfils three main functions; the continuous formation and 
drainage of aqueous helps to: 1. maintain intraocular pressure; 2. meet the metabolic 
requirements of the avascular structures of the eye, the lens, cornea, drainage 
meshwork and anterior vitreous, by delivering oxygen and nutrients, and removing 
waste products; 3. maintain a transparent and colourless medium between the 
posterior cornea and the lens (Millar & Kaufman, 1995).
14
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Aqueous humour formation
AH is formed continuously by the ciliaiy epithelium. The formation of AH in the 
mammalian eye is widely believed to occur by ultrafiltration of blood plasma into the 
stroma and then active transport o f ions, followed by diffusion o f water, across the 
PE and NPE into the posterior chamber (Bill, 1975; Brubaker, 1991).
It is now widely accepted that the active transport of solutes across the ciliary 
epithelium against a concentration gradient acts as the driving force behind AH 
formation, contrary to previous beliefs of a simple process of diffusion or 
ultrafiltration (Caprioli, 1992). In the mammalian eye the rate o f AH formation is 
believed to depend on the rate o f active transport by the ciliary epithelium (Cole, 
1977).
Ultrafiltration favours the movement o f water from the plasma into the ciliary 
stroma, but water cannot filter freely from the stroma into the posterior chamber 
(Bill, 1975). It was calculated that hydrostatic and oncotic pressures across the 
ciliary epithelium would favour reabsorption o f AH into the ciliary processes if 
ultrafiltration was the driving force behind AH formation (Figure 4). Assuming an 
lOP o f 15 mm Hg and a stromal oncotic pressure o f 14 mm Hg due to protein 
leakage through the fenestrated capillaries, capillary hydrostatic pressure would have 
to exceed 29 mm Hg in order to drive an ultrafiltrate. Values for capillary 
hydrostatic pressure in the rabbit have been estimated between 27 - 28 mm Hg (Bill,
1975) and 25 - 33 mm Hg (Cole, 1977). It has been calculated that capillary
15
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Cap i l lary hydrostatic 
pressure < 30  mm Hg
'  N onpigm ented  epithelium
Oncotic 
pressure  
=  14mmHg
m Stromo
VenuleArteriole
= 15 mm Hg
Pigmented epithelium
Figure 4. Schem atic diagram o f  the hydrostatic forces involved in the production ol 
AH in the mammalian eye (Caprioli,  1992).
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hydrostatic pressure values exceeding 50 mm Hg would be required to drive 
ultrafiltration at a rate sufficient to produce normal AH flow (Green & Pedersen, 
1972). Therefore the net pressures do not favour ultrafiltration as a driving force for 
AH formation.
Histochemical studies show a large population of active enzyme systems on the 
basolateral membranes o f the rabbit NPE layer, including NaVK" -ATPases, adenylate 
cyclase and carbonic anhydrase (Bhattacherjee, 1971; Kaye & Pappas, 1965; 
Mishima et aL, 1982; Shiose & Sears, 1966; Tsiikahara & Maezawa, 1978). In 
the rabbit the NPE has also been shown to have a greater development of 
intracellular organelles and a higher metabolic rate than the PE (Cameron & Cole, 
1963). NaVlC-ATPase is a membrane-bound enzyme that catalyses the hydrolysis of 
ATP providing the energy to pump N a‘ and IC. Cardiac glycosides, such as ouabain 
or digoxin, inhibit the action NaVlC-ATPase and decrease the rate of aqueous 
fomiation by approx. 70% in a variety of species, including rabbits and primates 
(Becker, 1963; Bonting & Becker, 1964; Cole, 1977). Decreases in AH production 
due to inhibition of Na'-transport by cardiac glycosides suggest that N a’ is the 
actively transported ion, with C f or HCOf following to maintain electroneutrality 
(Figure 5). Recent investigations into the role of ion channels in aqueous formation 
indicate that N a'- IC- CF cotransporters are responsible for entry o f ions into the PE 
from the ciliary stroma in the bovine (Edelman et al., 1994) and human eye (Jacob 
& Civan, 1996; Millar & Kaufman, 1995; Von Brauchitscli & Cook, 1993). 
After entry into the syncytium, the ions are free to diffuse into the NPE cells via gap 
junctions, where they are transported across the basolateral membrane (Edelman et
17
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Figure 5. I'he transport and m ovem ent o f  elem ents responsible for the secretion o f  
salts and water into the AH. Gap junctions (gj) connect pigmented (PE) and non- 
pigmented (NPE) ciliary epithelial cells, fonning a functional syncytium (Jacob & 
C'ivan, 1996).
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al., 1993). There is also evidence of a basolateral N a‘-lC -C f cotransporter located in 
human NPE cells which may play a role in AH formation (Crook et al., 1992; Von 
Brauchitscli et al., 1990). However, administration of bumetanide, an inhibitor of 
the N a-K ^-C f cotransporter, did not affect AH formation, questioning its 
contribution to aqueous formation (Gabelt et aL, 1997).
Measurements o f electrical potential across the rabbit and bovine isolated ciliary 
epithelia indicate that the aqueous is positive with respect to the stroma (Cole, 
1961a; 1961b; 1962). Ouabain has been shown to reduce the transepithelial 
potential virtually to zero (Cole, 1961a; Krupin et al., 1984; Sears et al., 1991). 
These studies confirm the hypothesis that active transport o f Na" is responsible for 
generating the transepithelial potential and is the primary driving force behind AH 
secretion.
Chloride secretion is now believed to play an important role in AH formation (Cheii 
& Sears, 1997). Early experiments, in the rabbit eye, indicated that active transport 
o f C f may occur, although the magnitude o f this transport was thought to be small 
compared with Na' (Cole, 1969). Active C f transport across the rabbit and cat 
isolated ciliary body preparation has been shown, indicating that the transport of Cf 
may be an important part o f the secretory process (Holland & Gipson, 1970; 
Kisliida et aL, 1983). It has been suggested that C f entry into the rabbit and bovine 
RE is. due to Na"- IC- C f cotransport and C17 HCOf exchange (Carré et al., 1992; 
Heilbig et al., 1988). The identification of C f channels in the NPE and C f currents 
across the NPE suggests that C f channels may play a major role in the secretion of
19
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CI into the rabbit, bovine and human aqueous (Coca-Prados et aL, 1995; Chen &
Sears, 1997; Edelman et al., 1995; Jacob & Civan, 1996). The secretion of IC 
through selective channels is thought to be critical in providing the electrical 
potential to drive C f secretion (Edelman et aL, 1995; Jacob & Civan, 1996). Na^- 
IC- C f cotransporters and C f/ HCOf exchangers located in NPE cells are also 
believed to contribute to C f secretion into the rabbit and human AH (Crook &
Polansky, 1994; Matsui et aL, 1996; Murakami et aL, 1992).
Acetazolamide is a potent inhibitor of carbonic anhydrase (CA), which catalyses the 
reaction H^O + CO, HCOf + H". Systemic treatment with acetazolamide and 
other specific CA inhibitors decrease lOP through a reduction in the rate of aqueous 
secretion by 40 - 60% (Becker, 1959; Becker & Constant, 1955; Garg & Oppelt,
1970; Maren, 1967). Evidence suggests that acetazolamide directly affects the 
transport mechanisms of the ciliary epithelium (Cole, 1977). Acetazolamide 
decreases the rate of Na"" and HCOf transport into the posterior chamber by 
equimolar amounts in dogs and primates (Maren, 1976). Transepithelial electrical 
measurements in the isolated rabbit iris-ciliary body indicate that NaVK'-ATPase and 
HCOf are required for active ion transport (Krupin et aL, 1984). These studies 
suggest a coupling in the movement o f Na' and HCOf into the posterior chamber.
However, the exact mechanism is not known. Several hypotheses have been
-
postulated; (i) inhibition of CA causes a decrease in HCOf available for movement 
into-the intercellular channels between the NPE cells to maintain electroneutrality,
(ii) a decrease in H availability may inhibit NaVlC-ATPase, (hi) decreased, 
availability of H produced by CA catalysed reaction decreases NaVff exchange,
A
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reducing the availability o f intracellular N a‘ to be transported into the intercellular :v
channel (Caprioli, 1992).
Intraocular flow of aqueous humour
After secretion into the posterior chamber, AH moves by bulk flow through the pupil 
aperture into the anterior chamber, flowing in a radially symmetrical fashion towards 
the periphery o f the anterior chamber and trabecular meshwork (Da vs on, 1990).
AH drains continuously from the anterior chamber o f the eye via two main outflow 
pathways: (a) the trabecular or conventional route and (b) the uveoscleral or 
unconventional route (Bill, 1975).
(a) Trabecular outflow is the main outflow pathway for almost all mammalian 
species. At the angle between the iris and the comeo-scleral junction, referred to as 
the anterior chamber angle, AH passes into the trabecular or, in the cow, the reticular 
meshwork (Figure 6). The reticular meshwork of the calf eye differs considerably 
from the laminated, trabecular meshwork o f primates (Ericksoii-Lamy et aL, 1988). 
The network consists o f an extensive uveal meshwork with relatively large open 
spaces known as the spaces of Fontana (Johnson et aL, 1990). After passing through 
the uveal meshwork aqueous then passes through the reticular meshwork. This area 
is .equivalent to the human corneo-scleral trabecular meshwork, but lacks the 
organisation found in the human eye (Grierson et aL, 1985). From the meshwork, 
aqueous passes into the aqueous collector vessels of the angular aqueous plexus,
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which comprises a system anatomically analogous to Schlemm’s canal in humans 
(Johnson et at., 1990; Samuelson, 1991). The angular aqueous plexus gathers 
aqueous which drains into the vortex veins, via the intrascleral and episcleral veins 
(Samuelson, 1991).
Fecnnafe
l i gaments
Aqueousvein
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aqueous plexus
Ret icu lar
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S p a c e s  o f  
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Figure 6. Schematic diagram of the calf outflow system (Johnson et aL, 1990).
(b) Uveoscleral (unconventional) outflow. As there is no epithelial bam er between 
the anterior chamber and the ciliary muscle, AH may freely pass between the ciliary 
muscle bundles. Aqueous flows through the iris roots, across the anterior surface of 
the ciliary body and into the interstitial spaces between the muscle bundles of the 
ciliary muscle. These spaces in turn open into the suprachoroidal spaces from which 
fluid can pass via the venous circulation through the sclera and into the episcleral 
tissues (Bill, 1975).
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Although there does not appear to be any specific information on uveoscleral 
drainage in the bovine eye, previous literature shows that the contribution of 
uveoscleral drainage to total AH outflow varies greatly among different species. In 
humans, the importance of uveoscleral flow has been investigated in older patients. 
Approx. 5 - 20% of the total drainage was due uveoscleral outflow, however this 
value may be larger for younger patients due to ciliaiy muscle degeneration with age 
(Shabo & Maxwell, 1973). Indirect calculations estimate that the uveoscleral 
outflow value may contribute as much as 35% of the total drainage in young adults 
(Nilsson, 1997). Uveoscleral flow is greatest amongst primates, contributing 30 - 
50% of total drainage (Bill, 1971). Cats also have a well developed ciliary muscle 
and uveoscleral outflow is believed to make a small contribution to total outflow 
(Bill, 1966). Rabbits have veiy poorly developed ciliary muscles resulting in 
practically no drainage of AH via the uveoscleral pathway (Bill, 1975).
i
After removal o f the meshwork tissue between the anterior chamber and the canal of 
Schlemm the resistance to outflow o f the bovine eye is reduced by approx. 52% 
(Erickson-Lamy et aL, 1988). This is similar to the 40 -  75% decrease in resistance 
seen in the enucleated monkey (Peterson et aL, 1971; Peterson & Jocson, 1974) 
and human eyes (Ellingsen & Grant, 1971; Ellingsen & Grant, 1972; Erickson- 
Lamy et aL, 1991; Grant, 1963; Rosenquist et aL, 1985). This indicates that the 
reticular meshwork contributes the main resistance to outflow and drainage through 
the.sc.lera only has a small contribution to resistance to outflow.
In the mammalian eye contraction o f the ciliary muscle by parasympathomimetic
23
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drugs, such as pilocarpine, decreases the resistance to outflow. As the ciliary muscle 
contracts the muscle bundles become more tightly packed resulting in shortening and 
thickening of the muscle. This pulls on the scleral spur which physically alters the 
spaces in the trabecular meshwork, increasing the drainage through Schlemm’s canal 
(Leopold & Diizmann, 1986; Tamm et aL, 1992). At the same time uveoscleral 
drainage is almost completed stopped as tighter packing o f the muscle bundles 
compresses the interstitial spaces within the ciliary muscle. Substances which 
produce a relaxation o f the ciliary muscle, such as atropine, have been shown to 
increase drainage through the uveoscleral route due to increased spaces between the 
muscle bundles. However, drainage through the trabecular meshwork and 
Schlemm’s canal is reduced because o f tight packing of trabecular meshwork pores 
(Bill, 1971). Although cholinergic and adrenergic nerve endings have been identified 
in the trabecular meshwork their role in the regulation of AH outflow is not known 
(Nomura & Smelser, 1974). There is now evidence o f a direct phannacological 
effect on the endothelium of the trabecular meshwork. Bârâny (1962) suggested that 
trabecular meshwork cells might be contractile after observing that pilocarpine 
injected into the anterior chamber directly affected outflow facility. Studies with 
isolated trabecular meshwork strips have demonstrated contractile responses to 
cholinergic agonists, adrenergic agonists and endothelin (Lepple-Wienliues et aL, 
1991a; 1991b; Wiederhoit et al., 1996) and relaxant responses to prostaglandins and 
nitric oxide (Kraiiss et aL, 1997; Weiderholt et aL, 1994). It has been suggested 
that the contractile responses of the trabecular meshwork is due to smooth muscle­
like spindle cells containing actin filaments (Coroiieo et aL, 1991; Fliigel et aL,
1991). Recently several different receptor types including cholinergic, a,-adrenergic,
24
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j3-adrenergic, endothelin and prostaglandin receptors have been identified in 
cultured human and bovine trabecular meshwork cells (Anthony et aL, 1998; 
Lepple-Wienhues et aL, 1994; Sharif, 1996; Stainer et aL, 1996). Using the 
bovine anterior segment perfusion model, where the anterior uvea has been 
completely removed, contraction of the trabecular meshwork itself in response to 
cholinergic agonists, adrenergic agonists and endothelin results in a decrease in 
outflow facility (Wiederhoit et aL, 1995). Flowever, these compounds also contract 
the ciliary muscle and increase outflow facility in the intact primate (Bill, 1969; 
Kaufman and Bârâny, 1976; Kaufman, 1985) and human eye ( Erickson-Lamy et 
al, 1991). Therefore it is believed that the influence on outflow facility of trabecular 
meshwork contraction is dominated by ciliary muscle tone (Wiederhoit et aL, 1995).
25
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Composition of aqueous humour
A number o f differences exist in AH as compared with plasma (Table 2).
Table 2. The concentration of electrolytes, low molecular weight solutes and 
protein in bovine and human AH, and human blood plasma.
Components Bovine AH Human AH Human Plasma
Electrolytes
Na" (niM) 143.8 - 149.5 142 1 3 0 -1 4 5
lC(m M ) 4.5 - 7.1 4 3 .5 -5 .0
Cf(m M ) 116.3 - 124 131 -  136 92 -  125
HCOf(mM) 36 20 2 4 - 3 0
Organic solutes
Ascorbate (mM) 2 1 .0 -  1.1 0 .0 4 -0 .0 6
Lactate (mM) 7 .6 -8 .2 4.5 0 .5 -  1.9
Glucose (mM) 2.17 2 .8 -3 .9 5 .6 -6 .4
Protein (mg.mU) 0 .2 -0 .8 0 .3 -0 .7 6 0 - 7 0
Adapted from Bito & Salvador (1970), Caprioli (1992), Carter et al. (1973), Cole 
(1970), Davson (1949), Davson (1990), Doughty (1995), Johnson et al, (1986) 
Midelfart (1991), Novack & Leopold (1988), Pavao et al. (1989), Samuelson 
(1991) and Shahidullah (1994).
Under nomial conditions the tight junctions o f the blood-aqueous barrier limit the 
aqueous protein concentration to less than 1% of plasma protein concentration 
(Davson, 1990; Pavao et al., 1989). The plasma protein concentration is approx. 73
26
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-  106 mg.ml'' in bovine (Pavao et al,, 1989) and approx. 60 - 70 mg.nii"’ in humans,
i
whereas in AH protein concentration is approx. 0.2 -  0.8 mg.ml'^ in bovine 
(Doughty, 1995; Pavao et al., 1989) and approx. 0.3 -  0.7 mg.ml ' in humans 
(Novack & Leopold, 1988). Although the aqueous protein concentrations are low, 
separation and identification o f AH by electrophoretic techniques have shown that all 
plasma proteins are present (Davson, 1990).
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The concentration o f electrolytes in AH, compared to human blood plasma are shown 
in table 2. Na" is the major cation found in AH in both bovine and human eye, being 
very similar in concentration to human plasma. However, the concentration o f major 
anions shown some species differences. In bovine AH, H CO f concentrations are 
higher and C f lower compared with human AH. A similar relationship exists 
between anion concentrations in the aqueous of rabbits and humans (Kinsey, 1967).
Exchange o f substances between the aqueous and surrounding tissues, due .to 
diffusion or secretion, occurs continuously. Therefore the normal composition of AH 
depends on diffusion from blood plasma, secretion across the ciliary epithelium plus 
the passive and active exchange of substances between the aqueous and tissues it 
bathes. The corneal endothelium acts as a fluid pump, constantly secreting fluid into 
the AH to keep the cornea in a clear, deturgesced state. However, the small volume 
of fluid secreted does not contribute significantly to the flow o f AH (Fischbarg & 
Lim, 1974).
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Changes in the composition of AH have been reported in diseased human eyes. For 
example, greater levels o f heavy molecular weight proteins, found only in trace 
quantities in the normal eye, have been detected in AH of patients with both 
phagocytic glaucoma and primary open-angle glaucoma (Epstein et aL, 1978; 
Kijlastra et al.^ 1989). It has been suggested that the increased levels of high 
molecular weight proteins in the AH obstructs aqueous outflow pathways resulting in 
increased IOP.
Intraocular pressure
Intraocular pressure (lOP) is necessary for the maintenance of shape, stability and 
alignment o f internal structures. lOP in the in vivo calf eye has been measured at 
16.5 ± 5.5 mm Hg (Booffel, 1964). This is similar to the value found in healthy 
human eyes, where the mean pressure normally maintained is approx, 15 mm Hg 
(Davson, 1990). In the human eye there are no changes in mean lOP values between 
the ages o f 10 and 70, or between the sexes.
The three main factors concerned with the maintenance of I OP are the rate of 
formation o f AH, the ease with which AH exits the anterior chamber through the 
trabecular meshwork into the canal of Schlemm, and the pressure in the episcleral 
veins into which the canal of Schlemm empties. This results in a dynamic 
equilibrium where small variations in either rate of formation or rate of outflow from 
the eye can result in large changes in I OP.
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AH flows from the posterior chamber through the pupil into the anterior chamber, 
exiting the eye by the main outflow pathways by bulk flow and this is pressure 
dependent. This has been incorporated into the modified Goldman equation:
F = C (P. - P J  or F = A P C 
This equation relates aqueous flow (F) to the facility o f outflow (C) and the pressure 
difference across the meshwork (AP). The pressure head responsible for driving AH 
outflow is the difference between TOP (P,) and episcleral venous pressure (PJ. 
Episcleral venous pressure is the pressure in the blood vessels into whieh AH finally 
drains. Increases in episcleral venous pressure decrease the pressure head for 
aqueous outflow, resulting in engorgement of intraocular vascular beds and increased 
lOP (Hart, 1992).
The glaucomas and ocular hypertension
The glaucomas are a complicated group o f disorders often associated, although not 
always, with abnormally high lOP resulting in damage to the optic nerve head and 
loss o f visual field (Leopold & Duzman, 1986; Serle, 1994). After cataracts and 
macular degeneration, glaucoma is the third leading cause of blindness in the United 
States (Adkins & Balfour, 1998). Recent estimates of worldwide prevalence predict 
that 67 million people will suffer from glaucoma by the year 2000 (Flanagan, 1998). 
Gli-nically the damage to the optic nerve head and associated loss of visual field is 
manifested as cupping o f the optic disk and optic atrophy. If left untreated gahicoma 
can lead to blindness (Adkins & Balfour, 1998).
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The boundaries between glaucoma, low-tension glaucoma and ocular hypertension 
are indistinct. Glaucoma is often associated with an lOP greater than 21 mm Hg. 
Low tension glaucoma is the condition whereby the pathological changes associated 
with glaucoma, such as cupping of the optic disc and loss of visual field, are present, 
but within the boundaries of normal lOP. Ocular hypertension is characterised by 
lOP exceeding 21 mm Hg, but without the pathological changes associated with 
glaucoma. Patients suffering from ocular hypertension are more likely to develop 
glaucoma and are often treated to lower lOP (Sommer, 1989; Jay, 1992).
Predisposing risk factors for the development of glaucoma include family history of 
the disease, myopia, diabetes mellitus, long term topical or systemic corticosteroid 
use and ethnic group (Adkins & Balfour, 1998).
There are two basic types o f glaucoma determined by the adequacy o f drainage of 
AH through the main outflow pathway, the trabecular meshwork: open angle (GAG) 
where the AH has free access to the trabecular meshwork in the anterior chamber 
angle, and closed-angle (GAG) where the peripheral iris is in contact with the cornea 
or trabecular meshwork impairing outflow of AH.
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THE PHARMACOT.OGY OF OCIJT.AR HYPOTENSIVE AGENTS 
Parasympathomimetic agents
Parasympathomimetic agents include both direct- and indirect-acting drugs. Direct- 
acting drugs act like pilocaipine at the muscarinic receptors; indirect-acting drugs 
inhibit cholinesterase, allowing acetylcholine to accumulate at the parasympathetic 
nerve endings (Hiirvitz et al.^ 1991).
The muscarinic agonist, pilocarpine, is the most commonly used direct-acting 
cholinergic agent and has been established as a glaucoma treatment for more than 
100 years (Zimmerman, 1981). The primary mechanism for pilocarpine-induced 
lOP reduction is by increasing facility o f outflow o f AH through the trabecular 
meshwork. Cholinergic agonists also produces miosis and accommodation of the 
lens (Abraham, 1985). In primates and humans, pilocarpine contracts the ciliary 
muscle and this pulls on the scleral spur resulting in mechanical deformation of the 
trabecular meshwork causing an increase in AH outflow facility (Bill, 1967; Bill, 
1971). The effect of pilocaipine on outflow is lost following functional 
disconnection o f the ciliary muscle from the scleral spur (Kaufman & Bârâny,
1976). Although enhancing drainage by the conventional route and lowering lOP, 
pilocarpine has been shown to stop uveoscleral drainage almost completely (Bill & 
Waliiider, 1966; Bill, 1967). Pilocarpine contracts the ciliary muscle, which then 
appears much tighter than relaxed muscle, compressing the interstitial spaces 
between muscle bundles (Bârâny & Roheii, 1965). The effects of muscarinic
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agonists can be reversed by muscarinic antagonists such as atropine, which relaxes 
the ciliary muscle tending to increase uveoscleral flow (Bill, 1971). Clinically, when 
the anterior chamber angle is shallow pilocaipine can cause a paradoxical increase in 
lOP by decreasing uveoscleral outflow (Bleiman & Schwartz, 1979).
There is evidence that muscarinic agonists exert some direct influence on AH 
formation. Bill and Walinder (1966) demonstrated a reduction in API formation by 
intracameral infusion o f pilocaipine in cynomolgus and vervet monkeys. Topical 
pilocaipine has also been shown to lower AH formation rates in the cynomolgus 
monlcey, although no significant change in TOP was observed (Miichi & Nagataki,
1983). On the other hand, perfused pilocarpine had no effect on AH formation rates 
in the arterially perflised enucleated rabbit eye (Kodama et aA, 1985). Pilocarpine 
has been shown by fluorophotometry to increase AH fomiation in the normal human 
eye (Nagataki & Brubaker, 1982).
q ,-adreuergic agonists
When applied topically the a^-adrenergic agonist, clonidine, is effective in reducing 
lOP (Harrison & Kaufman, 1977; Krieglstein et a f, 1978). However, as topically 
administered clonidine penetrates the blood-brain barrier, systemic hypotensive side 
effects are often associated with this drug (Harrison & Kaufman, 1977; Krieglstein 
et «/., 1978). The development of apraclonidine and brimonidine, derivatives of 
clonidine with minimal penetration of the blood-brain barrier, has significantly 
reduced the side effects whilst retaining clonidine's lOP lowering properties
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(Abrams et aL, 1987; Chien et aL, 1990; Serle et al., 1991; Yüskel et aL, 1992).
Topically applied apraclonidine or brimonidine has been shown to lower TOP in 
rabbits (Burke & Potter, 1986), cats (Burke & Potter, 1986), primates (Burke & 
Potter, 1986; Gabelt et aL, 1994;Manlapaz et aL, 1997; Serle et aL, 1991) and 
humans (Gharagozloo et aL, 1988; Lee et aL, 1984; Schuman, 1996; Toris et aL, 
1995a; 1995b). In monlceys, brimonidine was more potent and effective in reducing 
lOP although the effects o f apraclonidine were longer lasting (Gabelt et aL, 1994). 
It has been suggested that local vasoconstriction, mediated via ag-adrenergic 
stimulation, leading to a decreased blood flow to the ciliary processes could be 
responsible for the decreased aqueous flow and fall in lOP (Abrams et aL, 1987; 
Burke et aL, 1986; Krieglstein et aL, 1978). It is now generally accepted that 
adrenrgic agonists act to lower lOP by reducing AH formation (Gharagolozoo et aL, 
1998; Mittag & Tormay, 1985, Toris et aL, 1995). However a,-adrenergic agonists 
may reduce lOP by altering more than AH formation. It has been suggested that 
brimonidine and apraclonidine augment the local release o f prostaglandins, which 
may increase uveoscleral outflow, resulting in a reduction in lOP (Crawford & 
Kaufman, 1987; Gabelt & Kaufman, 1989; Nilsson et aL, 1989; Poyer et aL,
1992). The a,-adrenergic agonists brimonidine and oxymetazoline, but not 
apraclonidine have been shown to increase total AH outflow via the uveoscleral 
pathway (Toris et aL, 1995; Wang et aL, 1993). Brimonidine has no effect on 
trabecular outflow facility (Toris et aL, 1995a). Contradictory results have been 
reported on the effect of apraclonidine on trabecular outflow facility. One study 
shows apraclonidine does not change tonographic outflow facility (Robin & 
Pollack, 1988), whereas another shows that apraclonidine increases fluorometric
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outflow facility (Toris et al., 1995). It was suggested that the difference in outflow 
facility findings determined by tonography and fluorophotometry may be attributed 
to fundamental differences between the two techniques (Toris et al., 1995). 
Differences in the relative selectivity o f a^-adrenergic agonists for oi^-adrenoceptor 
subtypes (Bylund, 1988) may account for the differences obseiwed in their 
mechanisms o f action (Toris et al., 1995a; 1995b). It has also been demonstrated 
that apraclonidine, but not brimonidine lowers episcleral venous pressure by approx. 
1 mm Hg possibly due to decreased blood flow to the anterior uvea (Hurvitz et aL, 
1991; Toris et aL, 1995a; 1995b), resulting in an equivalent fall in IOP.
Receptor binding studies indicate a predominance of a ,-  and (3-adrenergic receptors
in the rabbit iris-ciliary body cell membrane (Mittag & Tormay, 1985) and human
iris and ciliary epithelium (Matsuo & Cynader, 1992). In vitro, brimonidine has
been shown to inhibit isoproterenol-stimulated cAMP accumulation in NPE cell
culture. This effect was prevented by pre-treatment with pertussis toxin, suggesting 
.the involvement o f inhibitory G proteins (Ogidigen et aL, 1993). Apraclonidine has 
also been shown to inhibit isoproterenol-stimulated cAMP accumulation in the 
isolated rabbit ciliary epithelial hi layer (Horio et aL, 1992) and rabbit whole ciliary 
processes (Bausher et at., 1989). This evidence suggests that the q^-adrenergic 
agonists may act by binding to q,-receptors in the ciliary epithelium which are 
negatively coupled to the membrane-bound enzyme adenylate cyclase, reducing the 
level o f cAMP production, which may lead to a reduction in AH formation (Gabelt 
et aL, 1994; Mittag & Tormay, 1985).
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Prostaglandins
Early studies on the effects of prostaglandins (PG) in the rabbit eye showed that high 
doses of topical application o f exogenous PG reproduced most o f the characteristic 
signs associated with acute ocular inflammation, such as increased lOP and 
breakdown of the BAB (Beitch & Eakins, 1969; Camras et aL, 1977; Eakins, 
1977; Kass et aL, 1972). However, the eyes o f cats and monkeys were found to be 
much more resistant and similar breakdown of the BAB was not observed after 
repeated topical application o f prostaglandins (Bito et aL, 1983). Increases in AH 
protein concentration after intracameral or topical administered PGE, or PGE^ 
provided evidence for an increased vascular or epithelial permeability (Beitch & 
Eakins, 1969; Kass et aL, 1972).
At lower dosage, PG have also been shown to cause a prolonged reduction in lOP. 
Intracameral injection o f PGE, or PGE, lowered lOP in rabbits after pre-treatment 
with polyphloretin phosphate, an anti-hyaluronidase which prevents increased 
capillary permeability in response to trauma (Starr, 1971). When applied topically 
as a single-dose, the ÎOP lowering effect of prostaglandin PGF,^ has been 
demonstrated on several species, including normotensive rabbits (Camras et al., 
1977; Kulkarni et aL, 1985; Lee et aL, 1984), cats (Bito et aL, 1983; Lee et aL,
1984), monkeys (Camras and Bito, 1981; Crawford et aL, 1987; Lee et aL, 1984) 
and humans (Lee et aL, 1988). Multiple-dose studies have demonstrated that topical 
application of PGF,^, in cats, monkeys and glaucomatous monkeys produced a 
maintained lOP reduction for up to several months, without any tolerance or
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tachyphylaxis observed after early multiple-dose experiments (Bito et aL, 1983; Lee 
et aL, 1988). Multiple-doses o f topically administered PFG,^ also produced 
significant ÎOP reductions in normotensive and glaucomatous human subjects (Lee et 
aL, 1988; Villiimsen & Aim, 1987). Recently, newly developed PGF,^ analogues, 
such as latanoprost, have been shown to decrease TOP with less side effects in 
experimental animals eyes as well as in the human eye (Toris et aL, 1997). In fact 
latanoprost is the only PGF,^ analogue which has already been approved for clinical 
use (Bito, 1997).
The mechanism behind the lOP-lowering effect of PG has remained obscure. Studies 
on AH dynamics have demonstrated that PG do not decrease AH formation (Gabelt 
& Kaufman, 1989; Havashi et aL, 1987; Lee et aL, 1984; Villumsen & Aim, 
1989) and have minimal effects on conventional outflow facility (Crawford et al., 
1987; Gabelt & Kaufman, 1989; Gabelt & Kaufman, 1990; Havashi et aL, 1987; 
Kaufman, 1986;Villumsen & Aim, 1989; Villumsen et aL, 1989), which are not 
great enough to account for the large drop in lOP. In some experiments PG have 
been shown to slightly increase AH formation (Crawford et aL, 1987; Nilsson et aL,
1989). It was suggested that other parameters of AH dynamics such as uveoscleral 
outflow may be involved (Kaufman, 1986). Measurements of the rate of movement 
o f intracamerally-infused tracers through the uvea were used to demonstrate that 
PGF,„ and its analogues increase uveoscleral outflow in monkeys (Gabelt and 
Kaufman, 1989; 1990; Nilsson et aL, 1989). As uveoscleral outflow is highly 
dependent on the degree of ciliary muscle tone, pilocarpine-induced contraction of 
the ciliary muscle blocks uveoscleral outflow completely, while atropine increases it
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(Bill & Walinder, 1966; Bill, 1969). Crawford and Kaufman (1987) provided 
evidence for the enhancement o f uveoscleral outflow by PGF,^ in cynomolgus 
monkeys by blocking the PG effect with pilocarpine. This antagonistic effect of 
pilocaipine was prevented by pre-treatment with atropine. In accordance with Bill 
and Walinder (1966) it was suggested that pilocarpine pre-treatment contracts the 
ciliary muscle, narrowing the intra-muscular spaces and closing off the uveoscleral 
drainage pathway.
In vitro studies on trabecular outflow have demonstrated a small direct relaxation 
effect of PG on pre-contracted isolated bovine trabecular meshwork strips, possibly 
mediated via EP receptor stimulation (Krauss et aL, 1997; Toris et aL, 1997). It has 
also been suggested that PGF,„ relaxes the ciliary muscle, widening the extracellular 
channels between the ciliary muscle fibres and subsequently increasing the outflow 
of aqueous. This idea originated after it was demonstrated that pilocarpine 
contracted the ciliary muscle and blocked the PG-induced increase in uveoscleral t
outflow and decrease in lOP (Crawford et aL, 1987; Nilsson et aL, 1989). Further 
evidence supporting this hypothesis includes reports that PGF,^ relaxes isolated 
ciliary muscle strips o f cats (Chen & Woodward, 1992; Goh et aL, 1995) and 
monkeys (Poyer et aL, 1995) which have been precontracted with carbachol.
Morphological studies of monkey ciliary muscle after multiple doses of PGF,^ over 
several days show narrowing of the muscle bundles, with widening of the spaces and 
a reduction in collagen between the muscle bundles (Lntjen-Drecoil & Tamm,
1988). PG have also been shown to induce substantial changes in the extracellular
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matrix around cultured human smooth muscle cells (Lindsey et al., 1997a; Lindsey 
et al., 1997b). These structural alterations may help explain the observed increase in 
uveoscleral outflow after PG administration. However, it is unlikely that such 
anatomical changes could account for the increases in outflow seen rapidly, 2-4 hours 
after single-dose topical administration o f PGF,^ (Nilsson et aL, 1989).
It appears that at least two mechanisms are involved in the increased aqueous 
drainage through the ciliaiy muscle, which accounts for the decrease in lOP in 
response to PG. It is likely that the initial lOP decrease results from ciliary muscle 
relaxation and the sustained lOP reduction results from restructuring o f the 
extracellular matrix (Toris et aL, 1997).
Recently PG binding sites, of the EP and FP receptor type with a high affinity for 
PGE, and PGF,^ respectively, have been identified in the rabbit, cat, bovine and 
human ciliary body (Bhattacherjee et aL, 1993; Csukas et aL, 1993; Krauss et aL, 
1997; Matsuo & Cynader, 1993). In the rabbit the EP, receptor appears to 
predominate, such a predominance of the EP, receptor was not observed in the cat or 
cow (Bhattacherjee et aL, 1993). In rabbits, prostaglandin induced breakdown of 
the BAB occurs mainly with agents that have a high affinity for the EP, receptor 
subtype (Protzniaii & Woodward, 1990). Agents which have a higher affinity for 
the FP receptor have very little effect on the integrity o f the barrier (Protzmau & 
Woodward, 1990). The PGF,„ analogue, latanoprost, has been shown to be highly 
selective for the FP receptor, with little or no affinity for the EP, receptor 
(Stjernschantz & Bito, 1992). No changes in the level of aqueous flare were
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observed after topical application o f latanoprost in rabbits or humans (Widergard et 
aL, 1998), indicating that the drug has no effect on permeability o f the BAB in these 
species.
There is now general acceptance o f Kaufman’s suggestion that the mechanism of the 
lOP-lowering effect of PGFj^  ^ is due largely to increase in uveoscleral outflow of AH, 
with aqueous outflow being partially redirected from the trabecular to the uveoscleral 
route. It has been postulated that the uveoscleral outflow route acts as a 
supplementary drainage alternative to prevent dangerous elevations in lOP due to 
possible obstruction o f the trabecular meshwork (Hurvitz et aL, 1991).
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OCULAR DRUG ABSORPTION 
Corneal permeation of topically applied drugs
The cornea is an optically transparent tissue that acts as the principal refractive 
element of the eye (Jarvinen et aL, 1995), in continuity with the sclera, constituting 
the anterior sixth o f the surface o f the globe (Pepose & Ubels, 1992). Anatomically 
the cornea consists o f a sheet o f connective tissue, the stroma, covered on either 
surface by a cellular layer (Maurice & Riley, 1970). A tear film covers the outer 
anterior cellular layer, the corneal epithelium. The supply o f nutrients and removal 
of metabolites from the avascular cornea is provided by exchange: across the corneal 
limbus with blood capillaries in peripheral conjunctiva and sclera; across the 
endothelium with AH circulating in the anterior chamber; across the epithelium with 
the tear film (Maurice & Riley, 1970). The cornea also exchanges O, and CO, 
directly with the atmosphere (Maurice & Riley, 1970).
Influences on corneal drug penetration
After instillation of ophthalmic drug solutions the primary route into the eye for 
many drugs is transcorneal permeation (Friedrich et aL, 1993). The quantity of drug 
that reaches the internal tissues o f the eye is determined by two main factors: (i) pre­
corneal drug loss such as drainage by the nasolacrimal system and absorption by the 
conjunctiva, much of which is then likely to be lost to the systemic circulation (Lee 
& Robinson, 1979), and (ii) the ability o f the drug to penetrate the layers o f the
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cornea (Friedrich et aL, 1993). 
Movement of drugs across cellular membranes
To traverse cellular barriers such as the cornea drugs have to cross lipid membranes. 
Drugs cross lipid membranes by two main mechanisms; passive diffusional transfer 
and carrier-mediated transfer.
The main factor which detennines the rate of passive diffusional transfer across 
membranes is lipid solubility, with molecular weight being a less important factor. 
Non-polar substances which dissolve in lipids and pass through the cell membranes 
freely, are refeixed to as lipophilic. However, many drugs are weak acids or bases 
whose state o f ionisation varies with pH according to the Henderson-Hasselbach 
equation. With weak acids or bases only the unionised species can diffuse freely 
across lipid membranes. The ionised species have a very low lipid solubility and are 
referred to as hydrophilic.
Hydration of the cornea
Generally the level of corneal hydration is expressed as the quantity o f water 
associated with unit dry weight o f the tissue (g f fO .g ') .  Alternatively, the relative 
wafer, content can be expressed as a percentage for corneal tissue (Doughty et aL, 
1996). Bovine corneal hydration has been calculated between 3.4 - 3.5 g H ,0 .g  ' dry 
weight (Davson, 1949: Duane, 1949) or 78 - 80% (Doughty et aL, 1995; Doughty
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et aL, 1996). These values coiTelates well with most other mammalian species where 
water constitutes between 2.95 -  5.7 g H ,0 .g ' dry weight (Maurice & Riley, 1970) 
or 75 - 80 % of the whole cornea (Maurice, 1983; Maurice & Riley, 1970). This 
value increases linearly with increasing comeal thickness. The corneal stroma swells 
readily with H ,0 , which binds to proteoglycans in the extracellular matrix. No 
significant differences were found between the hydration o f the intact cornea and 
epithelial-denuded stroma in monkeys (Ehlers, 1966) or rabbits (Otori, 1967). 
Oedema o f the cornea leads to alteration o f its structure and loss of transparency 
(Maurice & Riley, 1970). When moderate amounts o f water are taken up or lost 
from the cornea, there is an alteration in the thickness (Hedbys & Mishima, 1966). 
Therefore measurement o f corneal thiclmess can be a convenient and accurate way of 
assessing corneal hydration in the living eye (Lee & Davison, 1984; Mishima & 
Hedbys, 1967).
In the living mammalian eye normal thickness is controlled within narrow limits 
(Maurice & Riley, 1970). However, if  the excised mammalian eye is stored at 4°C, 
then the cornea loses some of its transparency and increases in thickness due to 
absorption of water from the AH (Davson, 1955; Doughty, 1989; Doughty, 1997; 
Doughty et aL, 1995; Harris & Nordquist, 1955). In the bovine eye this results in 
an increase from 3.4 g H,0.g"' dry weight to 4.55 g f f  O.g ' dry weight (Davson,
1990), or and increase in central corneal thickness from 1007 ± 73 pm to 1218 ± 62 
pm (Doughty, 1997). Transfem ng the mammalian eye to a moist chamber at 37°C 
can reverse this swelling (Davson, 1955; Harris & Nordquist, 1955). This 
“temperature reversal” effect still occurs after the epithelium is removed suggesting
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the pump removing fluid from the corneal stroma is located in the endothelium 
(Harris & Nordquist, 1955). When the cornea is treated with ouabain, which 
specifically inhibits the transport o f Na^, it is found to swell, indicating that active 
transport o f Na* and associated H ,0  movement due to osmosis is involved in 
maintaining corneal dehydration (Trenberth & Mishima, 1968). The active 
transport o f Na' is responsible for forming a small potential across the endothelium 
of approx. 0.76 mV, which is reduced to zero by ouabain, indicating the presence of 
Na'V KLATPase (Lim & Ussing, 1982). Na^ transport is known to be accompanied 
by a net flux o f HCOf out of the stroma, into the AH (Fiscbarg & Lim, 1974; Hull 
et aL, 1977). It has been suggested that active transport of H COf coupled to an 
energy source in a manner similar to NaV K^ATPase, may provide the osmotic 
gradient necessary for movement of water from the stroma (Riley, 1977).
Permeability of the cornea
The cornea is a unique tissue, which has an aqueous middle region, the hydrophilic 
stroma, between two hydrophobic or lipophilic layers, the epithelium and 
endothelium. This has great importance for drug penetration, restricting the comeal 
permeability o f hydrophilic and macromolecular compounds (Morimoto et aL, 
1987). Usually the comeal epithelium provides the main barrier to drug absorption 
into the eye (Maurice & Mishima, 1984). Drugs penetrate across the epithelium via 
the. .transcellular or paracellular pathway. Generally lipophilic drugs penetrate 
through the transcellular route, whereas hydrophilic drugs penetrate through the 
paracellular route (Jarvinen et aL, 1995).
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The permeability characteristics o f the cornea are of great clinical interest as the 
cornea must be crossed in order that topically applied drugs reach their target tissue 
in adequate concentrations. Topically applied drugs face losses via four routes; 
drainage o f AH back into the blood, uptake into the vascular system o f the anterior 
uvea, flow o f tears into the nasolacrimal duct and drug absoiption into the 
conjunctiva. Corneal permeability experiments estimated that the endothelium was 
-100  times more permeable to Na'" than the epithelium, indicating that the epithelium 
acts as a semi-permeable membrane, pemieable to H^O but not to solutes in tears 
(Maurice, 1951). Later it was calculated that the endothelium offers -1700 times 
more resistance to diffusion than the same thiclmess o f H ,0 . Endothelial 
permeability studies using the isolated cornea with the epithelium removed suggest 
that in general permeability decreases as molecular weight increases (Kim et aL, 
1971; Mishima & Trenberth, 1968). In these experiments using the isolated 
corneal preparation, the permeability o f Descemet’s membrane and the corneal 
stroma was separately measured, indicating that they do not offer a significant barrier 
to diffusion. The relative resistance to diffusion of small electrolytes provided by the 
corneal epithelium, stroma and endothelium has been determined to be 2000:1:10 
(Maurice, 1951; Mishima & Hedbys, 1967). The permeability of metabolically 
important substances such as glucose and amino acids is much greater than predicted 
from their size, due to carrier-mediated facilitated transport across the endothelial cell 
membrane (Davson, 1990).
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It is generally accepted that the epithelium represents the major barrier to diffusion of 
compounds across the cornea into the anterior segment o f the eye (Grass & 
Robinson, 1988b). The location o f the ban ier function is generally attributed to the 
outermost layer o f the epithelium, which is characterised by tight junctions between 
adjacent epithelial cells (Tonjum, 1974). This barrier is often considered to vary in 
magnitude according to the solubility characteristics of the drug (Sieg & Robinson,
1976). In 1942, Swan and White found that substances which are soluble in lipid as 
well as in water penetrate the epithelium rapidly. A strong correlation has been 
reported between the oil-water partition coefficient o f a compound and the ease with 
which it crosses the epithelium (Araie & Maurice, 1987). It is now widely accepted 
that lipid solubility, as reflected by the oil-water partition coefficient, is the major, 
but not the only factor influencing drug penetration into the cornea and AH 
(Jankowska et aL, 1986; Schoeiiwald & Hauiig, 1983; Wang et aL, 1991). This 
was highlighted experimentally, where despite an enormous difference in lipid 
solubility only a three-fold difference in absorption between methazolamide and 
benzol amide was found in the isolated intact cornea (Edehauser & Maren, 1988). 
Other physiocochemical drug properties including aqueous solubility, molecular size 
and shape, charge and degree o f ionization are now thought to influence the route and 
rate o f drug penetration (Grass & Robinson, 1988b; Hauiig et aL, 1989; Maren & 
Jankowska, 1985; Rojaiiasakul et aL, 1992; Sieg & Robinson, 1977).
Drugs which are soluble in water are generally unable to penetrate the epithelial 
barrier, therefore the rate-limiting barrier for ocular penetration o f highly hydrophilic 
drug is the lipophilic corneal epithelium (Jarvinen et aL, 1995). However lipid-
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soluble drugs which penetrate easily find difficulty in leaving; therefore some degree 
o f solubility in both aqueous and lipid media is required for optimum transcorneal 
permeation (Swan & White, 1942; Kupferman et aL, 1974).
Today, most ophthalmic drugs are available in a solution which is topically applied 
to the eye. Most drugs are ionizable and hence are present in a chemical equilibrium 
between the ionic (anion or cation) and non-ionic (free base) forms in aqueous 
solution (e.g., cation^ <-> free base + ). This greatly complicates the mechanism of
drug penetration through the cornea. Permeation of ionizable drugs (weak acids and 
weak bases) depends on the equilibrium between the ionized and unionized drug in 
the eyedrop and eventually the lacrimal fluid (Friedrich et aL, 1993). The 
epithelium and endothelium would present the greatest banier to corneal penetration 
if  the drug was predominantly in the hydrophilic (ionized) form, whereas the stroma 
would theoretically present the greatest barrier to a drug in its lipophilic (unionized) 
form (Friedrich et aL, 1993). As the epithelium and endothelium are lipid in nature 
the ionized form o f the drug would not readily penetrate these barriers. However, the 
paracellular pathway does allow a small degree o f penetration o f ionic drugs through 
the epithelial and endothelial barriers (Klyce & Crosson, 1985). Unionized, 
lipophilic forms of a drug pass across the epithelium and endothelium by 
transcellular diffusion directly through the cell membranes. The rate of penetration 
via the transcellular route is much higher than via the paracellular route (Friedrich et 
a/., 1993). However the ionised drugs exist at equilibrium with their unionized 
forms. Once an ionizable drug is applied to the tear film, the unionized and ionized 
form begin to penetrate across the epithelium. As the transcellular path is only
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available to the unionized form, the ionized form will accumulate at the interface 
between the epithelium and tear film. As the unionized and ionized fonns are in 
equilibrium in the tear film, there is an imbalance at the interface. This imbalance 
pushes the equilibrium towards the unionized fonn. This equilibrium reaction is 
reversed as the drug reaches the hydrophilic stroma. This results in an enhanced 
overall penneability across the epithelium and endothelium to ionizable drugs, 
compared to the permeability predicted by lipid-solubility (Friedrich et aL, 1993).
In the case of ionizable drugs, the charge on the molecule also affects their corneal 
penetration (Rojanasakul et aL, 1992). At the physiological pH of 7.4 hydrophilic 
cationic charged compounds permeate the cornea more readily than anionic species 
(Rojanasakul et aL, 1992). At acidic pH the cornea is selectively pemieable to 
negatively charged molecules, however acidic formulations are not tolerated by the 
cornea and formulations for ophthalmic use seldom have a pH < 5.5 (Rojanasakul & 
Robinson, 1989).
Sieg and Robinson (1976) have investigated the mechanism o f corneal penetration 
using the antiglaucoma drug, pilocarpine, which appears to possess optimum 
solubility characteristics being soluble in both polar (aqueous) and non-polar (lipid) 
solvents. The comeal epithelium is the rate limiting tissue and acts as both a barrier 
to drug penetration and as a reservoir of pilocarpine in the cornea (Sieg & Robinson, 
1-976). Removal of the epithelium prior to dosing produced a seven to eight fold 
increase in drug levels in the AH. The endothelium did not appear to offer any 
significant resistance to transcorneal permeation of pilocarpine. When the epithelium
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is removed there is also an absence of drug build up in the stroma and endothelium, 
eliminating the reservoir effect o f the cornea. These results led the investigators to 
suggest that in the case of transcorneal penneation of pilocaipine the stroma, 
endothelium and AH almost act as a single phase.
Following topical application o f drugs in vivo, there is rapid absorption across the 
cornea. Drugs with dissimilar physicochemical properties often show similar comeal 
absorption profiles. It has been shown that the drug contact time from 0 - 5 min 
postinstillation is critical for drug absorption into the cornea and AH (Sieg & 
Robinson, 1976), with drug concentrations in the AH peaking after 20 - 30 min 
(Makoid & Robinson, 1979; Sieg & Robinson, 1976). These early peak times are 
due to rapid elimination from the precorneal area (tear film), drug dilution in the tear 
film, drug loss via drainage into the nasolacrimal duct and absorption via the 
conjunctival sac into the systemic circulation, resulting in a rapid decrease in the 
concentration gradient between the precorneal area and the anterior corneal epithelial 
surface (Makoid & Robinson, 1979). Therefore the amount o f drug absorbed is 
very small relative to the total amount instilled (Sieg & Robinson, 1976). Typically 
<5% of the applied dose reaches the eye following application o f topical solutions 
(Jarvinen et aL, 1995).
It is very important to maximise the amount of drug absorption into the cornea and 
AH following application o f a topical dose.
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Ocular absorption o f topically applied drugs may be improved by increasing their 
lipophilicity via prodrug derivatives (Lee & Li, 1989), ion-pair formation (Wilson et 
aL, 1981) and optimized solution pH for the unionized form o f the drug (Fodder et 
aL, 1992). Increasing the drug contact time in the precorneal area has also been 
shown to increase drug penetration in rabbits (Chrai & Robinson, 1974; Patton & 
Robinson, 1975) and humans (Saettone et aL, 1982).
Soluble polymers, such as methylcellulose, hydroxypropyl methylcellulose and 
polyvinyl alcohol are commonly used in eyedrops to increase the viscosity of the 
solution, which decreases the dilution in the tear film and rapid initial drainage rate, 
resulting in an increased contact time in the precorneal area which sustains to some 
extent the initial tear concentration o f the drug (Adler et aL, 1971; Benedetto et aL, 
1975; Shell, 1985).
Ophthalmic ointments are a commonly used formulation for the delivery o f drugs to 
the eye which also offer the advantage o f  prolonged medication from each instillation 
(Shell, 1985). Drug bioavailability has been found to peak later with ointment 
vehicles than with solutions resulting in a significantly greater bioavailability to the 
eye (Seig & Robinson, 1975). The superior bioavailabilty o f drug from ointment 
formulations is believed to be due to several factors: (1) higher effective 
concentration o f drug in the formulation (Seig & Robinson, 1975; Shell, 1985), (2) 
increased tissue contact time (Seig & Robinson, 1975; Shell, 1985), (3) inhibition of 
dilution by tears (Seig & Robinson, 1977) and (4) resistance to nasolacrimal 
drainage (Norn, 1964). The mechanical shearing action of blinking is also believed
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to significantly enhance drug release from ointments by continually exposing new 
surface areas o f the fonnulation to the precorneal area, continually changing the 
thickness of the diffusional layer and dispersing droplets o f the drug in a water-in-oil 
emulsion (Seig & Robinson, 1979). On the other hand ophthalmic ointments 
present mixing problems between the ointment vehicle, which is lipophilic, and the 
tear film, which is hydrophilic (Sieg & Robinson, 1975).
Eyedrops, in the form of a topical emulsion or suspension have also been reported to 
prolong the therapeutic effect compared to a topical solution o f the same drug 
(Mazor et aL, 1979; Ticho et aL, 1979). In an emulsion formulation, drug can be 
bound to a polymeric material, resulting in a suspension of drug-polymeric complex 
with a low viscosity which is readily delivered as an eyedrop (Shell, 1985). In vitro 
studies have indicated that the prolonged therapeutic effect is due to both an 
increased drug permeation and to a prolonged drug release from the vehicle (Mazor 
et aL, 1979).
Increased vehicle contact time does not increase the epithelial concentration above its 
initial value, which is controlled by the concentration of the applied dose (Sieg & 
Robinson, 1976). Instead it maintains the epithelial concentration for an extended 
time, effectively increasing the time taken to reach peak drug concentration in the 
AH and the total amount of drug which penetrates into the AEI. Increasing the 
contact time has been shown to moderately increase the absoiption o f pilocarpine by 
a factor of two to three (Chrai & Robinson, 1974; Patton & Robinson, 1975).
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Several studies on ocular drug bioavailability indicate that drug solubility in the 
vehicle dictates the success o f a drug formulation in increasing bioavailability and 
prolonging drug release (Sieg & Robinson, 1977). Drugs which are lipophilic and 
therefore soluble in lipophilic ointments, show greater absorption and prolonged 
release when applied as an ointment formulation. In contrast it was suggested that 
more appropriate vehicles for drugs which do not dissolve readily in lipophilic 
ointments would be aqueous or perhaps an oil-in-water emulsion (Sieg & Robinson,
1977).
Transcorneal permeability varies among different species. In vivo epithelial diffusion 
studies showed that chloramphenicol, fluorescein and gentamycin penetrate less 
readily in humans than in rabbits (Maurice & Mishima, 1984). In vitro studies also 
show a significant difference between the permeability characteristics of rabbit and 
human cornea (Edelhaiiser & Maren, 1988). When the epithelium was intact the 
permeability of hydrophilic compounds was much greater in human cornea. This 
difference between the species disappeared when the epithelium was removed, 
leading Edelhaiiser and Maren to suggest that the rabbit epithelium is more o f a 
barrier to hydrophilic drugs, which probably pass through the cornea via aqueous 
channels. This agreed with previous reports and the general principle that the 
epithelium is a barrier to hydrophilic compounds (Maren et aL, 1983). The 
permeability to lipophilic compounds was essentially the same in corneas from both 
species with intact or removed epithelium, indicating that the lipid-barrier component 
of the epithelium functions in the same way for both rabbit and human (Edelhauser
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& Maren, 1988).
Compounds such as benzalkonium chloride and EDTA which are commonly added 
to topical drug solutions are known to disrupt the integrity o f corneal epithelial 
barrier, which may affect ocular drug absorption (Fodder et aL, 1992). Total corneal 
debridement is reported to increase penetration of hydrophilic (water-soluble) drugs, 
but not lipophilic (lipid-soluble) drugs into the cornea (Chien et aL, 1988; Hull et 
aL, 1974; Lesar & Fiscella, 1985). The relationship between drug penetration and 
comeal epithelial integrity was investigated using the antifungal drug, saperconazole 
(Johnson et aL, 1995). This drug has lipophilic properties and its penetration into 
the cornea is strongly influenced by the presence of an intact epithelium (O’Day et 
aL, 1992). The study showed that debridement of the corneal epithelium increases 
penetration of the antifungal drug into the rabbit cornea and AH. The relationship 
between epithelial defect size and drug penetration was not linear. A plateau value 
between 25% and 50% of total epithelial debridement was found to exist, beyond 
which no greater drug penetration was seen. This work agrees with a previous report 
where a positive correlation was shown between epithelial defect size and penetration 
o f fluorescein into the human cornea and anterior chamber (Berkowitz et aL, 1981). 
The poor solubility of saperconazole in aqueous solution was enhanced by the 
addition o f a hydrophilic carrier molecule to the antifungal agent (Johnson et al., 
1995). Therefore the saperconazole complex behaves as a hydrophilic substance. 
This helps to explain the increase in penetration into the cornea and aqueous of the 
lipophilic compound after removal of the epithelium, a layer which is permeable to 
lipophilic substances. Clinically, situations may arise where debridement of a
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portion of the corneal epithelium may be performed in an effort to increase 
penetration o f drugs into the cornea and anterior chamber (Johnson et at., 1995).
Herpes simplex virus and corneal damage
Herpes simplex virus (HSV) is one o f the most damaging infectious agents that can 
attack the eye. The virus is the most common infectious cause o f corneal ulcers and 
corneal blindness in developed countries, and has reached epidemic proportions in 
the United States with nearly 300,000 new cases reported annually (Pavan-Langston 
& Boisjoly, 1985).
Clinical manifestations o f primary HSV infection of the eye include tearing, 
conjunctivitis and epithelial keratitis. Primary herpetic keratitis is generally self 
limiting and usually heals within 4 weeks without scaning (Verdier & Kracher, 
1984). However, the virus can remain latent with periodic recunence producing 
clinical manifestations o f secondary herpetic keratitis. In primary herpetic keratitis 
the damage is generally limited to the surface epithelium, whereas in secondary 
keratitis the damage often extends to the stroma and endothelium and may persist for 
months producing irreversible morphologic changes which may result in permanent 
blindness (Hughes et at., 1993a; 1993b).
Herpetic keratitis can be treated with topical antiviral compounds, such as aciclovir 
(Pavan-Langston & Boisjoly, 1985). Unlike other DNA-inhibiting antiviral agents, 
aciclovir acts preferentially on HSV-infected ceils and is activated by the virus-coded
53
Introduction: Ocular Drug Absorption
enzyme, thymidine kinase (Abel et al.^ 1975).
The major barriers to the treatment of herpetic keratitis are frequent administration of 
topical solutions and the failure o f the active drug to achieve minimum inhibitory 
concentrations in ocular tissues (Hughes et al., 1993a; 1993b). Aciclovir has low 
ocular bioavailabilty due to its hydrophilic nature causing low epithelial permeability 
and rapid dilution and drainage from the precorneal area. Therefore it is important to 
maximise to the amount o f active drug which penetrates the epithelial barrier of the 
cornea.
Alkali burns and corneal ulceration
Alkali burns o f the eye are among the most disastrous o f ocular injuries, 
characterised by corneal opacification, vascularization, chronic irritation and 
conjunctival overgrowth. Burns commonly result in repeated ulceration or 
perforation o f the cornea (Brown et at., 1969a). The viability and future integrity of 
the alkali-burned cornea was found to be linked to the extent o f neovascularization 
(Brown et al., 1969a). When the corneas were completely vascularized, wounds 
healed as well as those of normal controls and perforations were rare (Brown et al., 
1969a). Investigations indicated that all the cells of the cornea were destroyed 
immediately after exposure to alkali (Brown et al., 1972). Seven to eighteen days 
after exposure, regrowing epithelial cells and cellular elements that are repopulating 
the stroma produce collagenase which ultimately ulcerates the cornea (Brown et al., 
1969a; 1969b; Mai Phan eta l., 1991).
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Alkali bum models have been extensively used to investigate the formation of 
comeal ulcers in rabbits (Berman et al., 1983; Levinson et al., 1976; Mai Phan et 
al., 1991; Pfîster & Paterson, 1977). After deep anaesthesia was induced, alkali 
bums were made by either: placing disks o f filter paper, saturated with 4N sodium 
hydroxide on the central corneal surface for 2 min (Berman et al., 1983; Mai Phan 
et al., 1991); or placing a circular Lucite well on the cornea and filling the well with 
IN sodium hydroxide for 20 sec (Levinson et al., 1976; Pfister & Paterson, 1977; 
Plister & Paterson, 1980). Alkali-burned corneas were then irrigated with 0.9% 
saline solution. In these models the corneal epithelial defect, induced by the alkali- 
bum, initially closes at a steady rate. This process usually ceases 3 - 5 days after the 
bum, with secondary epithelial breakdown eventually resulting in comeal ulceration. 
Thermal burns, formed by application o f a thermokeratophore probe at a temperature 
of 130 to the cornea for 2 sec, have also been used to induce corneal ulceration 
(Phillips et al., 1983).
Treatment with a variety o f agents including hypertonic ointments (Plister, 1983), 
epidermal growth factor (Singh & Foster, 1987), collagenase inhibitors (Brown & 
Weller, 1970), ascorbic acid (Levinson et al., 1976; Pfister & Paterson, 1977; 
Pfister et al., 1978) and the corticosteroid, prednisolone (Phillips et al., 1983) helps 
to reduce the frequency o f corneal ulcer formation in eyes with epithelial defects 
induced by alkali-burns. It has been reported that treatment o f corneal ulcers with 
corticosteroids increases the activity o f collagenase, which may associated with a 
rapid perforation of the corneal epithelium (Brown, 1971). Topical fibronectin has
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been reported to accelerate corneal epithelial wound healing in rabbits (Mai Phan et 
al., 1991; Nishida et al., 1984).
D rug absorption  in the bovin e perfused  eye
Utilisation o f the perfused bovine eye as an in vitro model for the study o f drug 
absorption allows the study o f drug penetration into the cornea and AH without the 
complications o f blinking, drug dilution in the tear film, tear drainage, drug loss to 
the systemic circulation, or influences of the CNS and CVS associated with in vivo 
models (Figure 7a), while maintaining the eye under controlled physiological 
conditions (Zhu et al., 1996).
In the isolated bovine eye, drug molecules permeating the cornea are partitioned in 
the AH and then distributed into surrounding tissues such as the iris and lens. As the 
AH is the most accessible compartment for drug molecules diffusing across the 
cornea and only a small amount o f drug molecules are distributed into the 
surrounding ocular tissues, it is assumed that the AH is the major compartment for 
elimination and distribution of drug (Zhu et al., 1996). Figure 7b describes the route 
of absorption following topical application of drug to the isolated perfused bovine 
eye. Under non-perfused conditions, corneal hydration o f the freshly collected 
bovine eye remains satisfactory up to an hour after death (Zhu et al., 1996). 
Commencement o f arterial perfusion with Ktnbs’ solution, within an hour after death, 
has been shown to maintain corneal hydration without significant alterations in 
corneal thickness for several hours (Zhu et al., 1996).
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DRUG IN TEAR FLUID
OCULAR ABSORPTION
(<5% OF THE DOSE)
CORNEAL ROUTE
•PRIMARY ROUTE 
•SMALL, LIPOPHILIC DRUGS
CONJUCTIVAL AND  
SCLERAL ROUTE
•LARGE HYDROPHILIC DRUGS
AQUEOUS HUM OUR
OCULAR 1 'ISSUES
SYSTEMIC ABSORPTION
(-50-100% OF THE DOSE) 
ROUTES:
CONJUNCTIVA
NOSE
AQUEOUS HUMOUR
i L l MI NANON
Figure 7a. Flow diagram representing the theoretical route of drug absorption 
following topical application m vivo.
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TOPICALLY APPLIED DRUG
OCULAR TISSUESAQUEOUS HUMOUR
CORNEAL ABSORPTION
ELIMINATION
Figure 7b. Flow diagram representing the theoretical route o f drug absorption 
following topical application in vitro.
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AIMS OF THE PROJECT
A general aim of this project was to develop the in vitro bovine perfused eye, to show 
whether it is a useful model for experimental work in studying drug mechanisms in 
the eye, whether from a pharmacodynamic or pharmacokinetic point of view.
There are two sections to the current work and their ultimate aims are; A), the 
development o f safer and more effective drugs for the treatment o f glaucoma by 
improving our understanding o f the mechanisms o f existing drugs. The present work 
sets out to show whether this model will be useful in predicting antiglaucoma drug 
activity in man; and B). the development o f a simple model allowing the study of 
corneal drug absorption under physiological and pathological conditions.
A. The effects o f pilocarpine, apraclonidine and prostaglandins, drugs which are 
known to have lOP-lowering properties in other species, will be studied on lOP. in 
the bovine perfused eye. Once the lOP-lowering properties of drugs have been 
confirmed in this model an attempt will be made to try to elucidate the mechanisms 
by which these drugs may alter lOP, by measuring facility o f outflow, uveoscleral 
outflow or rate o f formation of AH.
A further intention is to ascertain how various routes of drug administration might 
alter the effect o f these drugs upon lOP. It is most likely that drugs which influence 
lOP via an alteration in aqueous formation in the ciliary body will be most effective
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by the intra-arterial route, whereas drugs influencing lOP by altering outflow are 
more likely to do so following administration via the intracameral route.
Where there is evidence that a given drug may affect the integrity o f the BAB, the 
perfused bovine eye model will be used as a means o f testing the effect o f various 
drugs on BAB permeability by the inclusion of the high molecular weight substance, 
bovine serum albumin (1% w/v) in the arterial perfusate and measuring its leakage 
into the secreted AH.
B. Studies o f ocular drug absorption will utilise the bovine perfused eye as an in 
vitro model to investigate the absorption o f different fonmilations o f the anti-viral 
drug, aciclovir. The other major experimental variable will be chemical and physical 
damage to the cornea attempting to mimic the corneal damage associated with FISV. 
Clinically, damage to the corneal epithelium associated with HSV, results in 
perforations in the epithelial layer which if  severe enough may lead to the formation 
of corneal ulcers. As it is not feasible to keep the perfused eye model viable for the 
duration o f time required for comeal ulceration to develop, then the development o f a 
rapid, reproducible method o f damaging the cornea may be helpful in studying 
absorption o f aciclovir formulations.
High performance liquid chromatography (HPLC) will be used to analyze and 
quantify the amount o f aciclovir which is absorbed in acid extracts of the cornea and 
AH.
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MATERIALS AND METHODS 
The bovine perfused eye preparation
The procedure for dissection and setting up o f the constant flow method for the 
bovine perfused eye was initially described by Wilson and co-workers (1993). 
Bovine eyes were obtained from the abattoir, and transported to the laboratory. 
Temperatures during transportation depended on seasonal variation, ranging from 2 - 
20°C. The eyes were not transported on ice since the resulting solidity of the orbital 
fatty tissue seriously hampered dissection and cannulation (Wilson et al., 1993). It 
was also felt that the return o f the eyes’ core temperature to 37°C on commencing 
perfusion would be delayed considerably by cooling the whole eye on ice (Wilson et 
al., 1993). Immediately upon return to the laboratory, excess adnexal tissue was 
trimmed from the eye, taking care not to damage blood vessels running over the 
posterior surface o f the globe. The two posterior ciliary arteries were located, one of 
which was carefully cleared o f fatty and connective tissue, and cannulated distal to 
the ophthalmic artery but proximal to the dark blue pigmentation which appears in the 
arterial wall prior to entering the sclera. This portion of the artery is relatively large 
and robust, allowing easy cannulation and manipulation.
After cannulation, the eye was placed in a warming jacket maintained at 37°C and 
insulated with a plastic cover (Figure 8). The cannulated long posterior ciliary artery 
and thus the blood vessels of the anterior uvea were then perfused with a ICrebs’ 
solution at 37°C, containing (mM): NaCl, 118; KCl, 4.7; MgSO.,, 1.2; CaCF,
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Figure 8. The bovine isolated eye, showing perfusion o f the uveal vasculature 
through one long posterior ciliary artery under condition o f constant flow rate. 
Perfusion pressure and fOP were both monitored as shown (Wilson et al., 
1993).
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2.5; NaHCOj, 25; 1.2; glucose, 11.5; ascorbate, 0.05. The solution was
bubbled with 95% O, - 5% CO, to adjust the pH to 7.4. Flow o f Ki'ebs’ through the 
vasculature was induced via a Watson-Marlow peristaltic pump. Arterial perfusion 
pressure was recorded via a Grass FT03C transducer, bridge box amplifier and 
Linseis (LS 52-2) pen recorder. Arterial flow of Krebs’ was commenced at 0.2 
ml. min ' and increased in approx. 10 increments to 2.25 - 2.5 ml .min' ,  over a 40 min 
period. In some eyes that showed a low initial perfusion pressure, optimum flow rate 
was reached much earlier than this, sometimes within 20 min o f the start of perfusion. 
During this period arterial perfusion pressure often fluctuated, usually due to poor 
alignment o f the cannula with the artery, the twisting o f the artery to produce partial 
blockage o f the lumen or excessively tight ligatures around the cannula. After 40 
min, when AH secretion had restarted and the anterior chamber was firm, it was 
cannulated with a 2 3 0  needle connected via silicon rubber tubing (internal diameter 
0.8 mm) to a water manometer for measurement of TOP.
Measurement of intraocular pressure
lOP, expressed as mm FfO, was measured manually from the water manometer at 5 
or 10 min intervals depending on the duration of the experiment. When recording 
lOP for 90 min, measurements were taken at 5 min intervals; when recording lOP for 
180 min, measurements were taken at 10 min intervals. In order to minimise the 
effect of capillary surface tension on lOP, fine steel wire was used to disturb the FTO 
meniscus approx. 30 sec prior to taking measurements. lOP can be easily converted
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from mm H ,0  to mm Hg by dividing the value obtained from the water manometer 
by 13.546, the specific gravity o f mercury (specific gravity H ,0  = 1).
Criteria for accepting/ rejecting eyes
The criteria for proceeding further with each experiment, following an equilibration 
period o f a further 30 - 60 min, were as follows (Wilson et al., 1993):
• maintenance o f a stable lOP, with fluctuations of less than ±2 mm H ,0  over a 15 
min period, within the range 95 - 165 mm H ,0  (7 -1 2  mm Hg).
• maintenance o f a stable arterial perfusion pressure within the range o f 20 - 60 mm 
Hg.
• free flow o f perfusate from at least 2 vortex veins.
Eyes were also rejected for further study if  any o f the following were observed:
• air bubbles moved from the heating coils into the vasculature resulting in a sharp 
increase in lOP, >20 mm Hg, which failed to return to its previous value within 5 
min.
• perfusion pressure increased above 100 mm Hg at any point of the experiment.
« damage to the globe resulting in leakage o f perfusate from the long posterior 
ciliary artery.
Drug administration
Once lOP had stabilised, drug solutions or vehicles were administered by one of three 
routes; (i) by addition o f drug to the perfusate reservoir at an exact concentration, (ii)
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as a bolus dose injected intra-arterially or, (iii) as a bolus dose injected 
intracamerally. Bolus doses o f drug solution were injected in volumes of 3 - 10 ql 
using a microsyringe. Intra-arterial injections were administered immediately 
proximal to the arterial cannula through re-sealable rubber tubing. Intracameral 
injections were administered by cannulating the anterior chamber with a second 23G 
needle connected via silicon rubber tubing to a microsyringe. This secondary 
cannulation of the anterior chamber was earned out approx. 5 min after insertion of 
the manometer needle in order to minimise the disruption o f lOP associated with 
mechanically inserting needles through the cornea. Drug solutions were injected once 
lOP had stabilised after the disturbance of piercing the cornea. The time of 
administration o f the drug was designated as zero time.
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Measurements of pupil diameter
The effects o f a miotic agent on pupil diameter was tested in order to confimi that the 
isolated bovine perfused eye delivers drug, administered arterially, to the anterior 
uvea. Pilocarpine causes miosis by directly acting on receptors o f the pupillaiy 
muscle sphincter (Zimmerman, 1981). The diameter of the pupil was measured 
externally before, and 90 min after, drug administration, using a Vernier Caliper.
Effects of pilocarpine, apraclonidine and PGF.  ^on lO P
In order to develop further the isolated bovine arterially perfused eye as an in vitro 
model for the study o f the mechanisms by which drugs lower lOP, several drugs 
known for their lOP lowering properties in other species were tested for their effects 
on lOP. Drug effects on lOP are expressed as changes, compared to control eyes, in 
the mean slope of the regression line drawn on lOP v time. Microsoft Excel 
calculates the statistics for a line by using the "least squares" method to calculate a 
straight line that best fits the data, and returns a slope value (mm H ,0.m in ') that 
describes the line.
Pilocarpine
The cholinergic agonist, pilocarpine was administered to the eye in the perfusate at 
concentrations o f 10'  ^ M, 10' ’^ M, 3 x 10"^ ’ M and 5 x 10'^ ’ M. The vehicle for 
pilocarpine was distilled water. The effect o f pilocarpine on lOP was also tested in 
eyes perfused with a solution o f Krebs’ containing bovine serum albumin (BSA) (1%
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w/v). The drug was administered in the perfusate at concentrations o f 10'’ M, M, 
3 X lO'^ ’M and 10"^  M. At the optimum flow rate of 2.25 ml.min ' approx. 10 min was 
allowed for the drug to reach the eye due to the flow o f the perfusate from the 
reservoir through a heating coil via connecting rubber tubing. lOP was monitored for 
90 min after the approximate time when the drug reached the eye with readings taken 
every 5 min.
Apraclonidine
The (%2-adrenergic agonist, apraclonidine was tested for its effects on lOP. The doses 
used for apraclonidine were 10 nmol, 30 nmol, 100 nmol and 300 nmol. The vehicle 
for apraclonidine was distilled water. Drug solution or vehicle in volumes o f 3 or 10 
pi was injected as bolus doses intra-arterially into the perfusate as described 
previously, or intracamerally directly into the anterior chamber. lOP was monitored 
for 90 min after injection with readings taken at 5 min intervals.
PGF,«
The prostaglandin, PGF,^, was tested for its effects on lOP when the eye was perfused 
with IGebs’ solution or Krebs’ solution containing BSA (1% w/v). The doses used 
for PGF,„ was 20 nmol, 60 nmol, 200 nmol, 600 and 2000 nmol. The vehicle for 
PGF,^, was distilled water. Drug solution or vehicle (in these cases distilled FfO) in 
volumes o f 2 or 6 pi was injected as bolus doses intra-arterially into the perfusate as 
described previously. TOP was monitored for 180 min after injection with readings 
taken at 10 min intervals.
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Measurement of vascular effects
After drug administration, the magnitude o f vascular responses, indicated by changes 
in perfusion pressure, was measured after exclusion of injection artefacts.
The effects of selective g-adrenergic antagonists on the vascular response to 
agonists
The effects o f selective a ,-  and aj-adrenergic antagonists were investigated on (i) the 
short term (< 10 min) vascular response observed after intra-arterial injection of a 
bolus dose o f agonist and (ii) the sustained vascular response observed after continual 
intra-arterial perfusion of agonist.
Once a flow rate of 2.25 m l.m in' had been established and perfusion pressure was 
constant for a period o f 20 min, control dose-response curves to the agonists, 
apraclonidine (10'^ - 10'^ mol) or noradrenaline (10'^ - 10'^ mol), were constructed by 
intra-arterial injection o f bolus doses. The effect of the agonists on peak short term 
vascular perfusion pressure responses was expressed as the percentage increase in 
basal tone,
(i) Dose-response curves for the agonists were constructed in the presence and 
absence in the perfusate of the selective a,-adrenergic antagonist, prazosin (3 x 10 '' 
M), or the selective g,-adrenergic antagonist, yohimbine (3 x 10" M) (30 min pre­
incubation). The effect o f the agonists on peak short-term vascular perfusion pressure
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responses, in the presence or absence o f the antagonists was expressed as the 
percentage increase in basal tone.
(ii). The effect of the selective a,-adrenergic antagonist, delequamine (gift from Prof. 
J.C. McGrath), on the sustained vascular response was investigated by perfusing the 
vascular beds o f the isolated bovine eye with Krebs’ solution containing 
apraclonidine at concentrations o f 10'® M, 3 x 10'® M or 10“^ M. After adding 
apraclonidine to the reservoir, 10 min was allowed for the drug to reach the eye. The 
vascular response to apraclonidine was measured after a further 30 min perfusion 
(total o f 40 min after drug administration). Delequamine was then added to the 
perfusate at a concentration o f 10'® M and the effect on vascular response was 
measured after 40 min. This process was repeated for concentrations o f 10'  ^ and 10" 
M delequamine.
The effect o f the a,-adrenergic antagonist, prazosin on the sustained vascular 
response was also investigated by perfusing the eye with Krebs’ solution containing 
apraclonidine at concentrations o f 3 x 10 ® M or 10'  ^ M. The vascular response was 
measured after 40 min. Prazosin was added to the perfusate at a concentration of 10'® 
M and the effect on the vascular response was measured after 40 min. This process 
was repeated for concentrations of 10^ and 10" M prazosin.
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Sheep eyes
Due to difficulties in the supply of bovine eyes during part of the period o f this 
project, eyes from sheep (ovine) were used as alternatives to bovine. The dissection 
and cannulation was as described previously except that perfusion flow rates were 
restricted to a maximum of 1.5 ml.min ' in order to consistently maintain vascular 
perfusion pressure between 20 to 60 mm Hg. Pilocarpine, the only drug tested on the 
ovine eye, was administered, at a concentration o f 10" M, by the addition o f the drug 
to the perfusate reservoir. lOP was monitored for 90 min after the approximate time 
when the drug reached the eye with readings taken every 5 min.
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Testing the integrity of the blood-aqueous barrier of the isolated eye after drug 
administration
In order to test the integrity of the blood-aqueous barrier after drug administration the 
perfusate was supplemented with 1% BSA to mimic the osmotic pressure of plasma. 
At the end o f each experiment, samples o f AH up to a volume o f 1.5 ml were 
withdrawn from the anterior and posterior chambers of the eye. In order to remove 
AH the existing cannulation needle for measuring lOP was used, being inserted first 
behind, then in front o f the iris. AH samples from each eye were transfeired to 
Eppendorf tubes for storage and assay. The amount o f protein contained in the AH 
was measured by assay. TOP was measured as described earlier throughout these 
experiments.
Protein assay
The amount o f protein in the AH was determined by the Lowry (1951) method. The 
protein assay was done using a Dynatech Plate Reader, employing a 96-well plate. 
The product o f this assay, a complex between copper, phenol and protein has a 
distinct blue colour and absorbs strongly at a wavelength of 750 nm. The intensity of 
this colour, determined spectrophotometrically, is proportional to the concentration of 
protein present in the well at low concentrations. At high protein concentrations 
standard curves determined by the Lowry method cease to remain linear, resulting in 
a plateau. In order to accurately calculate the concentration o f protein present in AH, 
samples may have to be diluted to fit onto the linear portion of the standard curve.
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Standard curve preparation
A blank and 5 protein standards were prepared in Eppendorf tubes using BSA (200 
pg .m f') and distilled H ,0  as follows (Table. 3):
Table 3. Preparation of protein standards
Tubes BSA (fil) Distilled H^O (|il)
Blank 0 1000
Standard 1 200 800
Standard 2 400 600
Standard 3 600 400
Standard 4 800 200
Standard 5 1000 0
A linear standard curve of absorbance values versus concentration of BSA was 
calculated to determine protein concentrations in the AH. An example o f a linear 
standard curve is shown in figure 9.
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Figure 9. Standard curve for protein concentration. The graph was linear with a 
correlation coefficient, r = 0.995 in the concentration range 0 - 200 pg.ml '.
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Plate set-up
Each plate consists of 96 wells, with each well containing a maximum volume of 300 
pi. Each sample was assayed in duplicate. A blank (distilled water) and 5 protein 
standards were included in the plate design (Figure 10).
B - blank
S - protein standard (1 -5 )
T - AH samples
1 2 3 4 5 6 7 8 9 1G 11 12
A 81 81 T3 T3 T il T il T19 T19 T27 T27 T35 T35
B SI SI T4 T4 T12 T12 T2G T2G T28 T28 T36 T36
C S2 S2 T5 T5 T13 T13 T21 T21 T29 T29 T37 T37
D S3 S3 T6 T6 T14 T14 T22 T22 T3G T3G T38 T38
E S4 S4 T7 17 T15 T15 T23 T23 T31 T31 T39 T39
F S5 S5 T8 T8 T16 T16 T24 T24 T32 T32 T40 T40
G T1 T1 T9 T9 117 T17 T25 T25 T33 T33 T41 T41
H T2 T2 TIG TIG TIB T18 T26 T26 T34 T34 T42 T42
' " i
A:
Figure 10. The layout o f a 96 well plate for spectrophotometric analysis of protein 
content.
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Assay procedure
The following reagent (soP A) was prepared;'
50 parts 4% (w/v) sodium carbonate dissolved in O.IN NaOH.
1 part 1% (w/v) potassium tartate dissolved in distilled H ,0 .
1 part 0.5% (w/v) copper sulphate dissolved in H ,0.
55 pi of blank, protein standard or diluted AH sample was added in duplicate to each 
well in accordance with the plate design.
109 pi o f soP A was added to each well containing blank, protein standard or AH 
sample and left for 10 min.
Following this 16 pi o f IN  Folin-Ciocalteau reagent was added, mixed thoroughly 
and allowed to stand for 30 min.
The plate was read at a wavelength o f 750 nm using a plate reader.
Calculation of results
The plate reader calculated the average absorbance of the duplicate samples, then 
subtracted the absorbance readings of the blank wells from the absorbance readings 
from the standards and samples from rest of the plate. The concentration of protein in 
each sample was calculated by identifying the absorbance reading on the Y-axis of 
the standard curve and reading the corresponding value on the X-axis. Any sample 
dilution factors were taken into account to find the concentration of protein in the 
AH.
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Absorption of aciclovir in the cornea and aqueous humour
The absorption o f the antiviral drug, aciclovir was tested across the damaged cornea 
in the isolated bovine arterially perfused eye. Absorption was tested using three 
different formulations o f aciclovir: (i) a standard ocular ointment, white soft paraffin;
(ii) a novel vehicle, polyvinylalcohol (PVA) film; (iii) an experimental aqueous gel. 
The cornea was damaged both physically, by removing the epithelium, and 
chemically, by alkali burning, in an attempt to mimic the damage to the cornea 
associated with herpes simplex virus.
Bovine eyes were dissected, cannulated and perfused as described previously. In 
contrast to the previous experiments, the anterior chamber was not cannulated as the 
recording of lOP was not necessary.
Absoiption o f aciclovir was tested on the undamaged (control), physically damaged 
and chemically damaged bovine cornea.
Physical damage
Physical damage to the cornea was induced by complete removal o f the epithelium 
exposing the surface of the underlying stroma. A 14 mm diameter circle was marked 
on the epithelium with a steel trephine 14 mm in diameter. Epithelium within the 
circle was removed with a corneal scalpel.
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Chemical damage
Chemical damage to the cornea was induced by burning the cornea with alkali. 14 
mm discs o f #1 filter paper soaked in 4N NaOH were placed on the cornea for 3 min, 
after which the filter paper was removed and the cornea was im gated with 10 ml of 
0.9% NaCl solution to wash away any residual NaOH from the cornea. The damaged 
epithelium, within the 14 mm diameter, was then removed with a corneal scalpel to 
expose the damaged comeal stroma.
Formulation and application of aciclovir
Three fomiulations of the anti-viral drug, aciclovir were used to assess drug deliveiy 
to the eye across the cornea. All drug formulations were applied carefully to the 
surface of the cornea within the area of damaged tissue or within a 14 mm diameter 
area of undamaged tissue for control purposes.
PVA film
PVA is an H ,0  soluble polymer in which drug can be dissolved and drawn into strips 
forming a film. This was applied to the cornea as discs 11 mm in diameter. As the 
amount o f drug per cm" of film was known and easily manipulated, the amount of 
drug applied per disc o f film could be easily controlled.
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e.g. amount o f drug/ cn r of film = 4 mg
amount o f d ru g /11 mm diameter disc = n f  x 4 mg
= 0 .9 5 x 4
3.8 mg
An example o f preparation o f PVA film containing aciclovir (20% w/w):
• PVA solution (% PVA w.r.t. HjO; % aciclovir w.r.t. PVA) containing 85% H^O, 
12% PVA and 3% aciclovir.
• Weigh out the required amount of PVA and 14,0.
• Dissolve the PVA in the H ,0  by heating to <95°C, whilst continually mixing and 
checking the temperature with a thermometer.
• Leave the dissolved solution overnight, allowing air bubbles to escape.
• Weigh out the amount of aciclovir required and add to the PVA solution, mixing 
carefully and slowly.
• Leave the mixture for 2 - 3  hr, allowing the release of any air trapped during 
mixing.
• Clean TLC glass plate with alcohol, allow to dry and apply a thin layer of 
repelcote, leaving to dry for 3 - 4  min.
• Draw mixture into strips along glass plate, allowing to dry overnight.
■
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White soft paraffin
Aciclovir ointment (3% w/w) or ‘Zovirax’ is currently used clinically to treat heipes 
simplex virus in the eye. The vehicle for dmg delivery, white soft paraffin has a 
melting point of 40°C and a density of 0.9 with respect to water (M erck, 1989). In 
order to apply consistent volumes and therefore consistent amounts of drug to the 
surface o f the cornea, the formulation was melted in a water bath at a temperature of 
approx. 55°C. Exact volumes o f the formulation were rapidly withdrawn and applied 
to the corneal surface using a 50 pi microsyringe before the ointment cooled and 
resolidified. The amount of dmg contained in a known volume of melted white soft 
paraffin could be easily calculated by converting volume to weight (weight = volume 
X density). In order to apply a smaller concentration of aciclovir (1% w/w) to the 
cornea the 3% aciclovir formulation was diluted three fold with additional white soft 
paraffin by trituration on a slab.
Aqueous gel
This proprietary formulation utilises an aqueous gel vehicle, based on carbomer and 
hydroxyethyl cellulose, containing aciclovir at a concentration o f 1% w/w. This 
formulation of aciclovir was received in unit dose dispensers designed to deliver 30 
pi drops containing 300 pg of aciclovir directly onto the surface o f the cornea.
Tissue sampling and extraction of aciclovir from cornea and aqueous humour
180 min after topical application o f the drug to the perfused eye, two separate tissue 
sampling procedures were conducted.
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Firstly, approx. 1.5 ml of AH is removed from the anterior and posterior chambers of 
the eye using a 23G needle and 2.5 ml syringe. 0.5 ml o f the AH was added to 1.5 ml 
of extraction medium in 3ml vials.
Extraction medium for AH (total volume = 2000 pi):
500 pi AH
500 pi 0.8 M Perchloric Acid 
80 pi 1 M Potassium Hydroxide 
720 pi distilled H ,0
200 pi internal standard (ganciclovir, 100 pg.m f')
Secondly, the full thickness corneal button 14 mm in diameter was removed using a 
steel trephine. Cornea was weighed, finely chopped up to increase surface area, then 
added to 2 ml o f extraction medium in 3 ml vials.
Extraction medium for cornea (total vol. -  2000 pi + H ,0  content o f cornea):
Finely chopped cornea (approx. 0.2 g)
900 pi 0.1 M Hydrochloric Acid 
900 pi distilled H ,0
200 pi internal standard (ganciclovir, lOOpg.mf')
Aqueous humour and cornea samples were vortex mixed and left to incubate for 24 hr 
at room temperature (18 - 24°C). After incubation all samples were stored at -20°C 
until HPLC analysis.
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HPLC analysis
Prior to analysis all frozen samples were defrosted thoroughly, then centrifuged at 
1OOOOG for 5 min. The resulting supernatant was sampled for HPLC analysis.
Samples were analysed using a Gilson 712 automated liquid chromatograph 
comprising a 506 B system interface module, a 412 autosampler, two 306 pumps, a 
805 manometric module, 811 C dynamic mixer and 118 UV-vis detector linked to a 
Viglen 486 PC utilising Gilson 712 software. Reversed phase seperations were 
carried out at room temperature using a 150 x 3.20 mm i.d., 5 pm ODS-hypersil C;g 
column fitted with a 30 x 3.20 mm, 5 pm ODS-hypersil C,g guard column 
(Phenomenex, Cheshire, England) and an isocratic mobile phase comprising 20 mM 
ammonium acetate containing 1.2% acetic acid adjusted to pH 3.6, eluted at a flow 
rate of 0.5 ml.min ’. Column eluent was monitored at 254 nm. At this wavelength 
the limit of detection was 10 ng and a 10 - 200 ng linear calibration curve was 
obtained for the ganciclovir standard. With corneal and API samples the 
homogeneity of the aciclovir and ganciclovir peaks was confirmed by co­
chromatography. Absorption peaks and retention times were recorded on the PC and 
expressed as area under the peaks. The amount of aciclovir detected in each 20 pi 
sample was calculated by comparison o f area under the peak corresponding to 
aciclovir with area under the peak corresponding to internal standard, ganciclovir. 
Dilution factors were taken into account in order to calculate the total amount and 
concentration of drug found in corneal and API samples.
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Calculation of concentrations and amounts of aciclovir
The following equations were used to calculate the concentration and amounts of 
aciclovir found in the cornea and AH after HPLC analysis:
Calculations for concentration o f aciclovir per gram of cornea:
[aciclovir] (pg.g"‘) = [i.s.] x area aci./area i.s. x total vol./ tissue weight,
n.b. total vol. (ml) = vol. o f extraction medium + H^O content o f corneal sample
= 0.2 + (0.78 X tissue weight).
Calculations for the total amount of aciclovir per 14 mm corneal button: 
amnt. of aci. (pg) ^  [i.s.] x area aci./area i.s. x total vol.
Calculations for concentration o f aciclovir per ml of AH:
[aciclovir] (pg.m f') = [i.s.] x area aci./area i.s. x dilution factor.
Dilution factor equals 8 for 0.5 ml AH samples diluted to a total vol. o f 2 ml in 
aqueous extraction medium.
Calculations for total amnt. o f aciclovir in the AH (total vol. in eye ~2 ml); 
amnt. o f aci. (pg) = [i.s.] x area aci./area i.s. x dilution factor x 2
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The concentration of internal standard present in cornea and AH extraction samples 
is dependent on the total vol. o f the extraction media + sample. AH samples have a 
total volume of 2 ml, containing 0.2 ml of i.s. (100 pg.m f'), resulting in a ten fold 
dilution o f i.s., and a final conc. in AH extraction medium o f 10 pg.m f'. Corneal 
samples have a greater total volume due to H ,0  content of the cornea, therefore the 
final concentration of i.s. is slightly less than 10 p g .m f (see equation below).
conc. o f i.s. in comeal samples = vol. o f i.s./total vol. x conc. o f i.s.
= 0.2 / (2 + (0.78 X tissue weight)) x 100.
Statistical analysis of data
Results are expressed as the mean ± SEM of n experiments (n = number of individual
eyes tested). Statistical comparisons were generally made by Student’s unpaired t-
tests for TOP, protein concentration and corneal absorption data. Statistical
»
comparisons for dose-response and concentration-response curves were made by 
one-way analysis of variance followed by the Bonferroni post-test. A value of p< 
0.05 was considered significant. Graphical representations and statistical analysis 
were performed using a computer-based programme (Graph Pad, Prism).
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Procurement and disposal of bovine and ovine eyes
Bovine and ovine eyes obtained from a local abattoir were transported to the 
laboratory in a labelled container in accordance with the UK ‘specified bovine 
material order 1997’ and ‘the heads o f sheep and goats order 1996’ (see Appendix 
IV). Material that was no longer required was stained with patent blue V colouring 
agent (0.5% w/v) and incinerated. A record of the weight of the specified material, 
place o f origin, date o f consigmnent, method and place o f disposal shall be kept for 2 
years.
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Results: The Effects o f  Drugs on TOP.
THE EFFECTS OF DRUGS ON TOP AND BLOOD-AQUEOUS BARRIER 
INTEGRITY OF THE BOVINE EYE 
Steady-state lO P
After camuilation o f the anterior chamber, the I OP usually stabilised at a value 
between 95 and 160 mm H^O. The steady-state or mean starting lOP was recorded at 
t = 0, prior to drug or vehicle administration, for eyes perfused with Krebs’ solution 
in the presence or absence o f 1% BSA (Table 4). Drugs were administered to the eye 
by intra-arterial or intracameral injection. Intracameral injection of drugs directly 
into the anterior chamber involves introducing a second needle through the cornea. 
The effect on steady-state lOP o f piercing the cornea with that second needle is also 
shown in table 4, using data from all eyes tested (i.e., those destined to be injected 
with either a drug or vehicle only). The data in table 4 also indicates that inclusion of 
BSA in the Ki'ebs’ solution had no significant effect on the starting lOP value at t = 0 
when the eornea was pierced with one needle only. Insertion of a second corneal 
needle caused a significantly higher starting lOP when perfusion was with Ki'ebs’ 
solution alone, whereas this manoeuvre appeared to have the opposite effect when 
BSA was included in the perfusate.
85
Results: The Effects o f  Drugs ou TOP.
Table 4. Steady-state lOP values for eyes perfused with Krebs’ solution or 
Krebs’ solution plus BSA (1% w/v).
Perfusate Route for drug administration n lOP (mm H P )
Krebs’ Intra-arterial 155 131.60 + 1.19
Ki'ebs’ Intracameral 49 136.43 ±2.05*
Krebs’ + BSA Intra-arterial 138 126.71 ± 1.34
Ki'ebs’ + BSA Intracameral 40 118T0±2.13***
Steady-state values for lOP, at t = 0, from eyes perfused with Ki'ebs’ solution or 
Ki'ebs’ + BSA (1% w/v). All pressures (mm H^O) are means ± SEM of the number 
o f eyes shown (n). To convert lOP from mm H^O to mm Hg, divide the value 
obtained from the water manometer by 13.546, the specific gravity of mercury 
(specific gravity H ,0  = 1). Significance of differences (Student’s unpaired t-test) 
among eyes prepared for intra-arterial vs intracameral drug administration: * 0.01 < 
p<0.05; ***p< 0.001.
86
Results: The Effects o f  Drugs on TOP...
Figure 11. Histogram of steady-state lO P values at t = 0.
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A histogram showing the range o f steady-state or mean starting TOP values (t = 0) for 
eyes perfused with Krebs’ solution or Krebs’ solution + BSA (1% w/v) is shown in 
figure 11. The average starting TOP (mean ± S.D.) value for 204 eyes perfused with 
Krebs’ solution alone was 132.76 ± 14.77 mm H P . When BSA was included in the 
perfusate the average starting lOP value for 178 eyes was 124.78 ± 15.60 mm H p .  
Conversion o f lOP from mm H^O to mm Hg, divide the value obtained from the 
water manometer by 13.546, the specific gravity o f mercury (specific gravity fÇO =
i)
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The effect of different vehicles and routes of administration on the ÏOP of eyes 
arterially perfused for control purposes
Variation in the I OP o f the isolated perfused eye was tested using two alternative 
vehicles for drug administration, distilled H P  or sodium bicarbonate solution (10 
mg.ml"'), injected via the intra-arterial or intracameral route. Eyes were perfused 
with Krebs’ solution or Ki'ebs’ solution plus BSA (1% w/v). Change in the vehicle 
or route o f administration was not found to significantly alter lOP. Table 5 shows 
the results in terms of mean slopes for all control groups.
The effect on lOP o f including BSA (1% w/v) in the perfusate was shown by 
comparing the mean slopes for all control eyes perfused with Krebs’ solution and all 
control eyes perfused with Ki'ebs’ solution plus BSA. It was found that inclusion of 
BSA in the perfusate did not significantly affect lOP (Table 6).
Figure 12 shows the representative graphs of the mean lOP recordings at each time 
point in control eyes perfused with Krebs’ solution or Krebs’ solution plus BSA. 
Mean lOP values from -15 to 0 min show the steady-state pressure with fluctuations 
less than ±2 mm H p  over this period. From 0 to 90 min changes in lOP occur in a 
linear manner allowing calculation o f the slope value to be made.
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Table 5. The effects of the vehicle and route of vehicle administration on 
control lO P responses.
Perfusate Vehicle Volume (|ul) Route n Slope (mm H p .m in  ')
Krebs’ nil i.a. 24 -0.05 ± 0.02
Krebs’ H P 6 i.a. 15 -0.02 ± 0.03
Krebs’ H P 10 i.a. 20 -0.03 + 0.02"'
Krebs’ H P 10 i.e. 14 -0.04 + 0.02"'
Krebs’ + BSA ----- nil i.a. 26 -0.02 + 0.01
Krebs’ + BSA H P 6 i.a. 8 -0.05 + 0.01"'
Krebs’ + BSA NaHCO, sol" 6 i.a. 6 -0.01 + 0.01 " '
Krebs’ + BSA NaHCO, sol" 6 i.e. 8 -0.06 + 0.02"'
The effects of the vehicle and route o f vehicle administration on control lOP 
responses in the bovine isolated eye perfused with Krebs’ solution or Krebs’ solution 
plus BSA (1% w/v) shown as the mean slope (mm H p.m in"') o f the regression line 
drawn on TOP vs time (90 min). Each value is a mean ± SEM of the number of 
experiments shown (n). Significance of difference (Student’s unpaired t-test) from 
control eyes perfused with Krebs’ solution or Krebs’ solution plus BSA; not 
significant.
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Table 6. The effect on control lOP responses of including BSA (1% w/v) in the 
perfusate.
Perfusate n Slope (mm H^O.min')
Ki'ebs’ 73 -0.04 ± 0.01
Ki'ebs’ + BSA (1% w/v) 48 -0.03 + 0.01"'
The effects o f perfusion with Krebs’ solution or Ki'ebs’ solution plus BSA (1% w/v) 
on lOP in control eyes, shown as the mean slope (mm H^O.mhv') of the regression 
line drawn on lOP vs time (90 min). Each value is a mean ± SEM of the number of 
experiments shown (n). Significance o f difference (Student’s unpaired t-test) from 
control eyes perfused with Krebs’ solution or Krebs’ solution plus BSA: not
significant.
9 0
Figure 12. The changes in control lOP responses o f eyes perfused with a) Krebs’ 
solution or b) Krebs’ solution plus BSA (1% w/v). The data is expressed as the mean 
± SEM at each time point for >20 eyes.
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Effect of pilocarpine on pupil size
Drug delivery to the anterior uvea o f the isolated bovine eye was tested by 
measurement o f the pupil diameter before and after 90 min of intra-arterial perfusion 
o f pilocarpine (lO'^’M). Pilocarpine was found to significantly reduce the diameter of 
the pupil. The results are shown in table 7.
Table 7. The effects of pilocarpine (10'  ^M) on pupil diameter.
n Pupil size (mm)
Before pilocarpine 5 16.5 ±0 .6
After pilocarpine 5 13.1+0.2**
Each eye was perfused with Krebs’ so iition at a flow rate o f 2.25 m l.m in' for 20 min
before the diameter (mm) o f the pupil was measured using a Vernier calliper. Each 
eye was then perfused for 90 min with Ki'ebs’ solution containing pilocarpine (10''’ 
M) before the pupil diameter was measured again. Each value is a mean ± SEM of 
the number of experiments shown (n). Significance of difference (Student’s unpaired 
t-test): ** 0.001 < p< 0.01.
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The effect of pilocarpine on lOP
The effect o f pilocarpine on lOP in the bovine isolated eye perfused with Krebs’ 
solution was studied over a period o f 90 rain. Table 8a shows the results in tenus of 
mean slopes for treated and control groups.
Unexpectedly pilocarpine caused a significant increase in lOP at all concentrations 
tested (3 X 10"^  - 5 X 10 '’ M). These results suggested that pilocarpine might be 
increasing lOP by disrupting the integrity o f the BAB. In order to test this the effects 
of pilocarpine were studied on eyes which were perfused with Ki'ebs’ plus BSA (1% 
w/v). lOP was recorded for 90 min as before and AH was sampled at the end of the 
experiment to determine whether protein had leaked from the vascular compartment.
After including BSA (1% w/v) in the perfusate lOP was found to be reduced 
significantly by three concentrations o f pilocaipine, 10"'’ M, 3 x 10"^  M and 10"" M. 
At 3 X 10"^  M there was no significant change in lOP. The results are shown in table 
8b.
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Table 8. The effect of pilocarpine on lOP.
a) eyes perfused with Krebs’ solution
Treatment Conc. (M) n Slope (mm H^O.min')
Control ----- 24 -0.06 ± 0.02
Pilocarpine 3 x 1 0 ^ 6 0.16 ±0.03***
10-6 12 0.01 ± 0.04**
3 x 1 0 ^ 6 0.35 + 0.05***
5 X lO" 6 0.23 ± 0.08***
;
:
b) eyes perfused with Krebs’ solution containing BSA (1% w/v)
Treatment Conc. (M) n Slope (mean ± SEM)
Control ----- 26 -0.02 ±0.01
Pilocarpine 3 x 1 0 ^ 10 -0.03 ± 0.04" '
10-6 8 -0.16 ±0.02***
3 x 1 0 ^ 16 -0.10 ±0.02**
lOC 12 -0.08 ± 0.02*
1
The effects o f pilocarpine on lOP in the bovine isolated eye perfused with a) Krebs’ 
solution and b) Krebs’ solution plus BSA (1% w/v), shown as the mean slope (mm 
H^O.min ') o f the regression line drawn on lOP vs time from 20 - 90 min after drug 
administration. Each value is a mean ± SEM of the number of experiments shown 
(n)_. .Significance o f differences (Student’s unpaired t-test) from control: not
significant; * 0.01<p< 0.05; ** 0.001<p< 0.01; *** p< 0.001.
4
■I
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The effect of pilocarpine on protein concentration in the aqueous humour
The effects o f pilocarpine on the concentration of protein in the AH are shown in 
table 9. At 3 X 10'^ M, 10"'^  M and 3 x 10"'’ M pilocarpine there was no significant 
change in protein concentration. However at 1 O'" M there was a significant reduction 
in protein concentration.
Table 9. Concentration of protein in the AH after perfusion with pilocarpine.
Treatment Conc. (M) n [protein] (pg.ml"')
Control ----- 19 814.47 + 97.41
Pilocarpine 3 x 1 0 ^ 10 914.70 ±64.23 " '
1(H 8 581.63 ±30.72"'
3 x 1 0 ^ 10 628.00 ±78.15"'
10" 9 410.00 ±51.95*
Effects o f pilocarpine on protein concentration in the AH, sampled 90 min after 
commencing drug perfusion, shown as pg o f protein per ml o f AH. Each value is 
mean ± SEM of the number (n) o f experiments shown. Significance of difference 
(Students unpaired t-test) from control: not significant; * 0.01 < p< 0.05.
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The effect of pilocarpine on lO P in the ovine eye
Pilocarpine (10"'’ M) had no effect on lOP in the ovine isolated eye perfused with 
Krebs’ solution (Table 10).
Table 10. The effect of pilocarpine on lOP in the ovine eye.
Treatment Conc. (M) n Slope (mm H^O.min"')
Control ---- - 6 0.03 ± 0.02
Pilocarpine ICCM 10 -0.01 ±0.02
The effects o f pilocarpine on lOP in the ovine isolated eye perfused with Krebs’ 
solution, shown as the mean slope (mm H^O.min') o f the regression line drawn on 
lOP vs time from 20 - 90 min after drug administration. Each value is a mean ± 
SEM of the number o f experiments shown (n). Significance o f differences (Student’s 
unpaired t-test) from control: not significant.
■
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The effect on IQP of apraclonidiiie injected intra-arterially.
The effects on lOP o f four intra-arterial bolus doses, 10, 30, 100 or 300 nmol of 
apraclonidiiie, were studied for a period o f 90 min. As the change in TOP in response 
to apraclonidiiie injection was non-linear over the 90 min period, regression lines 
were calculated over periods o f linearity (Figure 13). This resulted in two slope 
values conesponding to the initial changes in lOP from 0 - 30 min after injection 
(Table 11a) and the delayed changes from 30 - 90 min after injection (Table 1 lb). 10 
and 30 nmol doses of apraclonidiiie do not show a significant initial or delayed effect 
on lOP , whereas 100 and 300 nmol doses significantly increase the initial and 
delayed lOP response.
9 7
Figure 13. The change in I OP in response to a) intra-arterial injection and b) 
intracameral injection o f 100 nmol bolus doses o f apraclonidiiie. The data is 
expressed as the mean IQP at each time point for 8 eyes.
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Table 11. The effect on lOP of apraclonidine injected intra-arterially.
a) Slope calculated from 0 - 3 0  min after drug injection
Treatment Dose (nmol) n Slope (mm 13,0.m in ')
Control ----- 20 0.03 ± 0.02
Apraclonidine 10 8 0.08 ± 0.03
30 9 0.03 ± 0.05
100 8 0.26 ±0.12*
300 8 0.26 ± 0.06***
b) Slope calculated from 30 - 90 min after drug injection
Treatment Dose (nmol) n Slope (mm H^O.min ')
Control — 20 -0.04 ±0.01
Apraclonidine 10 8 -0.00 ±0.01
30 9 -0.07 ± 0.03
100 8 0.03 ± 0.03**
300 8 0.19 ±0.06***
.............. .... .................. .................
I
The effects o f bolus doses of apraclonidine injected intra-arterially on lOP in the 
bovine isolated perfused eye, shown as the mean slope (mm hbO.min'') o f the 
regression line drawn on TOP vs time; a). 0 - 30 min, b). 30 - 90 min. Each value is a 
mean ± SEM of the number o f experiments shown (n). Significance of difference 
(Student’s unpaired t-test) from control (intra-arterial injections o f 10 pi ofH .O ): 
not significant; 0.01< p< 0.05; 0.00l< p< 0.01; *** p< O.OOl.
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The effect of apraclonidine on protein concentration in the aqueous humour
Intra-arterial injection o f a single bolus dose of apraclonidine (300 nmol) had no 
significant effect on the protein concentration of the AH. Aqueous samples taken 90 
min after the injection o f 300 nmol apraclonidine in 10 eyes contained protein at a 
concentration o f 910.62 ± 168.23 p g .m f compared to a protein concentration of 
814.47 ± 97.41 pg.m f' for 19 control eyes. Statistical analysis was performed using 
a Student’s t-test for unpaired data.
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The effect on lO P of apraclonidine injected intracamerally
The effects on lOP o f four intracameral bolus doses, 10, 30, 100 or 300 nmol of 
apraclonidine, were studied for a period of 90 min. Changes in I OP over the 90 min 
period indicate linearity up to 30 min after drug injection and from 30 - 90 min after 
drug injection (Figure 13). A small but significant reduction in lOP was observed for 
the first 30 min after injection of the 30 nmol dose (Table 12a). No significant 
change in lOP was observed over this period for 10, 100 or 300 nmol doses. lOP 
was shown to significantly increase during the period 30 - 90 min after injection of 
100 or 300 nmol doses (Table 12b). No significant change in lOP was shown for 10 
or 30 nmol doses.
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Table 12. The effect on lO P of apraclonidine injected intracamerally. 
a) Slopes calculated from 0 - 3 0  min after drug injection
Treatment Dose (nmol) n Slope (mm H jO .m in')
Control ----- 14 0.05 ± 0.03
Apraclonidine 10 8 0.04 ± 0.02
30 8 -0.06 ± 0.03*
100 8 0.04 ± 0.04 " '
300 6 0.08 ±0.04'"
1
9
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b) Slopes calculated from 30 - 90 min after drug injection
Treatment Dose (nmol) N Slope (mm H^O.min ')
Control — 14 -a 0 8 ± 0 d %  f
Apraclonidine 10 8 0.01 ± 0 .02
30 8 -0.13 ±0.03
100 8 0.02 ± 0.03*
300 6 0.08 ± 0.05*
The effects on lOP o f bolus doses o f apraclonidine injected intracamerally in the 
bovine isolated perfused eye, shown as the mean slope (mm H^O.min') o f the 
regression line drawn on lOP vs time; a) 0 -  30 min, b) 30 -  90 min. Each value is a 
mean ± SEM of the number o f experiments shown (n). Significance of differences 
(Sfudenfs unpaired t-test) from control (intracameral injections o f 10 pi o f H^O); 
not significant; * 0 .01< p< 0.05.
■■I
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The effect of apraclonidine on vascular perfusion p ressure
intia-aiteiial injection o f bolus doses o f apraclonidine resulted in a dose-dependent 
increase in vascular perfusion pressure, characterised by an initial rapid increase in 
pi essuie, leaching a peak within 5 min post-injection. After the peak response the 
pressure decreased to stabilise at a level above the pre-injection pressure. Figure 14 
shows examples o f the vascular response to intra-arterial injection o f apraclonidine. 
After excluding the injection artefact, characterised by a slight increase in perfusion 
pressure (< 5 mm Hg) followed by an immediate return to the basal level, intra- 
arterial injection o f the drug vehicle, <10 pi distilled H ,0 , did not alter vascular 
perfusion pressure.
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Figure 14. Examples of changes in vascular perfusion pressure after intra-arterial 
injection o f a) 30 nmol and b) 100 nmol of apraclonidine.
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The effect of g-adrenergic antagonists on the short term vascular response to 
apraclonidine and iioi adrenaline
Intra-arterial injection o f bolus doses o f the control agonists, apraclonidine (10 nmol 
- Ipmol) and noradrenaline (10 nmol - Ipmol) increased vascular perfusion pressure 
in a dose-dependent manner (Figure 15).
In the repeated experiments the presence o f the Œg-adrenergic antagonist, yohimbine 
(3 X 10'*^  M) significantly decreased the vascular responses to apraclonidine (Figure 
16a), but failed to affect the responses to noradrenaline (Figure 16b).
In the repeated experiments the presence o f the a^-adrenergic antagonist, prazosin (3 
X 10"^ ’ M) significantly decreased the vascular responses to apraclonidine (Figure 17a) 
and higher doses o f noradrenaline (Figure 17b).
It was noted that there were slight variations in the control responses to the agonists, 
apraclonidine and noradrenaline (Figure 15, 16 & 17), due to different populations of 
eyes.
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Figure 15. Log dose-response curve following intra-arterial injection of bolus doses 
of the control agonists a) apraclonidine and b) noradrenaline. Each data point 
represents the mean ± SEM of >20 eyes.
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Figure 16. Agonist dose-response curve in the presence and absence o f yohimbine 
(3 X 10'  ^ M) following intra-arterial injection of bolus doses of the agonists a) 
apraclonidine and b) noradrenaline. Each data point represents the mean ± SEM of > 
10 eyes.
0.001; 0.001< p< 0.01 : significance of difference between control and
yohimbine pre-treated eyes (ANOVA, followed by Bonferroni analysis).
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Figure 17. Agonist dose-response curve in the presence and absence o f prazosin (3 x 
10'  ^ M) following intra-arterial injection of bolus doses o f the agonists a) 
apraclonidine and b) noradrenaline. Each data point represents the mean ± SEM of > 
9 eyes.
p< 0.001; 0.001< p< 0.01; 0.01 < p< 0.05: significance o f difference
between control and prazosin pre-treated eyes (ANOVA, followed by Bonferroni 
analysis).
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The effect of a-adrenergic antagonists on the sustained vascular response to 
apracloiiidine
Perfusion o f apraclonidine (10'^ - 10’^  M) produced a sustained increase in vascular 
perfusion pressure, represented by a “bell-shaped” curve (Figure 18).
The selective a^-adrenergic antagonist, delequamine (10 ® and 10'  ^ M) did not affect 
the sustained vascular response to apraclonidine. Although delequamine (10'^ M) 
decreased the sustained vascular response to apraclonidine, this effect was not 
statistically significant.
Prazosin (10"® - lO'*^  M) had no effect on the sustained vascular responses to 3 x 10 ® 
or 10"’ M apraclonidine.
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Figure 18. Log concentration-response curves showing the effect o f delequamine 
(10'® - 10'^ ’ M) on contraction to apraclonidine (10'® - 10'  ^ M) in the vascular beds of 
the bovine perfused eye. Each data point represents the mean ± SEM of > 8 eyes.
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Figure 18, Log concentration-response curves showing the effect of delequamine 
(10"  ^ - 10’^’ M) on contraction to apraclonidine (10'^ - 10'  ^ M) in the vascular beds of 
the bovine perfused eye. Each data point represents the mean ± SEM of > 8 eyes.
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The effect o fP G F ^  on lOP
The effects of five intra-arterially administered bolus doses, 20, 60, 200, 600 or 2000 
nmol o f PGF,,„ on lOP in eyes perfused with Krebs’ solution, were studied for a 
period o f 180 min. All five doses failed to significantly influence lOP compared to 
control groups (Table 13a).
After the inclusion of BSA (1% w/v) in the perfusate, intra-arterial injection of 20, 
200, 600 or 2000 nmol doses o f PGF,^^ did not significantly change lOP (Table 13b).
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Table 13. Effect of PGFja on the lOP
a) eyes perfused with Krebs’ solution
Treatment Dose (nmol) N Slope (mm H.O.min ')
Control ----- 15 -0.02 ± 0.03
PGF,, 20 7 -0.01 ± 0 .0 3 '"
60 8 0.05 ± 0 .0 2 '"
200 6 -0.01 ± 0 .0 2 '"
600 7 -0.07 ±0.02
2000 7 -0.03 ± 0 .0 2 '"
b) eyes perfused with Krebs’ solution containing BSA (1% w/v)
Treatment Dose (nmol) n Slope (mm H .O .m in’)
Control 8 -0.05 ±0.01
PGF,, 20 8 -0.12 ±0.03 " '
200 6 -0.03 ±0 .02  '"
600 6 -0.08 ± 0 .0 4 '"
2000 6 -0.07 ± 0 .0 3 '"
The effects o f bolus doses o f PGF^u injected intra-arterially, on I OP in the bovine 
isolated eye perfused with a) Krebs’ solution, b) Ki’ebs’ solution plus BSA (1% w/v), 
shown as the mean slope (mm PTO.min ') o f the regression line drawn of lOP vs time 
(180 min). Each value is a mean ± SEM of the number of experiments shown (n). 
Significance o f differences (Student’s unpaired t-test); " ' not significant.
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The effect of prostaglandins on the integrity of the blood-aqueous barrier
The effect o f intra-arterial (Table 14a.) and intracameral (Table 14b.) injection o f 600 
nmol of PGFia oii the integrity o f the BAB (expressed as changes in AH protein 
concentration) is shown overleaf. No significant change was observed in the protein 
concentration o f the AH for PGF,^ treated eyes compared to control eyes.
The effect o f intra-arterial (Table 14a.) or intracameral (Table 14b.) injection o f PGE, 
on the integrity o f the BAB was tested. Intra-arterial injection of 60 nmol PGE, 
significantly increased the concentration o f protein detected in the AH. 
Paradoxically, the small increases in protein concentration detected after intra-arterial 
injections o f 200 or 600 nmol PGE? were not statistically significant. Intracameral 
injection o f 600 nmol PGE^ significantly increased AH protein concentration. 
Smaller increases in AH protein concentration found following intracameral injection 
o f 60 or 200 nmol PGE^ were not statistically significant.
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Table 14. The effect of prostaglandins on protein concentration in the aqueous 
humour.
a) intra-arterial drug administration
Treatment Dose (nmol) n [protein] (pg.m f')
Control ----- 6 690 + 63.4
PGF,, 600 6 769 ± 102.1
PGE^ 60 6 2490 + 716.5*
200 8 1140 ±415.1 '"
600 9 1556 ± 555.6'"
b) intracameral drug administration
Treatment Dose (nmol) n [protein] (pg.mC)
Control - --- 5 652 ±50f8
PGF,, 600 6 698 ± 8 7 /F "
PGE, 60 5 1234 ± 574.8'"
200 13 855 +413.2
600 10 3490 ± 156.8***
Effects of prostaglandins injected a) intra- arterially ano b) intracamerally on protein
concentration, shown as pg of protein per ml of AH in eyes perfused with Krebs’ 
solution plus BSA (1% w/v). AH was sampled 180 min after commencing drug 
perfusion. Each value is mean ± SEM of the number (n) of experiments shown. 
Significance o f difference (Students unpaired t-test) from control; not significant; 
* 0 .01 < p< 0.05; p< 0,001.
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The effect of PGR, on lOP
The effect o f PGE^ on lOP cannot be expressed as the mean slopes for all eyes tested 
as these increases in lOP usually occuned in a non-linear manner and often 
continued above 300 mm H ,0  (the maximum value which could be registered on the 
water manometer). When these data for lOP are expressed as a function of the 
concentration o f protein detected in the AH (Figure 19), there was no correlation 
between these parameters.
Inspection o f the raw data indicates that while a substantial number o f eyes suffer an 
apparent breakdown o f the BAB, many others do not show a rapid lOP increase. In 
an effort to analyse the data for the latter population it was felt necessary to adopt an 
arbitrary criterion: those eyes which showed a rise in lOP > 0.5 mm H ,0.m in '' at 90 
min after drug administration were rejected. For the initial 90 min period after drug 
administration, 1 eye was rejected following intra-arterial injection (Table 15a.) and 
8 eyes were rejected following intracameral injection (Table 15b.). Calculation of 
the mean slope for the remaining eyes from 1 0 - 9 0  min following injection of the 
drug showed that PGE, has no significant effect on lOP (Table 15). Over the 
subsequent 90 min further eyes showed this rapid lOP response (Table 15).
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Figure 19. The effect o f a) intra-arterial and b) intracameral injections o f PGE, on 
the protein concentration of the AH. AH samples were removed from the eye 180 
min after drug injection. Each point represents an individual experiment. The x-axis 
represents the lOP expressed as mm H^O. Values exceeding 300 mm H^O are shown 
as 300 mm H^O. The y-axis represents the concentration o f protein detected in 
samples of AH expressed as pg per ml o f AH.
Results: The Effects o f  Drugs on lO P.
a .
9000-
E 6000
c
Û. 3000
0 -J
ë  m mm
100 200
lO P  (m m  H 2O )
300
b .
9000-
E 6000 
d )
CIa  3000
0 ^
■ 9 a
■ #
1 0 0 200
! 0 P  (m m  H gO)
300
115
Results: The Effects o f  Drugs on lO P ,,.
Table 15. The effect of PGEj on lOP, plus the number of eyes showing signs of 
breakdown in the BAB.
a) intra-arterial drug administration
Dose Total Slope No. of eyes showing an lOP response
(nmol) No. of (1 0 -9 0  mill) suggesting breakdown o f the BAB
Eyes (mm H^O.min ') (n) 0 - 90 min 90 - 180 min
Control 6 -0 . 0 1  ± 0 . 0 1  (6 ) 0 0
60 6 0.00 ±0 .05  (5) 1 5
2 0 0 8 -0.09 ± 0.03 (8 ) 0 2
600 9 -0.02 ± 0.04 (9) 0 6
b) intracameral drug administration
Dose Total Slope No. of eyes showing an lOP response
(nmol) No. of (1 0 -9 0  min) suggesting breakdown o f the BAB
Eyes (mm Ho0 .min ') (n) 0 - 90 mill 0 -1 8 0  mill
Control 8 -0.07 ± 0 .02  (8 ) 0 0
60 5 -0.04 ±0 .03  (4) 1 5
2 0 0 13 -0.05 ± 0 .02  (12) 1 3
600 1 1 0.01 ± 0 .02  (5) 6 9
'■'I
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The effects o f bolus doses of PGE, administered by a) intra-arterial or b) intracameral 
injection, on lOP, shown as the mean slope (mm H ,0.m in '') o f the regression line 
drawn of lOP vs time (10 - 90 min), for eyes which meet the criterion explained in 
the text. Each value is a mean ± SEM of the number of experiments shown (n). 
Column 2 shows the total number of experiments conducted. Columns 4 and 5 show 
the number of eyes that indicate an apparent breakdown of the BAB at 90 and 180 
min following drug administration respectively.
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ABSORPTION OF ACTCLQVTR IN THE BOVINE PERFUSED EYE
HPLC analysis
Under the chromatographic conditions described in the methods, the internal 
standard, ganciclovir, was identified with a retention time of approx. 8  min (Figure 
20a). Aciclovir in the cornea and AH was identified with a retention time o f approx. 
10.8 min (Figure 20b and c). The calibration graph for ganciclovir, obtained by the 
peak-area method, was linear with a coiTelation coefficient, r = 0.999 in the range 10 
- 200 ng (Figure 21). The limit o f detection o f aciclovir in the cornea and AH was 
calculated from the limit o f detection o f ganciclovir per 20 pi injection. The limit of 
detection of aciclovir in corneal buttons varied according to the pre-treatment of the 
cornea (Table 16). The limit o f detection in the AH was 2 pg/ml.
y?'
Table 16. Limit of detection of aciclovir in the cornea.
Corneal pre-treatment Limit of detection o f aciclovir (pg)
Undamaged 1.056
Physically damaged T053
Chemically damaged 1.083
■1;
,;,v;
'2
The limit of detection for aciclovir in 14 mm diameter full-thickness corneal buttons 
excised from pre-treated corneas.
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Figure 20. Sample chromatograms following isocratic reversed phase HPLC 
analysis of; a) the internal standard, ganciclovir; b) a corneal sample; and c) an AH 
sample. Samples of cornea and AH were taken 180 minutes after application of 3% 
film formulation to the physically damaged cornea. U unidentified peaks 
characteristic of b) corneal samples and c) AH samples. G = ganciclovir. A - 
aciclovir.
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Figure 21. The calibration curve of ganciclovir following injection of 10, 20, 100 
and 200 ng doses onto the HPLC column.
119
Results: Absorption o f  Aciclovir
Absorption of aciclovir into the cornea and aqueous humour
Following topical application o f different drug formulations, the level of aciclovir 
absorbed into the cornea and AH was measured in eyes which had been chemically 
damaged (4N NaOH burn), physically damaged (epithelium removed) or were 
undamaged (epithelium intact). An overview of all the results o f the concentrations 
o f aciclovir detected in the cornea and AH, for each formulation and corneal pre­
treatment, is shown in figures 22a and b. This overview indicates several main 
trends:
• Chemical and physical damage to the cornea greatly increases the concentration of 
aciclovir absorbed into the cornea and the AH.
• Generally, the level o f absorption is greater after removal of the epithelium 
compared with alkali burning o f the cornea.
• When the epithelium remains undamaged there is no detectable level o f aciclovir 
found in the AH except at the highest concentration of drug applied (20% film).
® The concentration o f aciclovir detected in the cornea and the AH varies according 
to the fonmilation in which it is applied, even when the dose is constant.
More detailed comparisons and statistical analyses of these data follow in figures 23 
to 29.
120
Figure 22. A general overview o f the results, showing the concentration o f aciclovir 
detected in a) the cornea and b) AH, after application o f different doses o f aciclovir 
contained in various foniiulations, following three different pre-treatments o f the 
cornea. Each bar represents the mean of at least 6  experiments.
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The effect of increasing the concentration of aciclovir in the film formulation
Increasing the concentration o f aciclovir in the film formulation increases the 
concentration o f aciclovir detected in the cornea (Figure 23a) and AH (Figure 23b).
After chemical or physical damage to the cornea, each increase in film concentration 
resulted in a significant increase in the concentration o f aciclovir detected in the 
cornea. In eyes with undamaged corneas, the apparent increases in the concentration 
of aciclovir detected in the cornea following each increase in film concentration were 
found not to be statistically significant.
After chemically or physically damaging the cornea, there were statistically 
significant increases in the concentration o f aciclovir detected in the AH between the 
1% and 1.6% film, the 1.6% and 20% film and the 3% and 20% film. The difference 
in concentrations between the 1.6% and 3% film was found not to be significant 
following either pre-treatment. Only at the highest aciclovir concentration of 20% 
was there any detectable level of absorption into AH where the cornea was 
undamaged.
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Figure 23. The differences in drug absorption in a) the cornea and b) AH among 
increasing concentrations of aciclovir in the film formulation. Each bar represents 
Ihe mean ± SEM of at least 6  experiments. Aciclovir concentrations represented here 
as zero, in fact indicate levels o f drug < the limit of detection in the cornea and AH 
(see table 15).
p< 0.001; 0.001< p< 0.01; ^ 0.01< p< 0.05: significance of difference among
concentrations of aciclovir detected in eyes which have been chemically damaged 
(pre-treated with 4N NaOH)
0.001 < p< 0.01; * 0.01 < p< 0.05: significance of difference among concentrations 
o f aciclovir detected in eyes which have been physically damaged (epithelium 
removed).
p< 0 .0 0 1 : significance o f difference among concentrations of aciclovir in eyes 
with undamaged cornea (epithelium intact).
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The effect of different pre-treatments on the weight of corneal buttons
Prior to acid extraction, full-thickness comeal buttons were removed from the eye 
and weighed. After chemically damaging the cornea with 4N NaOH the excised 
corneal buttons were found to be significantly heavier than comeal buttons from the 
physically damaged and undamaged cornea (Table 17). Undamaged corneal buttons 
were also significantly heavier than comeal buttons from physically damaged 
corneas where the epithelium has been removed (Table 17).
Table 17. The effect of different pre-treatments on the corneal button weight
Corneal pre-treatment n mean ± SEM (g)
Undamaged (epithelium intact) 57 0.143 ±0.002
Physically damaged (epithelium removed) 49 0.135 ±0.002**
Chemically damaged (4N NaOH burn) 58 0.212 ±0.004***
The effect of physically or chemically damaging t 1 6  cornea on the weight (g) of
excised 14 mm diameter corneal buttons. Each value is the mean ± SEM of the 
number of experiments shown (n).
Significance of difference (Student’s unpaired t-test) from undamaged corneal 
buttons: 0.001 < p< 0.01 ; *** p< 0.001.
Significance of difference (Student’s unpaired t-test) from physically damaged 
corneal buttons:  ^  ^  ^p< 0.001.
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The effect of different pre-treatments on the concentration of aciclovir detected 
in the cornea and aqueous humour
The effect o f different pre-treatments on the level of aciclovir absorption following 
application of the film, ointment or gel formulation is shown in figures 24 and 25.
Application of the 1% film resulted in a significantly greater eoncentration of 
aciclovir in the cornea when it was undamaged compared to chemically damaged 
(Figure 24a). Physically damaging the cornea also resulted in a significantly greater 
concentration of aciclovir compared to chemically damaged. No difference was 
deteeted between the physically damaged and undamaged cornea following 
application o f 1% film. Following application of 1.6 % film there were no significant 
differences in the concentration o f aciclovir detected in the cornea among all the pre­
treatments. Compared to the undamaged or chemically damaged cornea, physically 
damaging the cornea resulted in a significant increase in the concentration detected in 
the cornea following application o f 3% film. The difference between undamaged and 
chemically damaged cornea was not statistically significant. At the highest film 
concentration (2 0 %), chemical or physical damage to the cornea resulted in a 
significant increase in the concentration o f aciclovir detected in the cornea. There 
were no significant differences in the concentrations detected in the AH between 
chemically and physically damaged cornea following application of 1 %, 1 ,6 % or 3 % 
film (Figure 24b). Following application of 20% film, chemical damage resulted in a 
significantly greater concentration of aciclovir in the AH than did physical damage. 
Compared to the undamaged cornea, either chemically or physically damaging the
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cornea significantly increased the concentration o f aciclovir in the AH following 
application of 20% film. A similar conclusion may also be drawn from the data for 
the films with lower concentrations o f aciclovir, since absorption into the AH was 
undetectable in eyes with undamaged corneas.
Compared to the undamaged or chemically damaged cornea, physical damage 
significantly increased the concentration o f aciclovir detected in the cornea following 
application o f 1% gel (Figure 25a). Differences in absorption were even more 
pronounced when comparing aciclovir concentrations found in the AH of damaged 
eyes with that in undamaged eyes, where the level of drug was below the limit of 
detection (see table 16). There were no significant differences between the 
concentrations o f aciclovir detected following chemical or physical damage in the 
AH.
Paradoxically, the concentrations o f aciclovir detected in the undamaged cornea 
compared to the physically damaged cornea was significantly greater following 
application of 1% ointment (Figure 25a). No significant difference was found 
between the absorption levels in the damaged corneas following application o f 1 % 
ointment.
No significant differences were found in the concentrations of aciclovir detected in 
the cornea or AH between chemically damaged, physically damaged or undamaged 
cornea following application of 3% ointment (Figure 25b).
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Figure 24. The effect o f chemical or physical damage on the concentration of 
aciclovir detected in a) the cornea and b) AH following application of the film 
formulations. Each bar represents the mean ± SEM of at least 6  experiments. The 
data is identical to that in fig. 27; only the comparisons differ.
*** p< 0.001; ** 0.001< p< 0.01; * 0.01< p< 0.05: significance of difference from 
chemically damaged eyes.
p< 0.001; ^ 0 .01< p< 0.05: significance o f difference from physically damaged 
eyes.
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Figure 25. The effect o f chemical or physical damage on the concentration of 
aciclovir detected in a) the cornea and b) the AH following application o f the gel or 
ointment formulations. Each bar represents the mean ± SEM of at least 6  
experiments.
** 0 .0 0 1 < p< 0 .0 1 : significance o f difference from chemically damaged eyes.
^  0.001< p< 0.01; ^ 0 .01< p< 0.05: significance of difference from physically 
damaged eyes.
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Expression of the data as concentrations or amounts of aciclovir
The difference between expressing the data as a concentration or an amount of 
aciclovir is shown in figure 26a and b.
Following application of the 3% film, the concentration of aciclovir found in the 
physically damaged cornea was significantly greater than the concentration found in 
either the chemically damaged or undamaged eornea. There was no significant 
difference in the concentrations o f aciclovir found between the chemically damaged 
or undamaged cornea.
When the same data were recalculated as the amount of dmg per 14 mm corneal 
button, the significance of these differences changed noticeably. Following 
application o f 3% film, the amount of aciclovir detected in corneal samples that have 
chemically or physically damaged cornea was significantly greater than the amount 
detected in the undamaged cornea. There was no difference in the amount of 
aciclovir detected in physically damaged compared to chemically damaged cornea.
No significant difference in the concentrations or amounts o f aciclovir were detected 
among the chemically damaged, physically damaged or undamaged cornea following 
application of 3% ointment, although these trends were very similar to those seen for 
3% film.
1 2 9
Figure 26. Absoiption of aciclovir in the cornea following application o f 3% 
ointment or 3% film formulation expressed as a) the concentration o f aciclovir and b) 
the amount of aciclovir. Each bar represents the mean ± SEM of at least 6  
experiments.
* 0.01< p< 0.05; significance o f difference from chemically damaged eyes.
^ 0.01< p< 0.05: significance of difference from physically damaged eyes.
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Comparison of different formulations delivering an équivalent dose of aciclovir
Comparisons between the concentration o f aciclovir detected in the cornea and AH 
following application o f the ointment ( 1 % w/v), film ( 1 .6 % w/v) and gel ( 1 % w/v) 
formulations containing the same dose (300 pg) of aciclovir are shown in figures 27a 
and b.
Application o f the gel formulation resulted in significantly greater concentration in 
corneal samples compared with the ointment or film formulation, for damaged 
corneas. The film formulation also showed significantly greater corneal 
concentrations compared to the ointment formulation following damage to the 
cornea. When the cornea was undamaged, the level o f absorption was only 
significantly different between the gel and film formulations.
There was no detectable level o f absorption in AH samples following application of 
the ointment formulation to eyes in any of the treatment categories (Figure 27b). 
There was also no detectable level o f absorption in aqueous samples following the 
application of the film or gel formulation to the undamaged bovine cornea. 
Following chemical or physical damage to the cornea, significantly greater 
concentrations were detected in aqueous samples for the 1 % gel formulation 
compared to the 1 .6 % film formulation.
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Figure 27. The eoncentration of aciclovir detected in a) the cornea and b) AH 
following application o f the 1 % gel, 1 % ointment or 1 .6 % film fonnulation, each 
containing an equivalent dose o f aciclovir (300 pg). Each bar represents the mean ± 
SEM of at least 6  experiments.
*** p< 0.001; ** 0.001< p< 0.01; * 0.01< p< 0.05: significance of difference from 
1 % gel.
p< 0.001; 0.001< p< 0.01; 0.01< p< 0.05: significance o f difference from
1 .6 % film.
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Comparison between concentrations o f aciclovir detected in the cornea and AH 
following application of the ointment (3% w/w) and film (3% w/v) fonnulations 
containing the same dose (570 pg) o f aciclovir are shown in figures 28a and b.
No significant difference was found between the 3% ointment and 3% film 
formulation in the concentration o f acielovir in the cornea for chemically damaged, 
physically damaged or undamaged cornea. The concentration detected in the AH 
when the corneal epithelium had been physically or chemically damaged was 
significantly greater after application o f the 3% film. There was no detectable level 
of aciclovir in aqueous samples following the application o f the 3% ointment or 3% 
film to the undamaged bovine cornea.
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Figure 28. The concentration o f aciclovir detected in a) the cornea and b) AH 
following application o f the 3% ointment or 3% film formulation, each containing an 
equivalent dose o f aciclovir (570 pg). Each bar represents the mean ± SEM of at 
least 6  experiments.
*** p< 0.001; ** 0.001 < p< 0.01: significance of difference between 3% ointment 
and 3% film.
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C om parison  betw een the 1%  gel form ulation  and the 3%  oin tm en t form ulation
The concentration of aciclovir detected after application o f the 1% gel fonnulation 
(300 pg dose) was compared against the concentration detected with a 3% ointment 
formulation (570 pg dose). No significant difference was found between the 
concentration o f aciclovir detected in the cornea in eyes with physically or 
chemically damaged comeal epithelium (Figure 29a). Application o f the 1% gel 
compared to the 3% ointment resulted in a significantly greater concentration of 
aciclovir in the aqueous of eyes with physically or chemically damaged comeal 
epithelium (Figure 29b).
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Figure 29. The concentration of aciclovir detected in a) the cornea and b) AH 
following application of the 1% gel (300 pg dose) or 3% ointment (570 pg dose) 
formulation. Each bar represents the mean ± SEM of at least 6 experiments.
0.001; ** 0.001< p< O.OT. sigmficauce o f difference between 1% gel and 3% 
ointment.
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Total drug recovery from the cornea and aqueous humour
The total amounts o f drug recovered from the cornea and AH for all formulations, 
following each pre-treatment, are shown in table 18. The amounts o f drug recovered 
are expressed as a percentage o f the dose applied.
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Discussion: The Effects o f  Drugs on lO P .
In Vitro m ethods for the study o f  drug m echanism s on lO P
The arterially perfused eye has become a frequently used model in the investigation 
o f ocular function (N iem eyer, 1981). Early studies investigating the physiology and 
pharmacology o f AH dynamics utilised isolated eyes from the cat (M aori &  
C evario , 1978a; 1978b; C hiou  et al., 1980a; L iu & C hiou , 1980; M aori et al., 
1980; van A lp hen  & M aori, 1981), rabbit (K odam a et al., 1983; 1985; van  
P inxteren  & van A lp hen , 1985) or bovine (K ish id a et al., 1985), The 
phanuacological effects on facility o f outflow in the perfused anterior segment of 
bovine (E riokson-L am y et al., 1988) and human (E riokson-L am y et al., 1991; 
E rick son -L am y & N ath an son , 1992) eyes have been measured.
Due to its availability, cheapness and comfortable size for experimental use the 
bovine eye provides an attractive model for conducting perfusion experiments. 
Although they recommended the bovine perfused eye for biochemical studies, 
Kishida et al. (1985) judged this preparation to be unsuitable for the study of AH 
dynamics. It was demonstrated by Wilson et at. (1993) that the delay in 
commencement o f perfusion beyond 1 hr post-mortem considerably reduces the 
probability o f achieving a stable lOP, which may explain the dissatisfaction Kishida 
found with the preparation. Further investigation into the bovine perfused eye, where 
perfusion commenced before 1 hour post-mortem, suggests that the preparation 
o-ffers a useful method for studying the mechanisms of action of drugs on lOP and 
AH formation, in isolation from CNS and CVS influences (W ilson  et al., 1993). 
Several categories o f drugs have now been shown to decrease lOP in this preparation
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(Shahidullah et al., 1995). The bovine arterially perfused eye has been kept viable 
for almost 5 days, indicated by utilisation o f oxygen and glucose, when perfused with 
oxygenated serum-free Minimal Essential Medium under organ-culture conditions 
(de Coo et al., 1993).
In accordance with the experimental procedure o f the constant flow method of 
Wilson et al. (1993), in the present work bovine eyes were cannulated and perfused 
with Ki'ebs’ solution or Krebs' solution supplemented with BSA. After cannulation, 
some eyes were rejected due to failure to fulfil the following criteria: perfusion 
pressure did not exceed 100 mm Hg at any stage during perfusion; perfusate was 
flowing freely from at least two vortex veins; perfusion pressure did not display any 
major fluctuations, such as might be caused by an air bubble or blood clot blocking 
an artery; establishment o f a stable lOP. Failure to achieve anyone o f these criteria 
resulted in the rejection o f a substantial number of eyes before drug or vehicle 
administration.
?
In the present study, the mean steady-state lOP in 155 eyes perfused with Krebs’ 
solution was found to be 131.60 ± 1.46 mm H^O (see table 3). This was consistent 
with previously reported values of 127.43 ± 1.90 mm H^O for 88 eyes (Shahidullah,
1994) and 137.97 ± 4.33 mm H^O for a series of 25 eyes (Wilson et al., 1993) 
perfused with Krebs solution. Introduction of a second needle through the cornea, 
cannulating the anterior chamber for the purpose o f intracameral drug injection, 
resulted in a slightly greater steady-state lOP of 136.43 ± 2.05 mm H^O for 49 eyes 
perfused with Krebs’ solution. It is possible the physical trauma o f cannulating the
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anterior chamber with a second needle may be sufficient to cause minor damage to 
the blood-aqueous barrier resulting in a significant elevation in lOP. Perfusion of 
ICrebs’ solution plus BSA (1% w/v) in 138 eyes resulted in a steady state lOP of 
126.71 ± 1.34 mm H^O. Cannulation of the anterior chamber with a second needle 
for 40 eyes perfused with Ki*ebs’ solution plus BSA resulted in a steady-state lOP 
value of 118.10 ± 2.13 mm H^O, a value significantly lower than the lOP value for 
eyes perfused with Krebs’ solution plus BSA which were cannulated with only one
needle. Unexpectedly, the value for steady-state TOP does not increase when the 
anterior chamber is cannulated for a second time in eyes which are perfused with 
Ki'ebs’ solution plus BSA.
Various experimental inconsistencies may be responsible for the variation in steady- 
state lOP values. Values were recorded at t = 0 immediately prior to injection of the 
drug or vehicle. This measurement was taken at variable times after commencement 
o f the perfusion due to the variation in a) the time taken to increase perfusion flow 
rate to the optimum level of 2.25 ml.min ' and b) the time taken after cannulation for 
eyes to achieve a steady-state lOP. On-going changes in meat hygiene regulations in 
response to the bovine spongiform encephalopathy (BSE) crisis have also resulted in 
a fall in the average age of cattle that pass through the abattoir. However there is no 
reported correlation in the literature between increases in age and lOP (Davson, 
1990). There is also no control over the breed o f cattle from which bovine eyes are 
obtained. As many as 20 different breeds or cross-breeds o f cattle pass through the 
abattoir on a regular basis (Sandyford Abattoir, personal communication), which 
may contribute to the experimental variation.
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We have found that the lOP responses, expressed as the mean slopes for the duration 
of control experiments were not significantly different irrespective o f which vehicle 
or route of administration was used. This compares favourably with control 
responses for the same preparation found in the literature, which show that injection 
o f different vehicles (e.g. H ,0 , saline or DMSO), or injection via different routes, 
does not alter the mean slope o f the lOP response (Bellashher, 1998; Shahidullah, 
1994). The inclusion o f BSA in the perfusion fluid, which has the advantage of 
providing retrospective information relating to the permeability o f the blood-aqueous 
bander (Wilson et al,, 1993), was also found not to alter lOP over the duration o f the 
control experiments.
Pilocarpine
Cholinergic agonists such as pilocarpine are widely used in treating glaucoma, and 
have been shown to decrease lOP in a variety of species including rabbits (Jianming 
et aL, 1998), dogs (Chiou et al,, 1980b; Gwin et al., 1977), primates (Bill, 1962; 
Bill, 1967; Bill & Walinder, 1966; Crawford & Kaufman, 1987; Kaufman and 
Barany, 1976) and humans (Bill, 1971). Pilocarpine acts by binding to cholinergic 
receptors, producing a contraction o f the ciliary muscle, which in turn pulls on the 
scleral spur, opening the trabecular meshwork (Bill & Walinder, 1966). This 
increases the facility of AH outflow via the trabecular meshwork, resulting in a 
decrease in TOP.
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In the present work a decrease in lOP in response to intra-arterial administration of
The predominant overall effect o f pilocarpine is an increased lOP, suggesting that a 
direct contractile effect on the trabecular meshwork, similar to that shown in bovine 
isolated trabecular meshwork strips (Weiderholt et aL, 1995; 1996), may be 
involved. Lack of dose-dependence may be partly due to variable absorption of drug
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pilocarpine was not observed in the bovine isolated eye, at least when it was perfused 
with Krebs’ solution. Instead a significant increase in I OP was observed at all 
concentrations o f dm g administered, although there was little sign of dose- 
dependence.
Constriction o f the pupil, in response to pilocarpine, indicated that the drug had 
access to the anterior segment of the eye, including the iris sphincter and therefore 
very probably the ciliary muscle, since their arterial supply is common. In the 
mammalian eye contraction of the ciliary muscle would be expected to result in a 
decrease in resistance to outflow. However the ciliary muscle in the bovine eye is 
poorly developed with very little functional activity (Prince et aL, 1960). The 
limited ability o f the ciliary muscle to accommodate the lens is a general 
physiological trend found in other herbivores including rabbits, sheep and horses 
(Bill, 1975; Diescem, 1975; Prince, 1964; Prince et aL, 1960). It is therefore not 
surprising that pilocarpine does not decrease lOP in the bovine eye as the contractile 
response of the ciliary muscle might not sufficiently alter the structure of the 
trabecular meshwork to significantly increase the facility o f AH outflow.
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into the avascular meshwork tissue. Influences such as a decrease in uveoscleral 
outflow, an increased production of AH, or a breakdown o f the BAB may also 
contribute to the I OP response.
Contraction o f the ciliary muscle in primate and human eyes, in response to 
pilocarpine, has been shown to decrease AH outflow via the uveoscleral route, due to 
a reduction in the spaces between ciliary muscle bundles (Bill, 1971; Bill & 
Walinder, 1966; Crawford and Kaufman, 1987; Nilsson et aL, 1989). However, 
the contribution of uveoscleral outflow to the total outflow in the bovine eye is 
unknown. It is possible that the bovine eye will act in a similar manner to the rabbit 
eye, where a rudimentary ciliary muscle results in practically no aqueous drainage 
via the uveoscleral route (Bill, 1975). If this is true then contraction o f the ciliary 
muscle is unlikely to affect I OP.
Previous evidence in the literature concerning the effect of pilocarpine on AH 
production is contradictory and subject to species variation. Pilocarpine has been 
shown to have no effect on AH formation in rabbits (Kodama et aL, 1985), decrease 
AH formation in primates (Bill & Walinder, 1966; Miichi & Nagataki, 1983; 
Walinder & Bill, 1969) and increase AH formation in humans (Nagataki & 
Brubaker, 1982). In order to determine the effect in the bovine eye, future 
experiments would investigate the effect of pilocarpine on AH formation detennined 
by the fluorescein dilution technique (Millar et aL, 1997; Shahidullah et aL, 1995; 
Wilson et aL, 1993).
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The most likely explanation is a breakdown o f the BAB, nonnally indicated by a
continually rising I OP. Pilocarpine induced increases in BAB peiineability to high
molecular weight molecules (i.e. plasma proteins) have been reported in dogs
(Kroliiie, 1994; Krohne et aL, 1998) and humans (Mori et aL, 1992). This theory
was tested by the addition o f a high molecular weight substance, albumin, to the
perfusate. This substance is unable to cross the BAB under normal physiological
conditions and so would remain undetected in the AH at the end o f the perfusion.
However if  the BAB was not intact, then leakage of high molecular weight
substances into the posterior chamber would occur. A correlation between
breakdown of the BAB, continually rising TOP and leakage of albumin into the
chamber has previously been reported (Wilson et aL, 1993). After sampling and
protein analysis of AH at the end o f 90 min perfusion with K rebs’ containing BSA,
,there was no significant increase in protein concentration at any concentration of 
pilocarpine. In fact, the protein concentration was significantly reduced at the 
highest pilocarpine concentration (10'^ M). Examination o f the lOP responses, 
recorded for the duration o f the experiment, shows a trend where pilocarpine, at all 
except the lowest concentration, significantly decreases the lOP. This suggests that 
the presence o f BSA in the perfusate o f this preparation may play a permissive role in 
the lOP response to intra-arterially perfused drugs. The results may even indicate 
that pilocarpine-induced damage to the BAB is prevented by the inclusion of BSA in 
the perfusate, despite the fact that the addition of the high molecular weight 
substances, dextran (3% w/v) and albumin (0.5% w/v), does not significantly
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increase the likelihood o f achieving a stable lOP under control conditions (Wilson et 
aL, 1993).
Apraclonidine
Apraclonidine, a derivative of clonidine, is an a^-adrenergic agonist with some 
activity (Tons et aL, 1995b). Topical application of clonidine, apraclonidine or 
brimonidine has been shown to lower lOP in a variety of species, including rabbits 
(Burke & Potter, 1986), cats (Burke & Potter, 1986; Chiou, 1983), primates 
(Burke & Potter, 1986; Gabelt et aL, 1994: Serle et aL, 1991) and humans 
(Gharagozioo et aL, 1988; Lee et aL, 1984; Toris et aL, 1995a; 1995b). These a^~ 
adrenergic agonists are believed to lower lOP primarily by reducing API formation, 
presumably by acting on the NPE o f the ciliary body (Adkins & Balfour, 1998; 
Burke & Potter, 1986; Gharagozioo et aL, 1988; Mittag and Torinay, 1985; 
Toris et aL, 1995b).
In the bovine isolated perfused eye, intra-arterial injection of apraclonidine increased 
the lOP in a non-linear manner. Analysis o f the raw lOP data, expressed as the mean 
value for each time point plotted against time (see figure 17), showed an initial 
substantial linear increase in lOP for the first 30 min after drug injection, followed by 
a decline to a smaller rate of increase over the next 60 min. This suggested that the 
slopes of lOP vs time for each drug response should be calculated over the periods of 
linearity from 0 - 3 0  min and 30 - 90 min.
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Intra-arterial administration of high doses of apraclonidine produced a significant 
increase in lOP characterised by a large increase over the first 30 min followed by a 
smaller increase over the following 60 min. Immediately after intra-arterial injection 
of the drug, vasoconstriction, presumably mediated via a ,-  or aj-adrenoceptors, 
resulted in a transient increase in vascular perfusion pressure, which decreased 
slightly to a plateau. This was sustained for the remainder o f the experiment.
The increase in lOP, observed after intra-arterial injection of high doses of 
apraclonidine, is similar to the short term rise reported by Murray & Leopold (1985) 
following topical application of various a ,-  and a,-adrenergic agonists in the rabbit, 
although such findings do not correspond to the majority o f reports which describe a 
decrease in lOP after topical application in vivo to primate and human eyes. In vivo 
responses to apraclonidine are generally measured over a longer time scale, starting 
from at least 1 hr after drug administration, and hence may fail to observe possible 
early influences on ÎOP. It is generally believed that apraclonidine lowers I OP 
primarily by decreasing the rate o f flow of AH, plus a combination of increasing the 
facility of outflow and decreasing episcleral venous pressure (G haragozioo et aL, 
1988; Toris et aL, 1995b).
In order to determine any effect o f apraclonidine on the penneability of the BAB, the 
perfusate was supplemented with BSA and AH was sampled 90 min after drug 
injection. Intra-arterial injection of 300 nmol apraclonidine did not significantly 
change the protein concentration in the AH, indicating that apraclonidine does not
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affect the penneability of the BAB in the bovine perfused eye. This agrees with a 
previous result showing that in humans topical application o f apraclonidine has no 
effect on BAB permeability (Gharagozioo et aL, 1988).
It is possible that the increase in perfusion pressure occurring after intra-arterial 
injection of apraclonidine contributes to the increase in lOP. In vivo studies show 
that the a,-adrenergic agonists have both local and systemic cardiovascular side 
effects including a decrease in systolic blood pressure (Lee et aL, 1984), a decreased 
episcleral venous pressure (Krieglstein et aL, 1978; Toris et aL, 1995b) and a dose- 
dependent decrease in systolic and diastolic ophthalmic arterial pressure in patients 
with open-angle glaucoma (Heilmaiin, 1973). These factors plus the suggestion that 
apraclonidine constricts blood vessels to the anterior uvea resulting in a decrease in 
ocular blood volume (Chako & Camras, 1994), indicate that the vascular effects 
caused by a,-adrenergic agonists are more likely to contribute towards a decrease in 
lOP, not an increase. However, the occurrence o f vasoconstriction in the vascular 
beds of the anterior uvea o f the perfused eye would not result in a decrease in ocular 
‘blood’ volume, since perfusion is carried out using a constant flow method. Instead, 
resistance to flow would result in the observed increase in vascular perfusion 
pressure which might contribute to a short term increase in lOP by causing the 
distension of blood vessels proximal to the constriction and hence an increase in 
intraocular volume. Constriction of vascular beds may also redirect the flow of 
ICi'ebs’ solution, which could result in an altered rate of perfusion in particular areas 
o f the eye, although the total flow rate through the whole eye must remain constant. 
Again this is unlikely to contribute to an increase in lOP as even substantial changes
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in the perfused flow rate o f the bovine eye do not significantly alter the lOP (Wilson 
et aL, 1993).
Unlike intra-arterial injection, there were no significant increases in I OP over the 30 
min following intracameral injection o f the drug (see table 11). Instead after 
injection o f 30 mnol apraclonidine, lOP was observed to decrease significantly over 
this period. In contrast, from 30 - 90 min after intracameral injection of high doses 
o f apraclonidine there was a significant increase in lOP.
Administration o f apraclonidine by intracameral injection delivers the drug directly 
into the anterior chamber, and hence rapid access to the trabecular and uveoscleral 
outflow pathways. When administered intra-arterially, the drug passes through the 
vascular system of the anterior eye, supplying the ciliary processes. Access of the 
drug to the AH and outflow pathways is relatively slow with aqueous production at 
less than 13 pi.min ' (Shahidullah et aL, 1995; Wilson et aL, 1993).
Comparison between the changes in lOP for apraclonidine administered via different 
routes, shows that relative to their controls, intra-arterial injection of high doses 
produces a significant rise in lOP over the initial 30 min, whereas intracameral 
injection does not. This suggests that the early rise in lOP is due to vasoconstriction 
as vascular perfusion pressure also increases during this period. In the longer term 
(30 - 90 min post-injection), the drug has time to diffuse to most ocular tissues 
regardless of the route of administration, producing a similar moderate rise in lOP by 
either the intra-arterial or intracameral route.
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In the perfused eye, the peak short term increase in vascular perfusion pressure 
associated with intra-arterial injection of apraclonidine was inhibited by inclusion in 
the perfusate of the selective a,-adrenergic antagonist, prazosin or the selective a ,-  
antagonist, yohimbine. This suggests that the increased vascular perfusion pressure 
in response to apraclonidine is mediated via action on both a , - and a,-adrenoceptors. 
In order to confirm the selectivity o f prazosin and yohimbine on a ,-  and a ,-  
adrenoceptors, respectively, in the bovine perfused eye, their effects on the a ,-  
adrenergic agonist, noradrenaline were investigated. The short term increase in 
vascular perfusion pressure associated with intra-arterial noradrenaline was inhibited 
by prazosin, but not by yohimbine. Therefore it appears that in the bovine perfused 
eye, yohimbine at a concentration o f 3 x 10'  ^ M is relatively selective for a ,-  
adrenoceptors. This confirms that the short-term vascular response to apraclonidine 
is mediated through both a ,-  and a^-adrenoceptors.
This couesponds with previous work by Murray and Leopold (1985), who showed 
that topical application o f the a,-adrenergic agonist, methoxamine or the a ,-  
adrenergic agonists, oxymetazoline or clonidine caused early dose-related rises in 
lOP, with peak responses occurring between 1 5 - 3 0  min after drug application. 
These hypertensive lOP effects were inhibited by pre-treatment with prazosin or with 
yohimbine. Various studies have also noted an initial hypertensive effect following 
topical or systemic application o f the adrenergic agonists, adrenaline and 
noradrenaline in rabbits (Langham & Krieglesteiii, 1976; Langham & Palewicz, 
1977) and humans (Kupfer & Ross, 1971). This increase in lOP was attributed to a
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decrease in outflow facility, due to constriction of aqueous and episcleral veins 
(Langham & Palewicz, 1977; Wilke, 1974). It was also shown that the 
hypertensive lOP response to a-adrenergic agonists could be blocked by the a - 
adrenergic antagonist, phenoxybenzamine but not by the p-blocker, propranolol, 
suggesting the involvement o f an a-adrenergic mechanism (Langham & 
Krieglesteiii, 1976), In the bovine perfused eye, Wilson et al. (1993) assume that as 
the vortex veins have been cut then pressure in the episcleral veins will be virtually 
zero. However, substantial vasoconstriction, occumng in the aqueous and episcleral 
veins, could still have an effect on resistance to outflow and hence on lOP (see 
‘modified Goldman equation’, pg. 36). Direct measurement of episcleral venous 
pressure in the bovine eye would be necessary to establish whether vasoconstriction 
in these vessels may be the cause o f the initial rise in lOP due to apraclonidine.
The sustained increase in vascular perfusion pressure, associated with apraclonidine 
was investigated by perfusing the eye with Krebs’ solution containing apraclonidine, 
and attempting to reverse the elevated perfusion pressure with prazosin or the 
selective a,-adrenergic antagonist, delequamine. Delequamine was chosen as its’ 
selectivity for a,-adrenergic receptors is higher than that o f yohimbine. At 10"'’ M, 
delequamine appeared to reduce the elevated vascular perfusion pressure associated 
with apraclonidine, though this effect was variable and not statistically significant. 
Prazosin did not have any effect on the sustained vascular response to apraclonidine. 
These results suggest that a,-adrenoceptors are not associated with the sustained 
increase in vascular perfusion pressure, which occurs after perfusion o f the bovine
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eye with apraclonidine. The apparent decrease in perfusion pressure in response to 
delequamine indicates that a^-adrenoceptors may well be involved.
While many a,-adrenoceptors are located at presynaptic sites, they have also been 
observed at post-junctional locations in the vasculature of many species, including 
rats (Dyke & Widdop, 1987), rabbits (McGrath & McKean, 1981), dogs 
(Matthews et aL, 1984) and humans (Thom et aL, 1985; Jie et aL, 1984; 1987), and
are believed to be involved in the vasoconstriction induced by a-adrenergic agonists 
(Langer & Hicks, 1984). However, in most vascular beds, the a,-adrenoceptor is 
the predominant receptor mediating vasoconstriction (Langer & Hicks, 1984). It 
has been postulated that the vascular smooth muscle contractile response differs 
between these two a-adrenoceptor subtypes (McGrath, 1982). The a,-adrenoceptor 
response is rapid in onset, short-lived, utilises internal Ca'' and responds to short­
term stimuli such as bolus injection o f catecholamines; the a,-adrenoceptor response 
is slower in onset, longer-lived, utilises external Ca‘" and responds to more prolonged 
stimuli such as circulating catecholamines. In the present work, the vascular 
responses to intra-arterial injection o f apraclonidine correlate with the hypothesis of 
McGrath (1982), where stimulation of a ,-  and a,-adrenoceptors mediates different 
contractile responses in vascular smooth muscle.
Post-junctional a^-adrenoceptors have also been identified in the ciliary body, 
choriocapillaris, retina and iris o f the rabbit (Huang et aL, 1995), porcine (Wikberg- 
Matsson et aL, 1996), bovine (Byluiid et aL, 1997) and human eyes (Matsuo & 
Cynader, 1992). Since there can be no neural activity in the isolated eye, it is
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unlikely that presynaptic receptors could influence either vascular tone or TOP, 
indicating a possible involvement o f post-junctional a,-adrenoceptors.
The relationship between the early rise in lOP associated with stimulation of a - 
adrenoceptors, possibly located in the blood vessels o f the anterior uvea, could be 
investigated by pre-treating the eye with selective a ,-  or a,-adrenoceptor antagonists 
such as prazosin, yohimbine or delequamine and monitoring the lOP response to 
intra-arterial injection o f apraclonidine.
In order to understand other possible mechanisms underlying the lOP response to 
apraclonidine in the bovine perfused eye, further experiments detenuining its effect 
on AH formation and facility o f outflow would be required. In the present work, we 
chose not to investigate these parameters as the effects, which did occur, were often 
small, generally short-lived and consisted o f an increase in lOP rather than a 
decrease. Such an effect clearly indicates a major difference from that in man, and 
did not merit further investigation as the usefulness o f the bovine perfused eye model 
could not be furthered.
Prostaglandins
Previous studies have shown that prostaglandins, in particular PGF^ and its 
analogues, including latanoprost, lower lOP in rabbits (Camras et al., 1977), cats 
(Bito et aL, 1983a), primates (Camras and Bito, 1981; Crawford et aL, 1987) and 
humans (Lee et aL, 1988). It is generally accepted that treatment with PGF,,^ does
153
Discussion: The Effects o f  Drugs on lO P ....
not induce a fall in lOP by lowering AH production (Brubaker, 1989; Camras et 
aL, 1987; Lee et aL, 1984; Toris et aL, 1997). Instead PGF,„ acts by increasing AH 
outflow, via the uveoscleral outflow route (Crawford and Kaufman, 1987; Gabelt 
and Kaufman, 1989). The mechanism for the lOP reduction was unclear until it 
was demonstrated that pilocarpine antagonises PGF^^-induced ocular hypotension in 
primates (Crawford and Kaufman, 1987; Nilsson et aL, 1989). PGF,^ is reported 
to alter the extracellular material between the ciliary muscle bundles, providing an 
alternative pathway for drainage o f AH from the anterior chamber (Liitjen-Drecoll 
& Tamm, 1988; Tamm et aL, 1989). Recent investigations indicate that 
prostaglandins can induce substantial changes in the extracellular material around 
human ciliary smooth muscle cells in vitro, supporting the hypothesis that 
prostaglandin-induced alteration in extracellular material between ciliaiy muscle 
bundles plays a role in increasing uveoscleral outflow facility (Lindsey et aL, 1997a; 
1997b; Weinreb et aL, 1997).
In the present study PGF^^ had no effect on lOP when compared to control groups in 
eyes perfused with Krebs’ solution or Ki'ebs’ solution plus BSA. Inclusion of BSA 
in the perfusate had no significant effect on the lOP response following intra-arterial 
injection o f PGF^^. Intra-arterial injection of PGF^^ had no effect on vascular 
perfusion pressure, perhaps due to a lack of vascular tone in the perfused eye 
preparation. Possible explanations for these observations are that the contribution to 
total outflow provided by the uveoscleral route in the bovine eye may be minimal, 
due to the poorly developed ciliary muscle (Prince et al., 1960). However, PGF^ _^  
has been shown to effectively lower I OP in rabbits which also has a poorly
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developed ciliary muscle, as well as cats and humans where uveoscleral outflow 
accounts for considerably less than 50% of total aqueous drainage (Crawford and 
Kaufman, 1987). During in vivo experiments the drug is generally administered 
topically over a successive period o f 3 - 5 days before a reduction in lOP is observed 
(Crawford and Kaufman, 1987; Gabelt and Kaufman, 1989). This suggested that 
administering PGF^^ intra-arterially to the bovine perfused eye over a period o f three 
hours may not be an ideal model for testing this type o f drug. Over a three hour 
period the time scale may be insufficient to allow the physical widening of and loss 
o f extracellular material from the connective tissue-occupied spaces between the 
ciliary muscle bundles demonstrated by morphological studies (Lütjen-Drecoll & 
Tamm, 1988). On the other hand, the drug has been shown to produce a 60% 
reduction in lOP, 3 hours after administration as a single dose in cynomolgus 
monkeys (Nilsson et aL, 1989). Nilsson suggested that increased uveoscleral 
outflow, contributing up to 80% of total outflow facility compared with 40 - 50% in 
control eyes, was responsible for the fall in lOP. Interestingly, a larger lOP- 
reduction was observed following 3 - 5  days of daily treatment rather than a single 
dose treatment (Camras et aL, 1987; Crawford et aL, 1987), suggesting that the 
long term effect of prostaglandins is mainly structural, while the short term effect is 
mainly due to relaxation of the ciliary muscle (Nilsson et aL, 1989).
Evidence in the literature suggests that high doses o f prostaglandins, particularly 
PGEj and PGE^, elevate lOP and AH protein concentration, indicating an increased 
permeability o f the BAB (Beitcli & Eakins, 1969; Kass et aL, 1972; Waitzman & 
King, 1966). The presence o f a low level of protein (300 - 700 p g .m f) in the AH of
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mammalian eyes demonstrates that the barrier function of the BAB is not absolute 
(Novack & Leopold, 1988). Protein concentrations from control eyes, where AH is 
sampled at the end o f 180 min o f perfusion with Ki'ebs’ solution, did not differ 
significantly from freshly excised bovine eyes where AH was sampled upon reaching 
the lab. The level of protein found in the bovine eye corresponded with a previous 
report in the literature (Doughty, 1995).
In the bovine perfused eye, the lack of a significant elevation in AH protein 
concentration in response to intra-arterial or intracameral administration of 600 nmol 
PGF^a indicates no BAB-disrupting effects at this dose. Other investigators have 
also shown negative or minimal effects of PGF^^ on disruption of the BAB in 
primates (Crawford et aL, 1987; Gabelt & Kaufman, 1989).
Intra-arterial and intracameral injection o f PGE^ shows a trend towards increase in 
protein concentration at all doses tested, though this is only significant following 
intra-arterial injection o f 60 nmol PGE^ or intracameral injection o f 600 nmol PGE^. 
The wide range of concentrations detected following administration of each dose 
indicate that although PGE^ appears to increase the permeability o f the BAB the 
effects are sporadic and non-reproducible in the bovine isolated perfused eye. In 
rabbits, increases in lOP and aqueous protein levels following administration of 
prostaglandins are thought to be due to a highly developed BAB breakdown 
mechanism, characteristic of animals with virtually 360° fields o f vision (Bito, 
1997). Responses observed in cats and primates, which do not have such a wide 
visual field, occur to a lesser degree. It is believed that the large species differences
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which exist in response to ocular irritation and trauma, such as administration of 
prostaglandins or paracentesis, may be a result of the evolution o f different types of 
visual systems (Bito, 1997).
Previous investigations have indicated that a direct correlation exists between 
elevations in lOP and aqueous protein concentration in rabbit (Beitch & Eakins, 
1969) and bovine eyes (Wilson et aL, 1993). Expression of all the raw data in the 
form o f protein concentration as a function o f lOP immediately prior to AH sampling 
(see figure 23) did not show a clear conelation between increases in protein 
concentration and increases in lOP for intra-arterial or intracameral injection of 
PGE^. lOP values which increased above 300 mm H^O in response to PGE^ 
exceeded the maximum value on the water manometer scale and were necessarily 
represented as 300 mm H^O in the scatter plot (figure #). What is clearly 
demonstrated by the scatter plots is that more than one population exists within the 
data. Both plots show that eyes, with lOP values which fall within the presumed 
normal range o f 95 - 165 mm H^O (Wilson et al., 1993), are associated with a low 
concentration of protein. There are no eyes found within this lOP range which are 
associated with an increased concentration o f protein which suggests breakdown of 
the BAB. As lOP values increase above 165 mm H^O associated protein 
concentrations either remain nonnal or increase to a level indicating breakdown of 
the BAB.
The lOP response to PGE^ administration in the bovine isolated perfused eye differs 
greatly from other species. In vivo responses to PGE^ are characterised by an initial
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increase in lOP to a peak witliin 30 min of drug administration followed by a slow 
fall in lOP back towards the initial value. In rabbits the initial increase in lOP is 
large and is associated with breakdown of the BAB and protein leakage into the 
anterior chamber (Camras et aL, 1977). However, other species show a less marked 
initial increase in lOP with little or no effect on the BAB (Nilsson et aL, 1989). It is 
now generally thought that the unique sensitivity o f the BAB to PG in rabbit make 
this species a poor model for the study of BAB integrity and AH dynamics (Bito, 
1984; Toris et aL, 1997). The bovine isolated perfused eye does not show a 
reproducible initial increase in lOP followed by a decrease back to the initial value. 
In the majority o f eyes there is no significant change in lOP over the 90 min 
following drug administration.
The lack of a reproducible or dose-dependent response to PGE, could result from 
several factors: the variation in the responses to prostaglandins due to species 
differences could account for the sporadic effect of PGE^ on permeability of the BAB 
in the bovine isolated perfused eye; the delay of any breakdown o f the BAB may be 
highly variable (if the onset of the sudden rise in lOP is any indication), allowing 
very different concentrations o f protein to accumulate in the anterior chamber by the 
end o f the experiment; the volume o f AH removed from the anterior and posterior 
chamber o f the eye is not uniform. In the normal eye, up to 2 ml o f AH can be 
removed. However, if the lOP has exceeded 300 mm H^O for the majority of the 
experiment the volume removed can be as little as 0.2 ml, presumably due to gross 
oedema o f the anterior uvea. The experiments conducted suggest that the bovine 
isolated perfused eye does not appear to be an effective preparation for reproducibly
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demonstrating drug induced permeability changes in the BAB. Measurement of 
aqueous flare in the anterior chamber might provide a more effective method of 
determining permeability changes in the BAB in the preparation, avoiding the 
reproducibility problem associated with AH sampling. This method may provide 
infonnation regarding the time course o f the breakdown response to PGEj.
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Conclusion ü)
Although previous investigations have demonstrated lOP-reductions in response to 
several classes o f drugs, including the carbonic anhydrase inhibitor, MK-927, [3- 
adrenoceptor antagonists, timolol, oxprenolol and betaxolol (Wilson et al., 1993), the 
P-adrenoceptor agonist, terbutaline (Shahidullah et at., 1995) and vasodilator 
agents, including atriopeptin (Shahidullah et at., 1995), it was shown that neither 
pilocarpine, apraclonidine, PGFja or PGE, acted to lower lOP in this preparation.
The failure of pilocarpine, PGF^o, or PGE^ to produce an lOP-lowering response 
might well have been expected due to the rudimentary development and lack of 
functional activity in the bovine ciliary muscle. The lack of correlation between the 
bovine eye and other species for drugs which increase trabecular or uveoscleral 
outflow suggests that this preparation is not suitable for screening anti-glaucoma 
drugs which act primarily on AH outflow. On the other hand, where a drug does 
lower lOP, the bovine eye offers a simple cheap system with which drug mechanisms 
can be studied.
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The isolated perfused bovine eye as a model for investigation of corneal drug 
absorption
In the present study on the bovine perfused eye, the effects on ocular drug absorption
of different dmg fonnulations and experimentally induced corneal damage have been 
studied utilising single time point determinations. However, no phamiacokinetic 
data on drug absorption has been evaluated. A kinetic profile with minimal 
variability can only be constructed by measuring the AH drug concentrations from a 
sufficient number o f time intervals to adequately characterise the absorption, 
distribution and elimination process (Qiu et al., 1993; Solanki & Morton, 1988; 
Taiig-Liu & Burke, 1988). In general serial measurements are carried out in vitro 
on isolated corneal preparations as AH samples from the anterior chamber cannot be 
taken continuously in vivo (Riehman & Tang-Liu, 1990). However, it has been 
shown that the bovine perfused eye model allows repetitive sampling flom the 
anterior chamber, provided that 50 pi sample volumes are immediately replaced with 
an equivalent volume o f AH substitute (Wilson et al., 1993). This allows the 
kinetics of absoiption to be followed with relative ease under controlled 
physiological conditions (Zhu et al., 1996). Under normal physiological conditions, 
drugs which are absorbed across the cornea into the anterior chamber will be 
concentrated adjacent to the posterior surface of the cornea as mixing in the anterior 
chamber occurs very slowly, being influenced by aqueous flow from the posterior 
chamber, outflow of aqueous via the trabecular and uveoscleral drainage pathways 
and convection cuiTents due to temperature gradients. In order to obtain an accurate 
measurement o f AH drug concentrations from 50 pi aqueous samples, mixing of the
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anterior chamber contents has to be increased. In the present study this complication 
is avoided, at the expense o f pharmacokinetic data, by single time point 
determinations where all the available AH from the anterior chamber is sampled at 
the end o f the perfusion. A more important reason for single sampling was that 
HPLC would not have been able to detect aciclovir in many o f the small samples 
taken at intervals. However, this method of analysis does appear to be adequate for 
the present puipose o f comparing the effects of different fonnulations and pre­
treatments on comeal absoiption.
HPLC analysis
In the present study, HPLC provided efficient and clean separation of aciclovir and 
the internal standard, ganciclovir, from samples o f cornea and AH. The ganciclovir 
and aciclovir peaks, eluted at 8 min and 10.8 min respectively were not subject to 
interference by any coeluting compounds, allowing the concentration or amount of 
aciclovir absorption to be calculated accurately.
The retention time identified for ganciclovir compares favourably with previously 
reported retention times under similar HPLC conditions (Arevalo et al., 1995; 
Kiipperman et al., 1993).
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The effect of increasing the concentration of aciclovir in the film formulation
As expected, increasing the concentration of aciclovir dissolved in the PVA film 
resulted in an increase in the concentration of aciclovir detected in the cornea and 
AH, by increasing the gradient between the medicament and the surface o f the 
cornea, thus accelerating diffusion o f drug into the eye.
When the corneal epithelium is undamaged, intercellular tight junctions located 
between the apices o f adjacent superficial epithelial cells remain intact and fonn the 
major barrier to ocular drug absoiption (Grass & Robinson, 1988b; Tonjum, 1974).
The barrier property of the epithelium is highlighted following chemical or physical 
damage to the cornea. With each increase in aciclovir film concentration the 
concentration o f aciclovir detected in the cornea increased significantly in a 
concentration-dependent fashion. This relationship was not so clear when the cornea 
was undamaged, probably due to the limitations in the sensitivity of the HPLC 
system. Increases in aciclovir film concentration generally produced significant 
increases in aciclovir absorption into the AH following damage to the cornea.
However, when the cornea was undamaged no detectable level of absorption was 
found in the API except at the highest concentration of 20% aciclovir.
The barrier property of the corneal epithelium is often considered to vary in 
effectiveness according to the solubility of the drug (Sieg & Robinson, 1976). The 
lipophilic epithelium is relatively impermeable to water-soluble drugs, whereas lipid-
:
soluble drugs penetrate easily (Jarvinen et al., 1995). A previous study,
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investigating the physicochemical properties of aciclovir, has shown that the drug is 
relatively hydrophilic (octanol: water partition coefficient = 0.06 ± 0.01) and would 
thus be expected to have low epithelial pemneability (Hughes et al., 1993). Due to 
the physicochemical properties of aciclovir and the 1 4 - 1 8  cell layer thickness of the 
bovine corneal epithelium (Diescem, 1975; Prince et al., 1960), it is not surprising 
that the drug is poorly absorbed into the cornea and AH following application of the 
film formulation to eyes with undamaged corneas.
Physical or chemical damage to the cornea removes the barrier function of the 
epithelium, resulting in direct contact between the medicament and the hydrophilic 
corneal stroma. Aciclovir in the hydrophilic film will readily move down its 
concentration gradient into the stroma. In order for the drug to enter the anterior 
chamber it must pass through Descem efs membrane and the lipophilic corneal 
endothelium. Although tight junctions are present between adjacent endothelial 
cells, they are not as tight as those found in the epithelium, resulting in a “leaky” 
barrier between the AH and comeal stroma (Grass & Robinson, 1988b). It has also 
been suggested that in the human eye, the endothelium does not offer any significant 
resistance to hydrophilic drugs such as pilocarpine (Sieg & Robinson, 1976). After 
removal of the epithelium there was an absence of drug accumulation in the comeal 
stroma and endothelium following topical application of pilocarpine. Sieg and 
Robinson suggested that in the case of transcorneal permeation of pilocarpine the 
stroma, endothelium and AH act as a single phase, allowing free movement of 
hydrophilic molecules. In the bovine eye, the 1 0 - 2 5  pm thickness of Descem efs 
membrane, is approx. double that found in man (Diescem, 1975; Prince et at., 1960),
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and might cause a relative decrease in the ease of drug movement into the anterior 
chamber. However, it is reasonable to suggest that aciclovir, due to its hydrophilic <1
nature, will behave in a similar manner to pilocarpine and move with relative ease 7
from the stroma into the anterior chamber. This mechanism explains the detection of 
substantial amounts of aciclovir in the AH following physical or chemical damage to 
the cornea.
The effect of different pre-treatments on the concentration of aciclovir detected 
in the cornea and aqueous humour
After application o f different formulations at various doses following different pre­
treatments to the eye, comparison between the concentration o f aciclovir detected in 
the cornea and AH highlighted several trends. Generally, much larger concentrations 
o f drug were absorbed in the cornea and AH following damage to the eye. 
Application of 1% film and 1% ointment formulations provided exceptions to this 
trend, with greater concentrations o f aciclovir being absorbed in the undamaged 
cornea. However, the drug concentrations detected in these two examples 
approaches the limit o f detection for this system (see table 16) and consequently may 
not be an accurate measure of the level o f aciclovir. No detectable absorption was 
found in AH samples following application o f the ointment or gel formulation when 
the epithelium remained undamaged. These trends confirm that the comeal 
epithelium is a major barrier to drug absorption through the cornea. We have shown 
that removal of the comeal epithelial barrier, as a result o f physical or chemical 
damage, generally results in an increase in the concentration o f drug absorbed. This
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is in good agreement with previous data in other species showing that removal of the 
epithelial barrier results in a significant increase in absorption o f topically applied 
hydrophilic, but not lipophilic drugs (Edelhauser & Mareii, 1988; Hull et al., 1974; 
Lésa: & Fiscella, 1985; Ma: eu et al., 1983; Sieg & Robinson, 1976).
Comparison between the drug concentration detected in the cornea following 
chemical or physical damage indicates a trend where there is an apparent increase in 
absorption in corneas which have been physically damaged. These apparent 
increases are statistically significant following application o f the film formulations 
containing 1%, 3% or 20% aciclovir. There were no differences between the 
aqueous drug concentrations except after application o f 20% film formulation where 
the concentration o f aciclovir detected in the chemically damaged cornea was 
significantly greater. Although there is no conclusive reason explaining the 
differences in absoiption between the two pre-treatments, it is important to realise the 
differences in the nature o f the experimentally induced damage. When the cornea is 
physically damaged the epithelium is débrided exposing the underlying stroma. 
Corneal transparency and thickness do not appear to alter. However, when the 
cornea is chemically damaged with sodium hydroxide, the underlying stroma rapidly 
loses its transparency and swells, as indicated by a visible thickening and approx. 
50% increase in the weight of excised corneal buttons (see table 17). This effect is 
presumably due to sodium hydroxide-induced damage to the endothelial cells, 
resulting in a loss o f the endothelial regulatory function on cornea! hydration (see 
‘Hydration of the cornea’, page 41). These observations agree with previous reports 
where severe alkali burns of the rabbit eye resulted in corneal opacification and
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increased stromal hydration (Mai Phan et al., 1991; Pfister et al., 1971). It is 
therefore reasonable to suggest that the nature and severity o f chemically induced 
damage to the cornea may affect the level of drug absorption, resulting in the 
apparent differences between chemically and physically damaged corneas. The 
alkaline environment, induced by NaOH pre-treatment, may also influence vehicle 
and drug stability in the eye. However, very little evidence was found in the 
literature to suggest that alkaline hydrolysis of aciclovir occurs under such 
experimental circumstances.
Experimental damage to the cornea was performed in an attempt to mimic the 
corneal damage associated with HSV infections, which in humans is often 
characterised by epithelial keratitis which may lead to corneal ulceration (Grayson, 
1983; Newell, 1996; Pavam-Langston & Biosjoly, 1985; Verdier & Krachmer, 
1984). This results in damage to the cornea ranging from the appearance of multiple 
microscopic pits on the epithelium to digestion o f areas o f epithelial and stromal 
tissue by enzymes (Grayson, 1983; Newell, 1996; Pavam-Langston & Biosjoly, 
1985; Verdier & Krachmer, 1984). It is likely that such damage to the cornea 
would greatly limit the barrier function o f the epithelium, resulting in an increase in 
absorption of topically applied hydrophilic drugs. It is purely speculative to consider 
how well the two models o f experimentally induced corneal damage mimic the 
damage associated with HSV infections. Detailed morphological examination of the 
various types o f damage would be required before this could be assessed. However, 
the pathological manifestations o f severe HSV infection, such as enzymatic digestion 
of corneal tissue, are linked with the later stages of alkali burns where collagenase
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production in the epithelium and stroma results in corneal ulceration which if left 
untreated can lead to corneal ‘melting’ (Brown, 1971). The NaOH model used in the 
present work would doubtless show severe disruption especially of the epithelium 
and superficial stroma since NaOH dissolves both lipid and protein structures. On 
the other hand, exposure was brief and the experiment was too short for collagenase 
release to occur. In the present work, we have confirmed that chemically or 
physically damaging the cornea provides two relatively reproducible methods of 
inducing experimental damage to the cornea, resulting in the loss o f the banier 
function o f the corneal epithelium, a situation which also appears to occur during 
HSV infections.
Differences between the expression of the data as concentrations or amounts of 
aciclovir
The data shown in figures 22 - 25 and 27 - 29 have been expressed as the 
concentration (pg.g ‘ of cornea or pg.m f' of AH) of aciclovir detected in the cornea 
and AH. When the data is expressed as an amount (pg) then the interpretation of the 
levels of corneal absorption may alter. This is highlighted in the figures 26a and b. 
Concentration in the cornea is influenced by the weight of the corneal button from 
which the level o f absorption is calculated. In the chemically damaged cornea, the 
tissue is swollen with water from the AH resulting in a dilution in the concentration 
o f drug contained in each sample. In the case of the 3% film there is no difference in 
the amounts o f aciclovir found between chemically and physically damaged cornea, 
whereas the difference in concentration between them is statistically significant. The
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same applies in another way to the difference between amounts and concentrations 
following 3% film application in corneas which are chemically damaged or 
undamaged. The difference in the amounts o f drug found between the two pre­
treatments is statistically significant, whereas no difference is found between the 
concentrations. On the other hand, changing the expression o f the data for the 3% 
ointment from concentrations to amounts did not change the relationship between 
pre-treatments.
It is clear that chemical damage to the cornea increases the weight of the sampled 
corneal buttons presumably due to an increased water content o f the stroma. When 
the data for all pre-treatments is expressed as concentrations, the swelling of the 
cornea after chemical damage results in a decrease in concentration of drug relative 
to the other treatments. The difference between two treatments may thus appear to 
alter according to whether the data are expressed as concentrations or amounts of 
drug.
The effect of aciclovir formulations on corneal absorption
This study shows that penneation o f aciclovir into the cornea and AH of the perfused 
bovine eye is greatly influenced by the formulation o f the applied drug. Topical 
application o f aqueous gel, PVA film and ointment formulations, each containing an 
equivalent 300 pg dose o f aciclovir, resulted in significantly greater drug 
concentration in corneal and aqueous samples with the aqueous gel than with the 
other formulations (Figure 27a and b). When the cornea was experimentally
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damaged the film fomiulation also showed significantly greater absorption in corneal 
samples compared to the ointment formulation. There was no detectable absorption 
in AH samples following application o f the ointment formulation. This is not 
surprising as the very small concentrations of aciclovir which are detected in corneal 
samples were approaching the limit of detection. Differences in the levels of 
absorption among the fonnulations were calculated in eyes which had undergone 
identical pre-treatments.
The variations in the levels o f absoiption found among the formulations could be 
explained by the physicochemical properties of the drug and the vehicles. Aciclovir 
is hydrophilic in nature, with an octanol; water partition coefficient of 0.06 ± 0.01 
(Hughes et al., 1993). Therefore the drug will dissolve most readily in an aqueous 
vehicle. Once dissolved in the vehicle the formulation can provide drug readily. If a 
drug is insoluble in the vehicle then only drug molecules in immediate contact with 
the tear film can dissolve and become available for absorption. It has been reported 
that drug solubility in the vehicle dictates the success o f a drug formulation in 
increasing bioavailability and prolonging drug release (Sieg & Robinson, 1977). In 
the bovine perfused eye, prolonging the presence o f the medicament is not an 
important consideration since in vivo factors, such as blinking, dilution in the tear 
film and drug loss via conjuctival absorption and nasolacrimal drainage, are not 
present. As each application of medicament contains an equivalent dose of aciclovir, 
initial concentration gradients between the formulation and the cornea will be 
similar. This leaves the ability o f the formulation to release aciclovir as the most 
important factor.
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The low level o f absorption in the cornea and undetectable level in the AH found 
when using a lipophilic ointment vehicle containing 1% aciclovir agrees with 
previous reports where low levels o f corneal absorption are found when formulations 
combine hydrophilic drugs with lipophilic vehicles (Sieg & Robinson, 1977).
The film formulation is a hydrophilic vehicle containing a high percentage of PVA, a 
soluble polymer which is commonly used in eyedrops to increase the viscosity of the 
solution, resulting in an increased contact time in the precorneal area. However, as 
mentioned above, increasing the contact time does not affect dmg absorption in the 
bovine perfused eye. The increased corneal and AH absorption when compared with 
the 1% ointment fomiulation is likely to be due to the hydrophilic nature o f the drug 
and PVA film formulation. When the levels o f absorption from the 3% film and 3% 
ointment were compared, there was no significant difference between corneal 
samples following any o f the pre-treatments. However, the concentration of drug in 
AH samples was significantly greater for chemically and physically damaged 
corneas. Although for the 3% film and 3% ointment there were no significant 
differences between the drug concentrations in corneal samples, the overall trend 
agrees with that observed for the 1% film and 1% ointment as the total amount of 
drug absorbed into the cornea and AH is greater for the 3% film (Table 18). When 
the total amount of drug recovered from the cornea and AH is calculated and 
expressed as a percentage of the applied dose (570 pg), the amount of drug detected 
is significantly greater following application o f the 3% film to both the physically (p 
= 0.029*) and chemically (p < 0.001***) damaged cornea. It is also possible that
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other factors may influence the level of absorption from the film formulation. 
Saettone et al (1982) have shown that from a group o f equiviscous polymeric 
vehicles, PVA significantly increased the transcorneal penetration of pilocarpine, 
indicating that non-viscous factors such as a direct effect on corneal permeability 
may be responsible for the increase in penetration.
AThe proprietary aqueous gel formulation was a new formulation developed to 
combine the adhesive properties o f carbomer and hydroxyethyl cellulose polymers in 
a preservative-free gel which will be more acceptable and better-tolerated in the eye 
(Rao, personal communication). This formulation demonstrated the highest 
absorption in the cornea and AH. Since this is a new formulation, no reference in the 
literature was available for direct comparison with our results. The enhanced 
absorption compared with the ointment is likely due to the hydrophilic compatibility 
between the drug and vehicle. However, it is not clear why this vehicle shows 
enhanced absorption compared with the PVA film as both vehicles are hydrophilic. 
It is possible that absorption o f aciclovir from the PVA film formulation is delayed 
by the time taken to re-hydrate the film and render the drug diffusible in solution. 
The development of two soluble gel formulations for the delivery o f pilocarpine has 
been reported (Goldberg et al., 1979; Mande!! et al., 1979; March et al., 1982), 
although to date neither drug release mechanisms nor kinetics have been reported. 
What has been shown is that these gel formulations enhance pilocarpine activity, 
indicating greater transcorneal penetration, compared to a pilocarpine aqueous 
solution containing equal drug concentration.
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Comparison between the concentration of aciclovir detected in the cornea and AH 
following application of the 1% gel or the 3% ointment highlights the ability o f the 
aqueous gel fonnulation to enhance absorption of aciclovir. Application of 30 pi of 
the 1% gel (unit dose applicator) delivers a 300 pg dose of aciclovir whereas 
application of 21 pi o f the 3% ointment delivers a 570 pg dose to the cornea. 
Despite applying almost double the dose, no significant differences in corneal 
absorption were found with the 3% ointment compared to the 1% gel in corneas 
which were undamaged, chemically or physically damaged. In contrast, vastly 
greater concentrations of aciclovir were found in the AH with 1% gel when the 
cornea was chemically or physically damaged. Therefore the total amount o f dmg 
detected in corneal and aqueous samples was found to be far greater following 
application of the 1% gel to eyes with damaged corneas. This suggests that if 
experimental damage is a reasonably good mimic of HSV-indiiced damage, then the 
gel formulation offers a major step forward in enhancing corneal absorption of 
aciclovir.
The absorption of aciclovir from the gel formulation may be enhanced by the larger 
applied volume and hydrophilic properties of the formulation, which will cover the 
14 mm diameter area o f the cornea relatively uniformly, providing a large surface 
area. Absorption from the ointment formulation may well be hampered as due to the 
semi-solid properties o f the ointment at room temperature (18 - 24°C), achieving a 
layer o f ointment o f uniform thickness over the 14 mm diameter area of cornea is 
difficult. In vivo, this problem is avoided as blinking spreads instilled solutions or
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ointment across the cornea, increasing the surface area of corneal contact (Sieg & 
Robinson, 1979).
Intraocular penetration of aciclovir in the human and bovine eye
Very little data has been published on penetration o f aciclovir in human eyes. 
Following repeated topical applications o f ophthalmic Zovirax ointment to 
uninfected human eyes prior to cataract surgery, aciclovir accumulated in the 
aqueous at a concentration o f 1.69 ± 1.13 pg/ml (Poirier et al., 1982). Since in the 
present study the limit o f detection for aciclovir in the AH was 2 pg/ml, such a level 
could not have been measured, we cannot directly compare bovine and human 
corneal permeability to this drug.
Despite this lack o f comparison, from the differences in the anatomy o f the bovine 
and human cornea (table 1), one would expect intraocular drug penetration to occur 
more readily across the human cornea.
Not surprisingly the level o f absorption in the human eye following topical 
application exceeds that following oral administration (Hung et al., 1984). It is this 
difference will be much greater between corneal contents following the two different 
routes of drug administration.
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Total drug recovery
Comparisons among the total amounts o f drug recovered from the cornea and AH 
following application o f each formulation shows that in the bovine perfused eye 
model the ointment formulation is not the best vehicle for delivering aciclovir 
following damage to the eye (Table 18). When the epithelial barrier has been 
removed, hydrophilic vehicles, such as the PVA film and aqueous gel, appear to 
greatly enhance the total absorption of this hydrophilic drug. Clinically, this may be 
of great relevance as the 3% ointment is currently the standard ocular formulation 
used for delivery o f aciclovir to the HSV infected cornea. The use of PVA film or 
aqueous gel formulations for delivery of hydrophilic drugs offers promising drug 
delivery systems for ocular administration and the results obtained in this study 
should be confinned with an in vivo study. When these formulations are applied in 
vivo the additional factors of drug dilution in the tear film, blinking, conjunctival 
drug absorption and drainage via the nasolacrimal duct will influence the level of 
corneal drug absorption. All the values shown in table 18 are greatly in excess of 
values you would expect to find in vivo as following application the medicament lies 
undisturbed on the surface o f the cornea. In vivo, less than 5% of most topically 
applied drugs are absorbed (Jarvinen et al., 1995). When this is coupled with the 
additional factor o f enhanced in vivo drug release from ointments due to the shearing 
action o f blinking (Sieg & Robinson, 1979), then the differences in absorption in 
viva among the formulations may not be so pronounced.
175
Discussion: Absorption o f  A ciclovir....
Despite a concentration dependent increase in the drug concentration in the cornea 
and AH following application of increasing concentrations o f aciclovir film 
formulations (see figure 23) this relationship is non-linear. As the aciclovir 
concentration of the film increases the percentage of drug recovered from the cornea 
and AH generally decreases (see table 18). Therefore a situation of diminishing 
return arises, where the increases in absorption are not proportional to increases in 
the applied concentration o f the drug, indicating a decrease in the efficiency of drug 
delivery.
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Conclusion HP
The bovine perfused eye provides a useful model for the investigation o f drug 
absorption in vitro. Following topical application of different drug formulations the 
level o f drug penetration in the cornea and AH can be measured without the 
complications associated with in vivo studies. This model is perhaps superior to the 
isolated corneal preparation normally used to assess corneal drug absorption, as 
experimental conditions are more physiological, avoiding edge-damage which is 
likely to occur following excision and clamping o f the isolated corneal preparation. 
The use o f the bovine eye again has the advantage that the eyes can be obtained from 
the local abattoir without the necessity o f killing animals for experimental puiposes.
This study confirms that experimentally damaging the cornea, effectively removing 
the barrier properties o f the corneal epithelium, increases the concentration of 
aciclovir in the cornea and AH compared with the undamaged cornea. Physically 
removing the layers o f the epithelium or exposing the cornea to alkali soaked discs of 
filter paper provides two relatively reproducible methods of inducing experimental 
damage to the cornea o f the bovine perfused eye.
From the present work, the formulations can be ranked in order o f corneal and AH 
absorption of aciclovir.
Ointment < PVA Film < Aqueous Gel
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The ointment formulation, used as a standard ocular vehicle for aciclovir, does not 
appear to be the best vehicle for transcorneal absorption o f this drug. PVA film and 
aqueous gel formulations seem to present promising drug delivery systems for ocular 
administration o f hydrophilic drugs, such as aciclovir. The fact that this is 
particularly true after experimental damage to the cornea, makes such a formulation 
especially appropriate in the treatment o f established HSV infection.
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The effects o f cholinergic agonists or prostaglandins on lOP in a variety o f species 
have been well documented in the literature. It is believed that these classes of drugs 
act to increase the drainage o f AH by altering ciliary muscle tone. The lack of any 
lOP-lowering effects in this model may be a result o f the poorly developed ciliary 
muscle in the bovine eye (Prince et al., 1960). This could be determined by 
investigating the constrictor effect of pilocarpine on isolated strips o f ciliary muscle, 
or the relaxation effect of the prostaglandins, PGF.a and PGE^, on tissue pre­
contracted with carbachol.
From the experimental data on lOP, the effect of pilocarpine was shown to alter 
following the inclusion o f BSA in the perfusate, suggesting that BSA may play a role 
in preventing drug-induced damage to the BAB. The inclusion in the perfusate of an 
alternative marker of BAB integrity, such as fluorescein, a molecule which does not 
cross the BAB under normal circumstances, could determine whether pilocaipine 
disrupts the integrity of the BAB. If the permeability of the barrier increased in 
response to pilocarpine then fluorescein would be detected in the chamber. Such 
experiments could also provide information on the effect o f the presence o f BSA in 
the perfusate.
There is very little evidence in the literature to suggest that pilocarpine increases the 
rate of AH formation. However, measurement of any change in AH formation rate 
(Wilson et al., 1993) in response to pilocarpine would help determine the mechanism
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behind the lOP response to pilocarpine in the bovine perfused eye, as would 
determination of facility of outflow using the isolated anterior segment model 
(Erickson-Lamy et al., 1991; Wiederholt et al., 1995).
The initial lOP response to apraclonidine is shown to be altered depending on the 
route of drug administration. Inclusion o f BSA in the perfusate and subsequent 
measurement o f AH protein content indicates that apraclonidine does not affect the 
permeability o f the BAB. Intra-arterial injection o f fluoroscein might confirm that 
no change in bainier permeability occurs in response to apraclonidine. Investigation 
into the effect o f apraclonidine on AH formation might help determine the 
mechanism behind the changes in lOP in response to high doses o f apraclonidine.
The results show that following intra-arterial injection o f apraclonidine, an increase 
in vascular perfusion pressure occur concurrently with an increase in lOP. Evidence 
in the literature suggests that vasoconstriction occurring in the aqueous and episcleral 
veins results in an increased resistance to outflow and increase in lOP. Direct 
measurement of episcleral venous pressure and AH outflow facility following intra- 
arterial injection o f apraclonidine in the bovine perfused eye would determine the 
role of these mechanisms in the lOP and perfusion pressure responses.
Monitoring the lOP response to intra-arterial injection of apraclonidine, in the 
pi'esence of selective a ,-  and a^-adrenoceptor antagonists might confirm which 
receptor(s) is involved in the lOP response.
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In general, the results o f experiments which investigated the effects of drugs on the 
BAB show that sampling AH at the end of each experiment for analysis o f protein 
content does not provide a consistent assessment of the integrity of the BAB. 
Instead, measurement of drug-induced changes in aqueous flare in the anterior 
chamber might provide a more effective method o f detemiining permeability 
changes, whilst also providing infonnation on the time course o f barrier-breakdown 
responses.
A logical extension o f the aciclovir absorption work would be to investigate the 
kinetics of absorption of the various fonnulations, following the different corneal 
pre-treatments.
Detailed morphological examination o f the two types o f experimental corneal 
damage would provide an opportunity to assess the relationship between corneas 
damaged experimentally in vitro and those which have been infected with HSV.
We have confinned, by pre-treating the cornea with NaOH, that the weight of 
excised corneal buttons increases significantly compared to those which are 
undamaged or physically damaged. Future work involving the assessment of H ,0  
content in the excised corneal samples would probably confirm that the increase in 
weight associated with NaOH damage was due to swelling o f the cornea with FfO 
from the AH.
181 i
Future work
For the further development of an alternative formulation of aciclovir, for ophthalmic 
use, the level o f drug absorption in the cornea and AH should be assessed in vivo.
perhaps in the rabbit eye.
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